Louisiana Tech University

Louisiana Tech Digital Commons
Doctoral Dissertations

Graduate School

Fall 2006

Fluorescent enzymatic smart tattoos comprising
hybrid silicate microparticles, metalloporphyrin
complexes, and mass transport-limiting nanofilms
Erich Wayne Stein
Louisiana Tech University

Follow this and additional works at: https://digitalcommons.latech.edu/dissertations
Part of the Biomedical Engineering and Bioengineering Commons
Recommended Citation
Stein, Erich Wayne, "" (2006). Dissertation. 544.
https://digitalcommons.latech.edu/dissertations/544

This Dissertation is brought to you for free and open access by the Graduate School at Louisiana Tech Digital Commons. It has been accepted for
inclusion in Doctoral Dissertations by an authorized administrator of Louisiana Tech Digital Commons. For more information, please contact
digitalcommons@latech.edu.

FLUORESCENT ENZYMATIC SMART TATTOOS COMPRISING HYBRID
SILICATE MICROPARTICLES, METALLOPORPHYRIN COMPLEXES, AND
MASS TRANSPORT-LIMITING NANOFILMS
by
Erich Wayne Stein, B.S. Biomedical Engineering

A Dissertation Presented in Partial Fulfillment
of the Requirements for the Degree
Doctor of Philosophy

COLLEGE OF ENGINEERING AND SCIENCE
LOUISIANA TECH UNIVERSITY

November 2006

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

UMI Number: 3261295

INFORMATION TO USERS

The quality of this reproduction is dependent upon the quality of the copy
submitted. Broken or indistinct print, colored or poor quality illustrations and
photographs, print bleed-through, substandard margins, and improper
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, if unauthorized
copyright material had to be removed, a note will indicate the deletion.

®

UMI
UMI Microform 3261295
Copyright 2007 by ProQuest Information and Learning Company.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.

ProQuest Information and Learning Company
300 North Zeeb Road
P.O. Box 1346
Ann Arbor, Ml 48106-1346

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LOUISIANA TECH UNIVERSITY
THE GRADUATE SCHOOL

August 28, 2006________________
Date

We

hereby

recommend

that

the

dissertation

prepared

under

our

supervision

bv Frir.h W Stftin_____________________________________________________________________

Fluorescent Enzymatic Smart Tattoos Comprising Hybrid Silicate Microparticles._____

entitled

_____________ Metalloporphvrin Complexes, and Mass Transport Limiting Nanofilms__________

be

accepted

in

partial

fulfillment

of

the

requirements

for

the

Degree

of

Doctor of Philosophy in Biomedical Engineering________

upervisor of Dissertation Research
Head of Department

Biomedical Engineering
Department
Recommendation concurred in:

Advisory Committee

o

X '

Approved:

Director of Graduate Studies

Dean of the College

Dean of the Graduate School

(j

GS Form 13
(5/03)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ABSTRACT

Diabetics are often required to self-monitor blood glucose levels to effectively
deliver prescribed therapies. However, the pain and bother associated with traditional
finger-prick measurements often result in decreased patient compliance and therefore
poor disease management, which could result in the early-onset o f complications.
Enzymatic “smart tattoos” - implantable luminescent particles that may be transdermally
interrogated with light - are being pursued as minimally-invasive diabetic monitoring
devices, with hopes of increasing diabetic compliance by reducing excessive pain and
bother associated with finger-prick measurements. These devices typically comprise an
oxygen-quenched luminescent dye and glucose oxidase (GOx), an enzyme that catalyzes
the oxidation o f (3-D-glucose. Under glucose-limited reaction conditions, local glucose
concentrations

can

be

extracted

from

oxygen-dependent

emission

spectra

or

luminescence lifetimes.
Previously, enzymatic smart tattoos comprising enzyme-doped alginate hydrogel
microsphere sensors and ruthenium complexes as oxygen indicators were reported. In
this dissertation, however, the integration of a more sensitive metalloporphyrin oxygen
indicator, Pt(II) Octaethylporphine (PtOEP), and the reference probe, Rhodamine B
Isothiocyanate (RITC), into enzyme-doped alginate-modified silica (“algilica”) particles
is presented. A particularly important feature of these sensors is the shift from traditional
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ruthenium-based oxygen indicators to metalloporphyrin complexes, due in part to higher
excitation wavelengths which reduce the effects of tissue scatter and absorption,
increased photostability, and higher oxygen sensitivity. Using the novel algilica matrix
and diffusion-limiting nanofilms, glucose sensitivities of two orders of magnitude greater
than ruthenium-based enzymatic smart tattoos were achieved with porphyrin oxygen
indicators.

O f central importance was the demonstration that surface adsorbed

polyelectrolyte nanofilms allowed glucose sensitivity and range to be controlled by
modulating substrate flux into the sensor, resulting in sensitivities (change in intensity
ratio) of 1 - 5 %/mg dL' 1 and upper range limits of 90 - 250 mg/dL. Remarkably, it was
shown that nano films only 12 nanometers thick could significantly affect response
behavior, confirming theoretical predictions based on models of reaction-diffusion
kinetics.
To approach clinical utility, implantable smart tattoos must maintain appropriate
function for at least 6 months. Therefore, to examine the effects of long-term operation
on sensor function, a mathematical model was developed and the output validated with
experimental results.

Both theoretical and experimental results demonstrated limited

device lifetime (~ 90 % loss of sensitivity over 24 hours) due to enzyme inactivation
resulting from hydrogen peroxide, a byproduct of glucose oxidation. To improve long
term stability, a first-generation bi-enzymatic smart tattoo prototype was constructed via
the co-incorporation of catalase, an enzyme that consumes hydrogen peroxide, which
enhanced response stability two fold over time. Furthermore, to design clinically viable
implantation schemes, it is important to understand how individual sensors within a
population contribute to overall response properties. Thus, an imaging technique was
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developed to perform real-time ratiometric imaging of individual sensor function. The
results indicated significant differences in sensor behavior depending on location within
the sensor population and/or physical parameters, as expected.

These findings

demonstrate the feasibility of engineering highly sensitive enzymatic-based glucose
sensors and lay the groundwork for developments of additional enzymatic analyte
sensors.
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CHAPTER 1

INTRODUCTION
In the United States alone, it is estimated that 20.8 million or 7% of residents are
afflicted with diabetes mellitus, a group of diseases characterized by hyperglycemia
(blood glucose levels greater than 180 mg/dL) elicited from defects associated with
insulin secretion, insulin action, or both.1 Depending on the underlying cause of
hyperglycemia, patients are diagnosed as either Type 1 or Type 2 diabetics.
Type 1 diabetes results from the progressive destruction of pancreatic beta cells the cells responsible for producing insulin, the hormone responsible for regulating blood
glucose levels. Beta cell destruction eventually results in absolute insulin deficiency,
thus eliminating the body’s natural ability to counteract elevations in glucose levels.2
Approximately 5% o f Type 1 diabetes results from idiopathic origins, conditions in
which there is no known etiology for beta cell destruction.2, 3 However, the most
common form o f Type 1 diabetes arises from autoimmune-mediated destruction of
pancreatic beta cells. Since the peak incidence o f Type 1 diabetes occurs in childhood
and adolescence, it is commonly referred to as “juvenile-onset diabetes”, and accounts for
5% to 10% o f all diagnosed cases.1 As with both classifications of Type 1 diabetes,
afflicted individuals eventually become completely dependent on supplemental insulin
for survival as the disease progresses.

1
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The most commonly diagnosed type of diabetes mellitus is Type 2 diabetes,
accounting for 90% to 95% of all cases.1 Two common classifications of Type 2
diabetics exists: patients who have predominant insulin resistance with relative insulin
secretion deficiency, and those with predominant insulin secretion deficiency with or
without insulin resistance.2 Although the exact cause of Type 2 diabetes is unclear, it is
well documented that certain factors such as race, age, diet, physical activity, and family
history play an important role in disease onset.4,5 Since the onset of Type 2 diabetes is
commonly observed in adults, this classification is commonly referred to as “adult-onset
diabetes”; however, an escalation in adolescent and childhood obesity has resulted in an
increased frequency o f Type 2 diabetes diagnoses in younger age groups.6 Commonly,
Type 2 diabetics can control their blood glucose levels by following a healthy lifestyle
(e.g. healthy diet and exercise regime) and taking prescription medications; however, in
♦

•

•

some instances, supplemental insulin may be required.

7

In both variants of diabetes, a clinical trial proved that proper care and
management o f blood glucose levels is critical in preventing or delaying the progression
of complications, which include cardiovascular disease, stroke, hypertension, retinopathy,
nephropathy, neuropathy, periodontitis, gingivitis, cataract formation, and pregnancy
complications.2,8 Through proper management of diabetes, it is estimated that the patient
will experience an additional 5 years o f life, 8 years of sight, 6 years free of kidney
disease, and 6 years free from amputations.9 In 2002, it was estimated that diabetes costs
in the United States alone totaled $132 billion - $92 billion attributed to direct medical
costs and $40 billion attributed to indirect costs such as disability, work loss, and
premature mortality - the majority due to complications.10

Therefore, to reduce
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complications, diabetics must effectively manage blood glucose levels using one or more
o f the following therapies: changing high-risk lifestyle habits, consuming prescription
medications, and administering supplemental insulin.

n

.

However, to effectively manage

therapy dosages, particularly supplemental insulin, patients must frequently and
accurately assess blood glucose levels.
Currently, the gold-standard method for self-monitoring blood glucose levels is
the “finger-prick” test, which involves lancing the skin and extracting a blood sample that
is subsequently placed in a portable device to extract glucose levels.

This method,

although proven highly accurate, is both painful and bothersome for the patient,
especially if the recommended testing frequency - at least 3 times per day - is practiced.7
However, according to several studies, only 40% of diabetics requiring insulin therapy
and 5% o f diabetics requiring prescription medications monitor their blood glucose levels
at least once per day, citing excessive pain and inconvenience as the principle reason for
lack of compliance.

11 13

'

Therefore, it is reasonable to conclude that the development of a

simple and painless method would increase patient observation of the recommended self
monitoring guidelines, which in turn would reduce overall complications.

The

development o f a minimally or non-invasive technique which can provide continuous and
spot measurements has long been considered one of the “holy grails” of diabetes
research.14 This dissertation is concerned with the development of a minimally-invasive
device which could potentially be used to provide diabetics a means to painlessly monitor
glucose levels while observing the recommended measurement frequency.
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1.1

Current and Future Trends in Continuous
Glucose Monitoring Technoloev

Traditional spot measurements using the standard finger-prick technique involve
lancing the skin and collecting a small volume of blood for ex vivo analysis in a portable
hand-held device that indirectly determines glucose levels through electrochemical or
photometric analysis.15 The blood is drawn into a test strip that contains the redox
enzyme glucose oxidase (GOx), which catalyzes the oxidation of glucose into hydrogen
peroxide and gluconic acid as indicated in the following reaction:
glucose + 0 2 ——x >gluconic acid + H 20 2
In electrochemical based systems, the redox current produced from glucose
oxidation is measured by an electrode. Since the redox current is directly proportional to
the concentration of glucose present, the measured current is easily converted into actual
blood glucose levels and displayed on the device. In photometric monitoring systems,
the oxidation of glucose is monitored through a colorimetric assay, whose proportional
change in color intensity is used to determine glucose levels.

Although the sensing

schemes have been insignificantly changed throughout the last decade, current trends in
measurement device technology center on minimizing the volume of blood needed to
perform a measurement, allowing alternative site testing (forearm, thigh, and abdomen
instead o f the fingertip) and easing data interpretation with built-in databases and trend
trackers.16
Minimally- or non-invasive monitoring techniques that completely replace fingerpricking are not yet commercially available; however, several manufacturers have
introduced continuous monitoring systems which reduce lancing frequency.17 Though
these devices determine glucose levels via electrochemical or photometric analysis, they
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employ minimally-invasive means to continuously extract interstitial glucose without
frequent lancing. One class of these devices uses the principle of reverse iontophoresis,
which drives the transdermal transport of uncharged molecules such as glucose from the
interstitium into a wrist-worn monitoring system through the application of a small
current.18 Another class o f continuous glucose monitoring systems involves the
subcutaneous implantation o f an electrochemical electrode into the abdomen. A redox
current is continuously obtained from the electrode and sent to an external read-out
device in which the glucose levels are continuously displayed. An additional class of
minimally-invasive monitoring devices uses the principle of microdialysis to transport
interstitial glucose to an external device. In this device, a microscale semipermeable
membrane-bound container is implanted into the subcutaneous tissue. Over time, glucose
diffuses from the interstitium into the membrane and is continuously transported by a
fluidic current to an external device, where the glucose levels are electrochemically
determined.

Although these devices do indeed minimize lancing and provide useful

information on metabolic trends, frequent calibrations rely on finger pricking to ensure
continued accuracy; therefore, these devices are not intended to completely supplement
traditional spot measurements. Additionally, all of the devices discussed above require a
direct transdermal connection to the implant, thus providing a potential infection pathway
as well as dermal irritation and constant replacement of the sensing element. Therefore,
the current status o f commercially available minimally-invasive technology leaves much
to be desired.
On the other hand, optical monitoring techniques, including fluorescence,19
absorbance,20 raman,21 and polarization spectroscopy22 have been heavily researched as a
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minimally-invasive means to measure glucose levels, but the high sensitivity and
selectivity associated with fluorescence-sensing techniques have led to increased interest
by many groups.19 A particularly interesting technique which has the potential to provide
both spot and continuous measurements of glucose levels are “smart tattoo” type sensors,
which consist o f micron-scale glucose-sensitive luminescent particles that could be
9-5

implanted into the dermis and transdermally interrogated with light. '

'jf :

Most of the

work in this field has primarily focused on the development of competitive binding-based
assays, which rely on changes in fluorescence emission properties modulated by
fluorescence resonance energy transfer (FRET) to optically transduce glucose levels.27'31
FRET is driven through the competitive binding of a fluorescent ligand and analyte to
receptor sites on lectins, glucose-binding proteins, or deactivated glucose-specific
enzymes, such that the ligand is displaced from the receptor when in the presence of the
analyte causing measurable changes in emission spectra.32,33 However, recent successes
with enzymatic-based smart tattoo sensors have also been reported, and this work has
aimed to further extend smart tattoo variants for use in diabetic monitoring.26
Enzymatic-based smart tattoo sensors are typically comprised of an oxygenquenched luminescent dye and GOx entrapped within a microscale container. As glucose
diffuses into the sensor, local oxygen levels are proportionally reduced through GOxinitiated catalysis. The glucose-dependent oxygen levels are then relayed through the
fluorescence emission o f the oxygen reporter, providing an indirect means to monitor
glucose levels.34 Although the integration of GOx into the sensing scheme provides
innate selectivity to the sensor as well as reversibility, controlling the reaction-diffiision
kinetics o f both glucose and oxygen are key to the realization of optimized sensors.35
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Initial work in this field was done using optical fibers with sensor components
immobilized in transport limiting matrices.36'38 While these devices exhibit desirable
sensor properties, in practice they would require a permanent connection to external
measurement devices, providing a potential infection pathway. Additional work showed
that sensor components immobilized within nano-scale polyacrylamide particles
reversibly responded to physiological glucose levels.39 Brown et al. advanced the
concept using calcium alginate hydrogel microspheres, which contained GOx, an oxygenquenched ruthenium compound, and diffusion-limiting nanofilms adsorbed to the surface
using layer-by-layer self-assembly.26’ 40, 41 By altering the physical properties of the
nanofilms, the analyte transport properties into the microsphere could be altered,
resulting in control o f overall response characteristics, such as sensitivity and linear
range.41 Although the results reported to date are promising, the majority of work has
focused on using phosphorescent ruthenium complexes as the reporter molecules, which
have a lower sensitivity than other oxygen probes, such as phosphorescent
metalloporphyrins.37,42,43,44
Since the overall response properties of enzymatic smart tattoo sensors depend
upon the oxygen probe, it is hypothesized that the integration of a more sensitive Pt(II)
porphyrin dye should result in an overall increase in sensitivity to glucose.

To our

knowledge there has only been one report utilizing Pt(II) porphyrins in enzymatic glucose
sensors.37

The lack of work with porphyrin indicators could be due to extreme

hydrophobicity, causing difficulties in aqueous applications.43

To overcome this

difficulty, researchers have since developed immobilization matrices comprised of
silicon, organic glassy, cellulose derivative, or fluoro-polymers, to which Pt(II)
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porphyrins can be adsorbed, thereby allowing dissolved oxygen measurements in
aqueous environments.44, 45 It is well documented that the immobilization matrix can
drastically affect the oxygen sensitivity and that silica-containing matrices produce high
sensitivities, although the exact mechanisms are still debated 42,46 We recently developed
a simple method to self-assemble mesoporous silicate particles comprised of
homogeneously distributed hydrophilic and hydrophobic domains using a model
hydrophilic polymer, sodium alginate.

These particles have been developed as an

immobilization matrix for enzymatic smart tattoo sensor components and will be used
exclusively in this work. Therefore, the central hypotheses o f this work are that the co
immobilization o f GOx and metalloporphyrin complexes into a silicate matrix would
produce highly sensitive enzymatic smart tattoos, and the adsorption o f polyelectrolyte
nanofilm to the surface would allow sensor behavior to be controlled by modulating
substrate flu x into the catalytic region o f the sensor.

1.2

Objectives and Novel Aspects

This work represents an advancement of the technology required in the
development of improved enzymatic-based smart tattoo sensors. In this dissertation, the
design o f enzymatic smart tattoos based on highly sensitive metalloporphyrin (PtOEP)
oxygen indicators and novel silicate microstructures is presented. A simple method to
self-assemble mesoporous silicate particles comprised of homogeneously distributed
hydrophilic and hydrophobic domains, so-called hybrid structures, was developed for use
as an immobilization matrix for GOx and PtOEP. Fluorescent nanofilms were adsorbed
to the surface to provide an oxygen insensitive reference signal as well as to control
analyte diffusion, allowing modulation o f sensor response properties. The development
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o f this technology was pursued due in part to recent successes reported with a similar
system utilizing less sensitive oxygen indicators and a hydrophilic matrix,

96

as well as

the interesting and complex engineering required to produce a working prototype. This
approach was also selected partly because of the innate selectivity and reversibility
associated with an active enzymatic assay, avoiding early problems associated with
affinity-binding FRET assays.

Additionally, a straightforward approach to directly

immobilizing enzymes to the sensor substrate can be utilized, whereas in affinity-binding
assays, the assay components must be allowed to move relative to each other, thus
complicating immobilization/encapsulation.
Therefore, the major objectives of this work include the development of
immobilization strategies for PtOEP within algilica microspheres, characterization of
oxygen sensitivity, development of co-immobilization strategies for PtOEP and GOx
within algilica microspheres, characterization of glucose sensitive response properties,
use of polyelectrolyte nanofilms to tailor glucose response properties, development of a
mathematical model to simulate continuous sensor operation, the assessment of long-term
sensor function, and development of an imaging technique to allow real-time imaging of
sensor function.
For all the work described herein, Dr. Huiguang Zhu developed the initial
protocol used to prepare the algilica microparticles and in conjunction with the author,
assisted in modifying protocols to achieve the desired particle characteristics.
Additionally, a substantial contribution was made by Dr. Patrick S. Grant in the
development of custom software to efficiently control the testing apparatus used to
perform dynamic glucose sensitivity experiments. Also, Mr. Dustin Ritter is credited for
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microchannel fabrication used to conduct real-time ratiometric imaging of sensor
function.
The novel contributions of this work to the field of engineering and science
includes the co-development of the novel immobilization matrix used in this dissertation
- algilica, whose unique properties readily allow immobilization of by hydrophilic and
hydrophobic species. Additionally, this work demonstrates the ability to engineer device
sensitivity and analytical range by simply adjusting the thickness of surface-adsorbed
nanofilm coatings to modulate substrate transport.

As a key concept, these results

demonstrate the utility of polyelectrolyte nanofilms to control molecular transport
properties, a concept which could be broadly applicable to situations requiring the precise
regulation of transport, such as filtration systems.

Also, the development of a

mathematical model to simulate the effect of continuous operation on sensor lifetime was
presented, the results o f which could be applied to other catalytic systems by simply
adjusting boundary conditions, geometries, and reaction kinetics. A technique was also
developed to allow real-time observation of sensor operation using microfluidics and
real-time ratiometric imaging, a tool which could prove to be useful for universal imaging
applications.
It should be noted that the implications of this work extend well beyond that of
glucose monitoring technology by laying the foundation for the development of
additional highly sensitive biochemical monitors, which may be obtained by simply
integrating other enzyme species specific to the target analyte. It is hoped that these
devices may be integrated into minimally-invasive diabetic monitoring systems, allowing
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diabetics to perform continuous and spot measurements of blood glucose levels without
the pain and bother associated with “finger pricking.”

1.3

Organization of Chapters

The chapters o f this dissertation have been organized such that the disseminated
material is presented in a clear and organized manner. Furthermore, several chapters are,
of themselves, manuscripts that will be submitted for publication or are already in print.
Chapter 2 gives an in-depth survey of currently available minimally-invasive monitoring
devices as well as state-of-the art technologies still under development, with particular
emphasis on optical-based sensing techniques, luminescent oxygen indicators, and mass
transport limiting materials. Chapter 3 characterizes the performance of algilica-based
metalloporphyrin oxygen sensors.

Chapter 4 describes the development and

characterization o f glucose sensor prototypes.

In Chapter 5, a mathematical model

describing sensor deactivation kinetics is presented and the results subsequently
compared with those experimentally obtained.

Additionally, an alternative sensing

scheme that could potentially increase sensor lifespan is presented. Chapter 6 describes
the design and fabrication of a microfluidic flow cell to be used in the real-time
ratiometric imaging o f sensor function under dynamic conditions. Chapter 7 concludes
the work presented in this dissertation and discusses the implications of this work in the
context of the current state of the art, as well as detailing future work.
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CHAPTER 2

BACKGROUND AND THEORY

In the work presented here, micro-scale glucose sensors are being pursued as a
minimally-invasive diabetic monitoring technology. These devices function by optically
reporting oxygen levels within the sensor as an indirect means to detect glucose levels.
Ultimately, these devices are envisioned to be implanted into the dermis of diabetics,
where transdermal optical interrogation/collection would allow painless acquisition of
glucose levels, the so-called “smart tattoo.” Given that these devices rely on knowledge
of several major fields - namely optics, material science, and enzymatics - it is important
to understand previous research contributions in the context o f this work.
Therefore, in this chapter, a review of the operating principles of commercially
available minimally-invasive glucose monitors is presented. More important, a review of
current state-of-the-art optical monitoring technologies under development is given, with
particular emphasis on enzyme-based fluorescence-sensing techniques.

Also, the

fundamentals o f skin optics are presented, along with a detailed discussion on previously
used diffusion-limiting materials and luminescent oxygen indicators.

12
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2.1

Commercially Available Continuous
Glucose Monitoring Systems

In this section, the literature on commercially available continuous glucose
monitoring systems is reviewed and classified according to operating principle. This
survey will consider only continuous monitoring systems classified by the FDA as
minimally-invasive, which includes devices that breach the skin barrier but do not disrupt
underlying vasculature.
2.1.1

Reverse Iontophoretic
Sampling
To date, the only continuous monitoring system employing reverse iontophoretic

sampling is the GlucoWatch® Biographer, a device worn on the arm or forearm of a
patient and similar in appearance to a wrist watch. On the underside o f the device lies an
anode and cathode which upon application of a constant current source drives the
convective transdermal transport of uncharged, polar species into the device.18 More
specifically, the applied potential causes the migration of positive counterions, namely
Na+, from the interstitium to the cathode. Cationic migration ultimately results in the
convective flow (termed “electro-osmotic flow”) of uncharged species such as glucose
between the anode and cathode, such that the transdermal glucose flux is proportional to
that in the interstitium (Figure I).47"49
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Constant current
soiree

Convective flow

Figure 1. Transdermal extraction of glucose using reverse iontophoresis.
Counterion ion transport induces convective flow of glucose into
the cathode sampling chamber. Taken from Sieg et al.47

In this device, reverse iontophoresis is merely the sampling technique used to
extract the interstitial fluid; therefore, a sensor is required to analyze glucose levels.
Glucose levels are determined in the cathode sampling chamber, which houses a
replaceable sensor.

A glucose oxidase-coated platinum electrode comprises the

replaceable sensor, whereby the redox current resulting from glucose catalysis is used to
determine interstitial glucose levels.48 It is noteworthy to state that the concentration of
glucose extracted is in the pM range, approximately 3 orders of magnitude less than those
observed in the interstitium; therefore, a highly sensitive detection assay is required and
is supplied by the electrochemical sensor described above.50
The latest version of the GlucoWatch® Biographer, the G2, allows up to 13 hours
of continuous monitoring, during which continuous measurements are displayed every 10
min - 3 min to extract the fluid and 7 min to determine glucose concentration. To ensure
accuracy, it is recommended that the sensor be replaced every 13 hours and the device be
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recalibrated with standard fmger-prick measurements. Following sensor replacement, the
device requires a 2 hour “warm up” period, during which residual glucose from the
epidermis is removed.51
Several problems traditionally associated with electrochemical sensors are
avoided in this device. Since glucose and oxygen are both required for glucose oxidation
to proceed, the reaction must operate in a glucose-limited regime to obtain a signal
directly proportional to glucose concentration. In this device, the sensor is exposed to
atmospheric oxygen levels relatively greater than those of the interstitial fluid, allowing
glucose-limited operation. Additionally, electrode fouling is greatly reduced since high
molecular weight species, such as protein and other macromolecules, are prevented from
contacting the sensing membrane by dermal filtering.

Also, other electrochemically

active components extracted are collected in the anode, thus preventing interference with
glucose measurement, which occurs at the cathode.47,50
Although this device has been shown to be fairly accurate (the mean error relative
to standard measurements was determined to be 7%) and its technology indeed
impressive, the diabetic community has not fully accepted it for the following reasons:
(1) an extensive amount o f data is generated, which could intimidate users; (2) frequent
sensor replacements and blood-draw calibrations are necessary to achieve true continuous
monitoring; (3) mild skin irritation can result from the applied current necessary to
extract interstitial fluid; (4) excessive perspiration prevents operation; and (5) the expense
o f the device has severely limited its adoption to a select few.

All these pitfalls,

combined with reports that hypoglycemic events could be overlooked,48 have severely
limited the mass market appeal of the GlucoWatch® G2 Biographer. A device requiring
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fewer finger-prick calibrations and sensing electrode replacements would be a substantial
improvement.
2.1.2

Implanted Electrochemical
Element
To date, most commercially available continuous monitoring systems use a

subcutaneously implanted electrochemical sensor to relay glucose levels to an external
device. The first FDA approved continuous monitoring system, the Continuous Glucose
Monitoring System (CGMS®) Standard Gold produced by Medtronic, is one such
device.16 In this device, a healthcare provider inserts a needle-type electrochemical
sensor into the subcutaneous layer of the abdominal wall. Glucose concentrations are
extracted and subsequently stored in an external device.
The sensing element provides 72 hours of continuous operation before necessary
replacement due to operational degradation resulting from biofouling. Glucose levels are
continuously determined and averaged over subsequent 5 min intervals to provide a mean
value. Although the sensor lifespan is indeed greater than that of the GlucoWatch®, the
CGMS Standard Gold requires 12 blood-draw calibrations (4 per day) throughout the
sensors operational lifespan to ensure accuracy.51 This device also requires a 2 hour
warm up period for reasons similar to those described above. Furthermore, reports have
characterized suboptimal performance of the CGMS Standard Gold in accurately
detecting hypoglycemic excursions.52
It is noteworthy to state that this device does not provide real-time measurements
to the patient but instead stores them for future retrospective analysis that is performed by
a healthcare professional. Therefore, this device is not intended to provide patients with
real-time

read-outs

o f glucose

levels

or

completely

supplement
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measurements, but is instead intended to “fill in the gaps” between traditional
measurements and allow careful analysis of metabolic trends throughout the 72 hours of
usage. Following the end o f the testing period (72 hours), the patient returns to the
healthcare provider, where the stored data are extracted and the trends analyzed.
In 2004, Medtronic was granted FDA approval to market the Guardian® RT, a
doctor-prescribed, patient-owned device.51 This device encompasses the exact sensing
element as the CGMS® Standard Gold and therefore operates using the same
electrochemical scheme.52 However, several key features differentiate the Guardian® RT
from the CGMS® Standard Gold. First, The Guardian® RT provides real-time glucose
level read-outs to the patient and audible alarms to alert oncoming hypo- or
hyperglycemic excursions, allowing the patient to take immediate corrective action.
Additionally, the Guardian® RT employs a small external radiofrequency transmitter to
wirelessly convey glucose levels to the monitor, reducing the possibility of inadvertent
sensor removal.

Although these advances do increase the user-friendliness of this

system, the Guardian® RT shares similar shortcomings as the CGMS® system, including
the requirement o f frequent blood-draw calibrations, limited sensor lifetime, and a
potential pathway for infection.
In summer 2006, Medtronic also made plans to release a complete closed-loop
system, the Paradigm® REAL-Time system, comprised of a continuous glucose monitor
and an insulin pump to deliver real-time insulin therapy for hyperglycemic correction.53
As real-time glucose levels are extracted through the same sensor/transmitter utilized in
the Guardian® RT, an insulin pump is used to continuously deliver the appropriate
insulin therapy to reverse hyperglycemic excursions.

However, similar shortcomings
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described in the Guardian® RT and the CGMS® Standard Gold are inherent due to
similar sensing elements.
The Diabetes Care division of Abbott Laboratories has currently applied for FDA
approval o f a minimally-invasive continuous monitoring system, the FreeStyle™
Navigator. The Freestyle navigator uses an electrochemical sensor implanted into the
subcutaneous tissue o f the upper arm and a wireless transmitter to convey real-time
measurements to a pocket-sized device.

Pending successful approval, which is

anticipated, this device would allow patients to monitor glucose levels in real time for up
to 3 days, a lifetime similar to systems previously described.

However, with the

FreeStyle™ Navigator, a single blood-draw calibration is required each time the sensor is
replaced, a marked improvement over the 12 required for Medtronic systems.
Additionally, the FreeStyle™ Navigator only requires a 1-hour warm up period,
compared to previously described devices which require 2 horns,51 but also suffers from
inaccuracies in the hypoglycemic range.54,55
Although these devices produced by Medtronic and Abbot Laboratories do
represent technological advances in terms of continuous monitoring systems, there are
indeed several significant shortcomings: (1) these devices are not designed to fully
supplement blood-draw measurements but are marketed as a means to track metabolic
trends; (2) limited lifetime o f the in vivo sensor due to fouling requires replacement every
3 days; (3) a potential infection pathway is created through a transdermal connection to
the sensor; and (4) inaccuracies plague monitoring of hypoglycemic events. It is clear
that these devices leave something to be desired for a minimally-invasive monitoring
system.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

19

2.1.3

Microdialysis Sampling
A. Menarini Diagnostics produces the only FDA approved continuous monitoring

system, the GlucoDay®, that utilizes microdialysis to constantly sample interstitial
fluid.56’ 57 The microdialysis principle is based on the passive diffusion of substances
across a semipermeable fiber implanted into the subcutaneous tissue of the abdomen. An
isotonic solution (termed the perfusate) similar in ionic composition to the interstitial
fluid is slowly pumped through the dialysis fiber allowing the perfusate to become
enriched with analytes, such as glucose, due to diffusion. It is important to note that the
perfusate flow rate must be such that a dynamic equilibrium between analytes within the
dialysis fiber and interstitial fluid is observed (usually on the order of p.L/min).58 The
analytes, including glucose, are subsequently transported to an external device housing an
electrochemical sensor (Figure 2).

perfusate
Influx
effU
dialysate
Skin

■«

Removal from extracellular
space, if concentration is
higher than in the perfusate

Delivery to the extracellular
space if concentration in the
perfusate is higher than in
the extracellular space

Figure 2. Interstitial fluid sampling using the microdialysis technique. Adapted
from Heinemann et al.58
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The GlucoDay® system provides up to 48 hours of continuous monitoring,
requiring only a single calibration point, and audible alarms signaling the onset of hypoor hyperglycemia.51 Although the lifetime of the sensor is shorter than commercially
available systems, the GlucoDay® requires no significant warm up period between
flowing sensor replacement, making this device more of a “true” continuous monitoring
system. Even though microdialysis techniques have been touted as having significant lag
times between measured glucose levels and actual interstitial glucose levels,14 studies
conducted on the GlucoDay® system indicate that the perfusate takes an insignificant 11
seconds to reach the sensor and a total time of 1 minute to determine the subsequent
glucose concentrations.56 Nonetheless, this device provides a potential infection pathway
inherent from the connection between the dialysis fiber and the detection device and
would require frequent sensor replacement to continuously monitor trends. Again, it is
reiterated that this device, along with all of the commercially available devices previously
discussed, is not intended to replace blood-draw measurement but is instead meant to
allow patients to closely observe metabolic trends.

2.2

Current Trends in Glucose Sensing

Although the currently available continuous systems described above do indeed
increase the user-friendliness of diabetes management, there are significant limitations;
therefore, it is no surprise that aggressive ongoing research is focused on developing nonand minimally-invasive glucose monitoring methods.

In this section, a survey of

techniques that are being pursued for continuous glucose monitoring is described.
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2.2.1

Transdermal Extraction
Methods
Several methods are used in the transdermal extraction of glucose, one them

previously discussed and incorporated into a commercially available system - reverse
iontophoresis, employed in the GlucoWatch® Biographer by Cygnus. Although the sole
application o f these methods does not permit glucose sensing, they do present a means to
extract interstitial fluid with minimal tissue disturbance to supply an external sensing
device, and therefore merit a brief review.
2.2.1.1

Skin suction blister
The skin suction blister technique involves the application of a vacuum to the skin

to purposely cause the formation of a blister between the epidermal-dermal junction. The
vacuum is removed and the blister fluid sampled immediately, using a large gauge
needle. Evidence o f cell damage was observed as well as extensive dermal inflammation,
leading the research community to ultimately conclude that this technique is no less
invasive than traditional blood-draw methods.47 Therefore, this technique has fallen out
o f favor with the biomedical research community.
2.2.1.2

Microporation
Microporation methods involve techniques to perforate the stratum comeum with

microscale pores to allow efficient extraction of interstitial fluid. Common techniques
used to form micron-sized (< 100 pm) pores in the stratum comeum are laser- and
thermal-mediated tissue ablation. The subsequent application of a mild vacuum to the
perforated area extracts the interstitial fluid, which is electrochemically analyzed to
determine the glucose levels.47 Although this technique is classified as minimally-
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invasive, no studies on the effects of long-term extractions have been reported, leaving
the scientific community pessimistic about its overall feasibility.
2.2.1.3

Sonophoresis
Sonophoresis is a technique originally investigated as a method to enhance the

efficiency of transdermal delivery.59 In this technique, low-frequency ultrasound waves
(~ 20 - 100 KHz) are applied to the skin surface. Several effects are induced, the most
important o f them believed to be cavitation. Cavitation results when gaseous inclusions
within the skin expand and collapse at the applied frequency, which is believed to cause a
reversible disruption o f stratum comeum, resulting in the modulation of skin
permeability.60 Following ultrasound application, the application of a hyperosmotic
agent enables the transdermal flux of interstitial fluid (order of magnitude greater than
that achieved by reverse iontophoresis), which is subsequently used in the
electrochemical determination of glucose levels.47,61 Although this extraction technique
does show promise, it is unclear how a complete system would be miniaturized and
packaged while maintaining a reasonable price tag. However, given the increased fluid
extraction rate observed with sonophoresis, a device based on this technique may have
the potential to provide continuous readings more rapidly than currently available
systems like the GlucoWatch® G2.

Nonetheless, a less invasive method would

ultimately have greater appeal to the diabetic community.
2.2.2

Non-Invasive Glucose Sensing
A review o f current progress in non-invasive glucose sensing, most of which

employ various optical techniques, is presented in this section.

Methods employing

optical techniques in the direct transdermal probing of glucose levels are considered truly
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non-invasive because methods do not involve the harvesting of body fluids to determine
glucose levels. These technologies involve the direct interrogation of skin tissue with
light and detect the subsequent changes in absorption, transmission, reflection, and
scattering properties to determine glucose levels. Given that most of the work in the field
of non-invasive glucose sensing is focused on optical interactions with tissue, a brief
overview o f skin optics along with how glucose affects optical characteristics is
warranted.
Skin is a complex tissue having many non-homogeneously distributed
components that absorb and scatter light in a complex fashion, which in turn attenuates
the propagating light. Absorption occurs when the energy of the propagating photon is
taken in by another molecule, resulting in an overall attenuation of intensity best
described using the Beer-Lambert law. Scattering occurs when a propagating photon is
forced to deviate from its trajectory by one or more non-uniformities in the medium, and
the anisotropy factor is used to determine the directional probability of the photon’s new
trajectory. The absorption (a a) and scattering (cts) coefficients, as well as the anisotropy
factor, describe light propagation through a medium - skin, in this case. Early work in
the field o f tissue optics observed a pronounced decrease in the scattering and absorption
coefficients o f the various skin layers with wavelengths above 600 nm (Figure 3).62 The
term “optical window” was subsequently coined as the wavelength region between 600
nm and 1300 nm, which allows increased light propagation by avoiding significant
scattering and absorbing from tissue components ( < 600 nm), while avoiding increased
absorbance by water ( > 1300 nm).
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Figure 3. Experimentally determined scattering (as) and absorption (oa) coefficients
for the stratum corneum, epidermis, and dermis. Taken from Van Gemert et al.62

Researchers have focused an increasing amount of work on exploiting the optical
window to probe glucose levels, most of them predicated on monitoring glucose-induced
changes in scattering and absorption properties. In principle, glucose-induced changes in
absorption properties are due to water displacement in the interstitium as glucose levels
increase, while scattering properties are altered through refractive index changes from
alterations in interstitial glucose levels.63

However, the normal variations in

physiological conditions such as skin temperature, hydration state, and even blood flow
have been reported to affect the skin’s optical properties, presenting a great challenge for
the realization o f reliable direct optical measurents.64
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2.2.2.1

Infrared spectroscopy
Most o f the work involving infrared probing of glucose levels employs near-

infrared (NIR) radiation. NIR spectroscopy techniques are based on the premise that
glucose-specific information embedded within the NIR spectral region (700 - 2500 nm)
can be obtained and extracted using multivariate chemometric analysis techniques.
Commonly, simple absorption and reflectance measurements have been performed to
collect spectra over various regions of the body, including the tongue, upper and lower
lip, nasal septum, and cheek. Although there has been much interest in the development
o f this technique, several disadvantages have challenged continued development. First,
there has been considerable dispute over the measurement location, which has been
observed to have a profound effect on results.65 Additionally, several common analytes
present within the skin share similar properties, making it difficult to determine spectral
changes specific to changes in glucose levels (Figure 4).
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Figure 4. NIR absorbance of interfering species commonly present during glucose
measurements. (A) whole blood and water (B) Common molecular species and
glucose. Taken from Sieg et al.47
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Given the complexity associated with extracting glucose measurements from
convoluted spectra, a considerable amount of work in this field has been dedicated to
multivariate analysis of the spectra. This complex undertaking involves characterizing a
standard error o f prediction, and a prediction’s correlation coefficient, while preventing
overfitting o f the calibration data traditionally acquired using blood-draw methods.
Recently, one report claimed that chance correlations in current models are present and
suggested frequent blood-draw calibrations to solve this issue, which would ultimately
detract from the non-invasiveness o f this techniqe.66 While there continues to be focus
on developing analytical and consistent calibration models, it is still unclear how a
portable device, packaged for home use, would be developed.47 Nonetheless, sustained
research programs are still pursuing NIR spectroscopy for the determination of interstitial
glucose levels, despite the obvious limitations.67
Additional techniques using mid-infrared (MIR) radiation have also been
explored.

Techniques involving MIR spectroscopy are similar in principle to NIR

techniques; however, glucose levels are determined by spectral signatures in the MIR
spectral region, 2.5 - 50 pm (4,000 - 200 cm'1). In this region, a more intense and
detailed spectral signature for glucose is obtained, when compared to that of NIR
measurements, allowing multiple peaks to be analyzed and concentrations extracted
(Figure 5).
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Figure 5. Optical absorption spectra of glucose in the MIR (A) and the NIR(B)
regions. Taken from Sieg et al.47

However, by switching to the MIR region for analysis, a high background signal
due to water absorption is often hard to account for in in vivo situations and severely
limits the penetration depth o f the propagating light.63 As with NIR techniques, changes
in skin optical properties measured via MIR spectroscopy could be non-specific, as
reports have shown that varying physiological conditions can affect measurements.64
2.2.2.2

Light scattering
Light scattering techniques have been used in several aspects of non-invasive

glucose monitoring. Several researchers have focused on using spatially resolved diffuse
reflectance and NIR frequency domain reflectance techniques to directly measure
changes in tissue scattering properties.68'70 As glucose levels fluctuate, concentration
differences in the interstitial fluid cause changes in the refractive index mismatch with
other tissue components, thus causing alterations in measurable scattering properties.
Work was done using light of various wavelengths to probe different tissue depths, while
moving the external detector 1 - 1 0 mm from the skin surface.68 Ultimately, the results
indicated a substantial amount of drift that attributed to non-specific changes in scattering
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properties.

Also, this technique collects measurements across multiple skin

compartments, and since individual compartments may have varying glucose transport
dynamics, it is difficult to quantify results.

Another report used a continuous

microdialysis sampling technique in parallel with scattering measurements, to establish a
calibration model. However, results showed that changes in scattering properties do not
always correspond to glucose fluctuations, corroborating results from previous work.69
Therefore, direct scattering measurements have been plagued by non-specific changes in
scattering properties and lack of ability to specifically probe individual tissue
compartments, both contributing to poor calibration models and lack o f robustness.
In an attempt to monitor scattering properties of localized tissue compartments,
occlusion spectroscopy was developed.

In this technique, the vasculature of the

measurement location (usually the finger tip) is occluded, resulting in the agglomeration
o f red blood cells (RBCs). This technique measures the changes in the refractive index
mismatch between the agglomerated RBCs and the blood plasma, which contains
glucose, with the premise that changes in glucose levels result in measurable changes in
«

the refractive index mismatch.

71

Hence, occlusion spectroscopy allows probing of

glucose levels within the vasculature and not the surrounding compartments, providing a
localized measurement not obtainable with direct scattering methods. However, as with
direct scattering measurements, non-specific changes in scattering properties due to blood
proteins, analytes, and oxygenation levels make calibration difficult.65
Optical coherence tomography (OCT) is an imaging technique initially applied to
the fields of ophthalmology and in vivo biopsies, but has found recent application in non*
•
•
72
invasive
glucose monitoring.

•
The principle
on which OCT relies is low coherence
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interferometry. The optical setup typically consists of an interferometer (typically
Michelson type) with a low-coherence, broad-bandwidth light source used to illuminate
the skin. The coherent light is split into and recombined from reference and probe beams,
respectively. The combination of the backscattered light collected from the skin and the
reference beam give rise to interference patterns, which are collected by a photodetector
(Figure 6).73
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Figure 6. Components of an OCT scanning system. Taken from Fercher et al. 72

By varying the position of the reference mirror, the scan depth can be altered, and
if scanning optics direct the probe beam, axial image profiles can be obtained with
micron precision and millimeter depth penetration.72 For glucose detection, OCT is used
to image individual skin compartments and determine changes in scattering properties
brought about by fluctuations in glucose levels.

Recent work has shown that by

analyzing localized compartments, an accurate calibration model can be obtained (Figure
7).65
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Figure 7. Comparison of OCT measurements to blood-draw calibrations. Taken
from Khalil et al.65

Although this method is promising, it remains affected by non-specific changes in
scattering properties when measurements are taken in environments that are not
stringently controlled.
Raman spectroscopy relies on infrared radiation, making this technique infrared
by nature; however, this technique detects the molecular signatures of scattered light,
justifying its discussion within this section. In this technique, samples are irradiated with
monochromatic light, some of it absorbed or transmitted, but a portion of it scattered.
Most o f the scattered light will have the same frequency as the incident radiation;
however, additional spectral signatures due to the vibrational and/or rotational energy of
the scattering molecules can be detected. Since light energy is proportional to frequency,
the frequency change o f this scattered light must equal the vibrational frequency of the
scattering molecules, an energy exchange process termed the Raman effect.74 Like the
infrared spectra collected by previously discussed techniques, highly specific spectral
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features can be used to identify individual molecules.

In comparison with the MIR

techniques, which sufferes from water absorption interference, Raman techniques have
fewer water overtones, easing measurement analysis.63 However, due to a weak signal,
researchers have searched for alternative testing sites, such as the anterior chamber of the
eye.75 While this work seems promising, safety and clinical efficacy remain to be
addressed.
Although scattering based techniques are indeed non-invasive, making these
techniques extremely attractive for diabetes management, several key limitations may
jeopardize the future implementation in commercial devices:

(1) a vast amount of

physiological and environmental effects can influence the scattering and absorption
properties o f the skin, making extended calibrations very difficult; (2) extensive dataprocessing techniques complicate measurement analysis and introduce uncertainty into
the final results; and (3) motion artifacts during measurements further complicate
analysis.
2.2.2.3

Polarimetrv
Polarimetry-based detection methods are predicated on tracking the optical

activity o f chiral molecules, in this case, glucose. When plane-polarized light is
transmitted through a medium comprising optically active solutes, its polarization plane
is rotated an angle, a , which is directly related to the concentration of the solute.76 For
this detection method to be truly non-invasive, radiation must pass through the medium
and be collected before total depolarization occurs.

Therefore, polarimetric

measurements require low scattering mediums, making even minimal path length
measurements (e.g., webbing between digits and external ear structures) through the skin
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infeasible.65 Therefore, researchers have commonly used this method to measure glucose
7 f t 7Q

levels in the anterior chamber of the eye, providing a low scattering medium. '

To

accomplish this task, incident radiation normal to the corneal surface is directed through
the anterior chamber and the exit beam collected as shown in Figure 8.
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Figure 8. Depiction of a polarimeter used for anterior chamber glucose
77
measurements. Taken from Cameron et al.

Before this approach can be considered a viable in vivo glucose monitoring
technique, several aspects must be addressed including (1) motion artifacts due to eye
movement; (2) interference from additional optically active compounds; (3) lag times
between glucose levels in the aqueous humor relative to blood and interstitial fluid levels;
and (4) artifacts due to uncontrollable environmental and physiological factors.65’79

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

33

2.2.2A

Photoacoustic spectroscopy
Photoacoustic (PA) spectroscopy uses optically-induced ultrasonic waves to

detect variations in interstitial glucose levels.

Specifically, this analytical technique

involves the conversion o f optical energy into acoustic energy. Picosecond pulses of
incident optical radiation (700 - 900 nm) are directed into the tissue, during which
photon absorption leads to localized heating that leads to volumetric expansion of the
region.

This pulsating expansion creates ultrasonic pressure pulses which are

subsequently measured by a piezoelectric detector.80 The rise in temperature is
characterized by the specific heat of the tissue. Increasing glucose levels decreases the
specific heat, which in turn causes an increase in acoustic velocity. Therefore, glucose
levels can be determined by monitoring relative changes in acoustic velocity.65
MacKenzie et al. summarized several in vivo studies using PA spectroscopy to determine
glucose levels, indicating that controlled calibration models could be obtained, but were
not robust.

Additionally, interfering species such as NaCl were identified as a

contributing factor to unsustainable calibration models.

These limitations, along with

minimal quantification o f long-term affects from continued usage, have slowed
commercial development.
2.2.2.5

Impedance spectroscopy
A particularly interesting non-optical approach that is capable of non-invasive

monitoring is impedance spectroscopy (IS), a technique that measures the dielectric
properties of the tissue. In this technique, a small alternating current is applied to the
tissue, and the impedance o f the tissue to the current flow is recorded as a function of
frequency. Fundamentally, skin tissue is both resistive and capacitive in nature, and by
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varying frequency, IS can separate individual resistive and capacitive contributions.
Previous work has shown the utility o f this technique to quantify transport properties and
hydration o f tissue.47 Work by Heinemann’s group significantly advanced applications
towards glucose monitoring through the development of a wrist-worn prototype currently
undergoing clinical evaluation.81,82 For glucose monitoring applications, the prototype
device uses 1 - 200 MHz frequencies, allowing the interfacial membrane polarization of
RBCs and other cell membranes to be studied. Since a modified membrane potential
arises from the concentration-dependent interaction between glucose and RBCs, glucose
levels can be determined. A reported change of 0.5 - 0.8

per mM of glucose was

reported, with a total percent change of approximately 10% over the range tested and
good correlation with standardized blood glucose levels, confirming that the device does
track blood glucose levels (Figure 9).
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Figure 9. Comparison of IS measurements from a prototype sensor to standardized
blood and interstitial fluid measurements. Taken from Caduff et al.82

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

35

To further extend the clinical efficacy of this test, extended clinical trials are
underway; however, artifacts resulting from excessive sweating and motion, as well as
temperature fluctuations, pose challenges in extracting accurate measurements over
extended periods o f time ( > 2 days).47
2.2.3

Fluorescence-Based
Glucose Sensing
Fluorescence is a phenomenon in which an excited molecule absorbs energy and

subsequently releases energy in the form of a photon.

For molecular detection,

fluorescence-based techniques have proved to be highly sensitivity, even affording
smg/e-molecule detection.

Additionally, since fluorescence-sensing techniques rely on

specific reporter molecules with unique optical properties to transduce analyte
measurements, readings are highly specific, unlike previously reviewed optical
techniques. Also, a variety of techniques can be used measure analyte concentration,
providing researchers a means to develop an array of sensing schemes for a particular
analyte of interest. Furthermore, given that fluorescence techniques are optically based,
implantable devices could be developed to allow minimally-invasive monitoring of
analytes. Thus, it is evident why an increasing amount of work has been focused on
developing various methods to quantify glucose levels using fluorescence techniques.19
In this section, direct and indirect glucose sensing schemes utilizing fluorescence
transduction will be reviewed, including those based on naturally occurring and
engineered glucose recognition molecules. Further, the work reviewed herein will be
classified according to glucose-binding moiety.
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2.2.3.1

Boronic acid based sensors
Boronic acid compounds form a reversible complex with cis 1,2- or 1,3- diols,

such as the common biological carbohydrates glucose, galactose, and fructose. Since the
complex is reversible, the integration of boronic acid derivatives as recognition elements
in glucose sensors is being aggressively explored. Many systems are predicated upon the
signaling of the diol binding event through modulation of fluorescence properties of the
boronic acid compound, which are typically comprised of a binding moiety and a
•

fluorescent signaling moiety.

84

In the early 1990’s, Yoon and Czamik were the first to report on anthrylboronic
acid-based fluorescent saccharide sensors, successfully showing saccharide binding could
signal a change in fluorescence properties.85 The high apparent pKa (~ 8.8) of the
compound resulted in an emission intensity decrease with increasing saccharide
concentration through a process termed “chelation-enhanced quenching.” While this
initial work was indeed an important “proof-of-concept,” anthrylboronic acid was found
to be more sensitive to fructose binding events than glucose.

The Shinkai group

advanced the concept through the integration of an amino group positioned between the
boronic acid and anthracene. The amino group effectively increased the compound’s
saccharide binding affinity by lowering the pKa and enhanced photoelectron transfer,
resulting in increased emission intensities with elevating saccharide levels (the opposite
o f which was seen with anthrylboronic acid).86 However, as with Yoon’s work, results
showed preferential binding of fructose over glucose (approximately 50-fold selectivity
for fructose at physiological pH).
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In an attempt to further increase binding affinity and enhance glucose selectivity,
•

Shinkai’s group devised and initially reported bisboromc acid compounds.

87

In this

work, sensing compounds were prepared with bisboronic acid configurations, and results
showed that glucose selectivity can be enhanced by appropriately orienting the boronic
acid compounds relative to the diol pairs on glucose. Further work showed that linker
chain length (and type) between the boronic acid moieties greatly affects glucose
selectivity, paving the way for the development of additional compounds with engineered
affinity properties.88

Using previous results as a guide, Kamati et al. prepared a

derivative with a glucose selectivity 43-fold greater than that of fructose, demonstrating
that boronic acid based sensors could indeed be designed for applications in glucose
sensing.

89

The James group further advanced the concept by demonstrating fluorophore
choice could affect overall selectivity, stability, and sensitivity of the sensors, as well as
using multiple pendant fluorophores to extend the emission wavelengths of the sensors
through fluorescent resonance energy transfer (FRET) - a novel concept for boronic acid
derivatives.90 This system utilized a phenanthrene donor and pyrene acceptor, such that
when excited with 299 nm light (the excitation maxima of phenanthrene) the entire
system would emit at 417 nm (the emission maxima of pyrene).
To compensate for source fluctuations and variations in probe concentration,
Heagy’s group incorporated ratiometric functionality into boronic acid derivatives.91 In
this work 3-nitronaphthalic anhydride and 3-aminophenylboronic acid were used with
various linker moieties to form a monoboronic acid sensor, where upon excitation with
377 nm light, bimodal emission spectra with peaks at 430 and 550 nm were observed. By
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analyzing peak ratio (430/550) changes induced by variations in saccharide
concentration, a response profile was generated (Figure 10).
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Figure 10. Titration curves against fructose (■), glucose (•), galactose (A ), and
ethylene glycol (T ), measured in 0.1 M phosphate buffer, pH 8.0 at 25 °C. Taken
from Cao et al.92

These results seemed to contradict earlier findings that demonstrated poor glucose
selectivity with monoboronic acid derivatives.

The authors suggest that competing

factors may be simultaneously operating, such as conformational restriction between the
phenylhydroxy-boronate: saccharide complex and its influence on the excited state, which
could result in enhanced glucose selectivity.92
Another approach to designing glucose sensitive fluorophores was studied by
Singaram, whose work is primarily focused on designing two-component boronic acid
sensors.

In previous work, single sensing moieties containing both receptor and

fluorophores were studied; however, in Singaram’s studies, the fluorophore - usually
anionic in nature - is quenched by a physically separate boronic acid substituted viologen
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receptor.

As the saccharide binds with the receptor, the quenching efficiency of the

viologen is reduced, resulting in an increased emission intensity of the fluorophore
(Figure 11).
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Figure 11. (A) One-component saccharide sensing system. (B) Two-component
saccharide sensing system. Taken from Cordes et al 93

This facile approach readily allows the interchange of fluorophores without any
modification of the receptor, a considerable advantage since transformations can cause
unwanted changes in the photophysical dye properties. This work demonstrated that
sensitivity and selectivity as well as optical properties of the boronic acid derivatives can
be modulated by interchanging different viologens and fluorophores.93,94
All previously described work on boronic acid derivatives has been performed in
solution phase; however, one group is investigating the feasibility of using boronic acid
derivative-doped contact lenses for continuous monitoring of glucose levels in tears.
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Geddes and Lackowicz have shown that boronic acid derivatives could be successfully
incorporated into an over-the-counter contact lens and still retain glucose sensitivity.95'97
Contact lenses, typically composed of polyvinyl alcohol hydrogels, allow diffusionfacilitated loading of boronic acid derivatives. After incubation and removal of excess
fluorophore, the fluorescence response to saccharide levels was characterized. Initially
lenses loaded with stilbene, polyene, and chalcone derivatives were studied. However,
results indicated a drastic difference in behavior o f the doped lenses when compared with
those obtained during solution phase testing.

This discrepancy was attributed to pH

differences between the testing environments - the local pH of the lenses was determined
to be 6, whereas most o f the solution phase testing was performed at pH 8. Therefore, the
authors sought to design boronic acid derivatives containing various quinolinium
moieties in an attempt to reduce the pKa of the probe to match the local pH of the sensing
environment. One particular probe, 7V-(boronobenzyl)-6-methoxyquinolinium bromide
(o-BMOQBA), was investigated and characterized accordingly (Figure 12).
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Figure 12. Spectral response (A) and calibration curve (B) of o-BMOQBA-doped
contact lenses. Taken from Badugu et al. 9 6
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The results obtained from the o-BMOQBA-doped lenses clearly demonstrate
saccharide sensitivity; however, glucose selectivity remains a significant obstacle.
Although this work represents a novel attempt to construct minimally-invasive sensors,
the development o f a device to collect and analyze glucose levels has not been addressed.
Additionally, the efficacy of using tears to manage diabetes has not been fully evaluated
and sensor stability has yet to be demonstrated in vivo where uncontrollable conditions
such as eye hydration may significantly affect measurements.
2.2.3.2

Competitive-binding based
sensors
Competitive-binding assays for glucose, where signal transduction is typically

based on resonance energy transfer (RET) mechanisms, are some of the most studied
schemes for preparing fluorescent glucose sensors. RET occurs whenever the emission
spectrum o f a fluorophore, termed the “donor”, overlaps with the excitation spectrum of
another fluorophore, termed the “acceptor”, such that the donor excited state is nonradiatively transferred to the acceptor, resulting in photon emission. RET efficiency (E)
is highly dependent on the distance (/-) between the donor and acceptor molecules as
shown in the following equation:

where R0 represents the Forster distance, the distance at which 50% efficiency is obtained
(typically in the A range).98
RET-based glucose transduction is driven through the competitive binding
between a fluorescent ligand and glucose to receptor sites on lectins, glucose-binding
proteins, or deactivated glucose-specific enzymes, such that the ligand (the donor) is
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displaced from the receptor (the acceptor) when in the presence of glucose, resulting in
measurable decreases in the acceptor emission intensity.32,33
Concanavalin A RET systems. The inception of competitive-binding assays to monitor
glucose levels was reported in the groundbreaking work of Mansouri et al., in which the
glucose-binding protein Concanavalin A (Con A) was immobilized onto the lumen walls
of a microdialysis fiber containing a high molecular weight fluorescein-labeled dextran
(FITC-dextran) solution." A single optical fiber (low numerical aperture) was used to
deliver and collect photons from the solution within the dialysis fiber.

When in the

presence o f glucose, FITC-dextran molecules are displaced and diffuse from the lumen
walls into the core volume of the fiber, resulting in a rise in FITC emission intensity that
could be correlated with glucose levels. Overall, a 60% change in intensity was observed
over the range o f 0 - 180 mg/dL of glucose; however, problems with drift occurred due
to the lack of internal reference.
The same laboratory added ratiometric functionality by incorporating RET
measurements between FITC-dextran and rhodamine-labeled Con A (TRITC-Con A)
within microdialysis fibers.100 In this scheme, a measurable decrease in RET efficiency
was observed as glucose displaced FITC-dextran, resulting in a decreased acceptor
emission intensity relative to donor emission intensity.

Results indicated a linear

correlation with glucose levels up to 200 mg/dL and 60% change in ratiometric intensity
over the range o f 0 - 900 mg/dL. The authors also noted problems with irreversible
aggregation o f Con A within a few hours, thereby restricting the development of this type
o f sensor.
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A novel scheme was devised by Ballerstadt et al. to eliminate the need for Con A
immobilization on the microdialysis fiber wall.33

In this work, Sephadex beads

comprising pendent glucose moieties and two highly absorbing dyes were used. Safranin
O and Pararosanilin were selected as dyes to block the excitation spectrum of Alexa
Flour® 488, the fluorophore used to label Con A (AF488-Con A). When in the absence
of glucose, excitation light passing through the beads is preferentially absorbed by the
Safranin O and Pararosanilin, resulting in poor emission from AF488-Con A. Upon
glucose diffusion into the fiber, glucose-binding releases AF488-Con A from the beads,
causing an increase in emission intensity that is well correlated with glucose levels.
Additional efforts by the same lab were focused on extending the wavelengths into the
NIR (to potentially make a system more suitable for transdermal applications) by using
alternative fluorophores.32 However, studies performed to evaluate long-term use of both
systems indicated significant leakage over time, resulting in poor performance - mostly
due to the lack o f a reference signal - and ultimately proving that additional advances
were necessary for future success.
Russel et al. showed that a Con A RET system could be encapsulated within
polyethylene glycol spheres and retain functionality.23 In this work, TRITC-Con A and
FITC-dextran were entrapped within polyethylene glycol (PEG) millispheres, where the
addition o f glucose resulted in FITC-dextran displacement and alterations in RET
efficiency. However, leaching of assay components, as well as long response times to
changes in glucose, proved to be significant problems. This work represented the first
reported attempt at a “smart tattoo” and will be further discussed in the later pages of this
text.
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The Lackowicz group was among the first to implicate that fluorescence lifetime
measurements could potentially alleviate problems observed with intensity-based RET
measurements.101 Given that fluorescence lifetime - the average time at which the
fluorophore remains in the excited state beforeretuming to the ground state - is
independent of fluorophore concentration and light scattering and absorption properties
of the sample, this particular measurement is potentially promising for in vivo
monitoring.

QO

In this work, the assay is based on the decreased decay time of a donor

fluorophore linked to Con A upon binding of acceptor-labeled a-D-mannoside. Upon
introduction of glucose into the system, the displacement of the labeled sugars results in a
decrease in energy transfer and an increase in the donor decay time. Results indicated
that this assay scheme could be used with various donor-acceptor pairs, demonstrating
the robustness and generality of this approach. Additional studies were performed on
similar systems based on long lifetime fluorophores such as ruthenium complexes,
reducing the need for high frequency light-modulation for phase-domain lifetime
measurements.102,103
Most recently, an in vivo investigation of a NIR Con A RET system was reported
and the host response characterized.104

In this work, Cy-7-labeled Con A and

AlexaFluor® 647-labeled dextran system were entrapped with a hollow microdialysis
fiber immobilized on the tip o f an optical fiber. The device was characterized in vitro,
the result o f which indicated a response range of 2 - 25 mM. More important, the device
was implanted in vivo and the response characteristics monitored throughout the course
o f 16 days. Results were promising, as the implant read-out retained a high degree of
correlation with blood glucose fluctuations (as measured by blood-draw methods). The
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authors noted that an increase in response time was observed at the end of the
experimental period, citing fibrous encapsulation of the sensor as the cause.
Additionally, the authors tested the cytotoxicity of Con A through direct administration to
the animal. Results indicated that even at 10 times the amount of Con A present in the
implant, that no significant toxicological or systemic response was observed.
Apo-enzyme RET systems. Recently, an alternative RET assay utilizing the inactive
form o f glucose oxidase (apo-GOx) as the target-binding molecule has been proposed, in
an attempt to overcome the aforementioned difficulties associated with Con A based
assays.27,105 In this work, a competitive-binding assay comprised of TRITC-apo-GOx
and FITC-dextran was studied first in solution phase, then entrapped within hollow
microscale polymeric containers.

Apo-GOx provided high specificity for glucose

binding as well as a high degree of reversibility, offering clear advantages over similar
systems based on Con A. Results from both studies were promising, as the authors
demonstrated high sensitivity (~ 3-fold greater than previous competitive-binding
systems) and reversibility throughout physiologically significant glucose levels.
Additional details concerning the behavior of the encapsulated assay as a smart tattoo
concept will be given later in this text. More recently, the authors have transitioned to
longer NIR wavelength dyes in efforts to reduce the effect of tissue scattering should a
transdermal device be realized, the results of which are equally as promising.106
2.2.3.3

Reagentless protein-based
sensors
In this section, current progress in fluorescent glucose sensors based on reagent

transduction mechanisms is presented. While competitive-binding assays rely on binding
interactions o f both the ligand and the analyte of interest, reagentless mechanisms depend
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upon a conformation change o f the receptor induced through analyte binding and require
only analyte binding for signaling to proceed. Environmentally sensitive fluorophores or
intrinsic fluorescence properties of the receptor molecule are used to signal the binding
event.
In the late 1980’s, Wolfbeis’ group reported that glucose-binding events triggered
measurable changes in the intrinsic flavine fluorescence of GOx; however, significant
changes were only observed with 1 . 5 - 2 mM glucose levels.107 By labeling the enzyme
with a fluorescein derivative, Castillo’s group designed a RET system between the
flavine group and fluorescein derivative, and demonstrated correlation between glucose
levels and the time between glucose addition and fluorescence change.108 Given the poor
understanding o f the underlying mechanism for Castillo’s RET system, other groups
worked on preparing reagentless sensors using apo-GOx.29 In this work, apo-GOx was
labeled with the environmentally sensitive fluorophore 8-anilino-l-anpthalene sulphonic
acid (ANS). The binding o f glucose to apo-GOx results in a conformational change such
that the steady state intensity of ANS decreased 25% and the mean lifetime of ANS
decreased about 40% from 1 0 - 2 0 mM glucose.

This work showed that apo-GOx

retained its high specificity and in many ways paved the way for advances in the
development o f a new biosensor genre.27,105,106,109 Additional work by the same group
was performed on the apo- form of glucose dehydrogenase, where similar results were
observed, thereby indicating the utility of deactivated enzymes as analyte recognition
elements in optical sensors.110
In similar work done by Maity et al. using yeast Hexokinase (HEX), a 30%
decrease in intrinsic tyrptophan fluorescence of HEX was observed during exposure to 12
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mM of glucose.111 The same group labeled HEX with an ANS derivative.112 Contrary to
experiments performed with ANS labeled apo-GOx, a decrease in sensitivity was
observed. Recent work has shown that HEX-based transduction schemes are particularly
vulnerable to excessive quenching when exposed to serum, indicating that a separation
from the biological environment is necessary for in vivo applications.19 With this concern
in mind, Pickup’s group immobilized HEX in a sol-gel matrix.

11T

Results were

promising, as a 20% change in intrinsic fluorescence was observed when immobilized
HEX was exposed to saturating levels of glucose (~ 20 mM).
As the field o f protein engineering advances rapidly, several researchers have
adapted a glucose-binding protein (GBP) commonly found in the periplasmic space of
Escherichia coli ( E. coli ) for use in glucose sensor applications. It has been shown that
upon binding with glucose, a conformation change is induced in GBP. This glucoseinitiated conformational shift was initially exploited by Marvin et al.114 In this work, the
authors incorporate allosterically-linked environmentally-sensitive fluorophores to the
GBP binding site using cystene mutations to site-direct fluorophore linkage.

Two

fluorophores were used, both them showing an approximate change in fluorescence
intensity o f 80% at saturating levels of glucose.

Tolosa et al. also used protein

engineering to strategically place cystene residues within GBP for site-directed labeling
with ANS. Results showed that ANS-GBP displayed a two-fold decrease in intensity
when exposed to saturating levels of glucose, with a dissociation constant of ~ 1 pM.115
The same report also showed that immobilization of ANS-GBP along with a long
lifetime ruthenium complex onto the surface of a cuvette could be successfully used in
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low frequency phase-modulation lifetime measurements to predict bulk glucose levels
within the cuvette.
More recently, the Schultz group reported on a RET-based GBP mutant created
by fusing two fluorescent reporter proteins (green fluorescent protein as the donor and
yellow fluorescent protein as the acceptor) to the C and N terminus, respectively.116 In
the case o f a glucose-binding event, the spatial separation between the fluorescent
proteins is altered, causing a change in RET efficiency. Given this group’s previous
experience with microdialysis fibers, a cellulose-based dialysis fiber was used to entrap
the GBP RET assay.

Upon exposure to solutions containing glucose, the emission

intensity at 527 nm was reduced. The response was shown to be reversible; however, a
maximum intensity change was observed at 20 pM, well below the physiological range
(Figure 13).
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Figure 13. Glucose response of a GPB based RET assay entrapped within a
microdialysis fiber. Taken from Ye et al. 116
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Although the majority of the sensors reported in this section show little or no
sensitivity within the physiologically significant glucose range, future development in
protein engineering techniques should further advances in engineered recognition
molecules, making these approaches particularly attractive for future applications.
2.2.3.4

Enzymatic-based Sensors
There are many examples of fluorophores that can be directly used to monitor

biological analytes such as Na+, K+, Ca2+, Mg2+, and Zn2+ through changes in
fluorescence properties.

To date, no reliable probes allow the direct monitoring of

glucose over physiological levels, despite current efforts on boronic acid based sensors
detailed in previous sections. Therefore, researchers have often integrated enzymes into
glucose sensing schemes, where the co-consumption of non-glucose substrates and the
generation of products are fluorescently tracked and used to indirectly determine glucose
levels. One of the most widely researched enzymatic sensing schemes relies on GOxcatalyzed oxidation o f glucose in the following reaction:

glucose + O 2 + H 2O —GO* >gluconic acid + H 2O 2

In this reaction, several schemes could be exploited to indirectly monitor glucose levels:
1. measurement of proton production (changes in pH due to gluconic acid
formation)
2. measurement o f hydrogen peroxide produced
3. measurement o f oxygen consumed
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In this section, sensors based on the above schemes will be discussed in detail.
Before the review is undertaken, it is worth noting that enzymatic-based sensors are
inherently very selective (enzymes contain highly specific binding sites), as well as
reversible due to the catalytic nature of enzymes, making them ideal for use in biosensor
applications.

However, there are several drawbacks to using enzymatic schemes: (1)

enzymes tend to spontaneously deactivate (denature) over time, leading to calibration
drifts; (2) to obtain accurate indirect measurements of glucose, the reaction must remain
glucose-limited, requiring control of reaction-diffusion kinetics; and (3) the consumptive
nature o f the enzyme could result in local depletion of glucose levels, leading to
ambiguous readings, as well as possible tissue damage due to excessive consumption of
glucose and oxygen.
Fluorescent pH transduction of glucose levels. This approach seems rather simple:
add a pH-sensitive fluorophore to an assay containing GOx and monitor the decrease in
pH due to GOx activity. However, this approach is inherently difficult because often the
initial pH and the buffer capacity of the sample are unknown, making accurate
calibrations difficult to obtain. Although little work has been done to develop this genre
o f glucose sensors, several significant contributions have been made.
In the late 1980’s, Wolfbeis’s group was the first to report a glucose sensor based
on pH transduction.117 In this work, GOx and a pH-sensitive dye (1-hydroxypyrene3,6,8-trisulfonate, HPTS) were physically immobilized on the tip of an optical fiber. As
the local pH was reduced by gluconic acid production, measurable changes in
fluorescence were observed. Using flow-through measurements with buffer solutions of
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various strengths, the optrode response time was determined to be 8 - 12 min, with a
detection limit of 0.1 - 2 mM glucose and response saturation at 2 - 3 mM.
In the mid 1990’s McCurley developed a fiber-optic-based glucose sensor that
operated on the principle o f pH-induced swelling.118 In this device, a polyacrylamide gel
was used to immobilize GOx and a rhodamine derivative fluorochrome on the tip of an
optical fiber. During exposure to glucose, a reduction in local pH due to gluconic acid
production caused the polyacrylamide hydrogel to swell by changing the ionization state
of the amine groups. Since the concentration of the fluorophore remains constant while
the surrounding hydrogel begins to swell, a measurable decrease in rhodamine emission
intensity can be correlated with glucose concentrations up to 300 mg/dL. However, this
sensor is not self-referencing and would require a direct connection to an optical fiber,
providing a potential infection pathway; thus, this device would be unsuitable for
sustained in vivo usage.
More recently, McShane’s group reported on RET-based transduction of glucoseinduced pH changes using chitosan microparticles.119

In this approach, chitosan

microspheres were prepared using an emulsion technique, followed by subsequent
labeling of the spheres with TRITC and AlexaFluor 647® (AF647).

Electrostatic

differences between GOx and chitosan were exploited to attract and entrap GOx
throughout the chitosan spheres.

When the spheres are exposed to glucose, local

decreases in pH cause the particles to swell.

The swelling of the particles causes a

separation of TRITC and AF647, thereby reducing RET efficiency. Although this work
represents a “proof-of-concept” study, true feasibility will be judged when the prototypes
are tested in increasing physiological (i.e., buffered) conditions.
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Fluorescent H2O2 transduction of glucose levels. Using H2O2 as an indirect means to
measure glucose levels has the advantage of minimal background interference because
significant levels o f hydrogen peroxide are not commonly found in body fluids.

I ^rv

However, most of these types of sensing assays require reaction coupling with peroxidase
(POx). In such a system, hydrogen peroxide produced through glucose oxidation is then
oxidized along with a non-colored substrate by POx, resulting in the formation of water
and a colored/fluorescent product. By monitoring the resulting absorbance/fluorescence,
correlations with glucose levels can be obtained.

Given that these assays are non-

reversible and somewhat complex, they have been commonly used in laboratory assay to
determine glucose but have not been implemented in long-term monitoring applications.
Therefore, for this technology to be considered further for long-term glucose monitoring,
a reversible, reagentless probe for hydrogen peroxide would need to be developed.
In 2002, Wolfbeis’s group reported the development of a reversible hydrogen
peroxide probe that functioned independently o f POx and used it to develop a fluorescent
glucose sensing assay.
tetracycline

(E U 3 T C )

1 mi
.
,
’
This unique europium-based fluorochrome - europium (III)

- is weakly fluorescent in an uncomplexed state; however, upon

binding with hydrogen peroxide, a 15-fold increase in emission intensity is observed.
Additionally, a 100% increase in decay time (from 30 ps to 60 ps in the presence of
hydrogen peroxide) indicates that this probe could also be successfully implemented into
lifetime measurements. While excited at 405 nm, a trimodal emission spectra with peaks
centered at 577, 592, and 616 nm can be used to extract glucose concentrations. The
results indicated a highly sensitive assay with a linear range of 2.2 - 100 pM as shown in
Figure 14.
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Figure 14. EU3 TC assay response to varying glucose concentrations. Taken from
Wu et al.

More recently, the same group introduced a GOx-based glucose sensor using
EU3TC.122 In this work, EU3TC and GOx were immobilized within a polyacrylonitrile-copolyacrylamide (Hypan) polymer matrix. The doped polymer was exposed to varying
concentrations o f bulk glucose, while continuously monitoring fluorescence emission at
616 nm (400 nm excitation light was used).

Results indicated a high degree of

reversibility with sensitivity to glucose in the range of 0.1 - 5 mM concentrations;
however, approximately 3000 sec were required for the sensor to equilibrate following a
2 mM glucose step (Figure 15).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

54

a« 4 8
c
■6*>*
c
“ 3.5
•U

■*^
/*

/

/

§ 1.8
2 m M g k ic o s a

1.51
1000

2000

3000

4000

t im e/s
Figure 15. Real-time response of a EU3 TC based glucose sensor to a 2 mM glucose
step. Taken from Duerkop et al. 1 2 2

Therefore, should additional advancements be made such that response time is
significantly reduced and the analytical range extended, this technology could potentially
be implemented into diabetic monitoring devices.
Fluorescent 0

2

transduction of glucose levels.

Unlike hydrogen peroxide based

transduction schemes, there are many reliable 0 2 sensitive probes to choose from.
Additionally, O2 transduction is dependent only on a single variable, unlike pH
transduction, which is dependent on buffer capacity as well as ionic strength. However,
because oxygen levels form a high background in physiological systems, a glucose sensor
based on O2 transduction could become oxygen-limited if not properly designed.
While the earliest known report of using oxygen to indirectly determine
concentrations o f glucose, lactate, and alcohol was reported in 1983,123 it was the
introduction o f longer wavelength oxygen indicators that renewed interest in this type of
sensor. 122 One of the first successful reports of optically transduced glucose sensing via
indirect oxygen monitoring was in 1988, where GOx and decacyclene were immobilized
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within a nylon membrane, and glucose-limited consumption of oxygen was measured via
fiber optic bundles.124 As bulk glucose levels increased, local concentrations of oxygen
deceased, allowing indirect monitoring of glucose concentration via decacyclene
emission. Experiments were performed in a flow chamber where air-equilibrated buffer
with varying glucose levels were exposed to the membrane. Results were promising, as a
response time o f 1 - 6 min and an analytical range of 20 mM were demonstrated;
however, since the excitation and emission properties of decacyclene (385/500 nm) are
not conducive transdermal applications, no further discussion will be given on
decacyclene-based devices.
Following the development of ruthenium-ligand complexes, which demonstrated
longer excitation/emission wavelengths than those of decacyclene a surge of work was
focused into developing oxygen-transduced glucose sensors. Again, Wolfbeis’ group
reported on one of the first glucose sensors to utilize a ruthenium compound [tris(l,10phenanthroline)-ruthenium(II)].125 The ruthenium compound was incorporated into a
silica gel, which was then placed onto the tip of an optical fiber. Oxygen sensitivity
experiments performed on the optrode show sensitivity over 0 - 750 torr. A layer of
immobilized GOx was added onto the ruthenium-doped silica gel. To optically insulate
the system, a surface coating of carbon black was adsorbed before testing in a flow
chamber. The fiber was indeed sensitive to glucose concentrations up to lmM, with
response times around 6 min. Although these results were promising, the operation range
would need to be greatly extended for this design to be useful in diabetic monitoring.
Additional work was done using luminescent porphyrin compounds (Pb and Pt) as
probes m glucose sensitive fibers.

In this work, porphyrin probes were selected as
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oxygen indicators due to higher sensitivity to oxygen than ruthenium compounds, leading
to the hypothesis that a system with superior sensitivity over ruthenium-based systems
could be developed.

In this system, a porphyrin-doped polystyrene membrane was

adsorbed to the surface of an optical fiber, onto which GOx was directly immobilized.
Glucose sensitivity tests were performed by dipping the optrode into air-equilibrated
solutions of glucose while monitoring the spectroscopic response in real-time.

The

authors observed a 400% increase in porphyrin emission intensity at saturating levels of
glucose, which were unfortunately below (1 mM saturation) the physiologically relevant
range. A probable reason fo r the poor analytical range is that the authors did not
incorporate diffusion limiting layers over the enzyme to modulate reaction-diffusion
kinetics; therefore, local oxygen levels were rapidly depleted, resulting in a low glucose
sensitive range.
Walt’s group developed a method to precisely deposit distinct regions of analytesensitive dye onto an imaging bundle.126 To accomplish this goal, the distal surface of
the fiber was silanized to functionalize the fiber surface with polymerizable acrylate
groups.

A thin film of poly(hydroxyethyl methacrylate) doped with a pH-sensitive

fluorescein derivative was deposited onto the functionalized fiber surface using a spincoating method. Using spot-directed UV illumination through individual fibers, selected
regions were photopolymerized, and upon rinsing, revealed a pH-sensitive optical array.
This ingenious approach was further applied to the area of glucose sensing, where Li et
al. described an optical fiber capable of monitoring glucose and oxygen continuously.127
In this work, oxygen sensitive optical arrays were prepared by mixing Ru(4,7diphenyl(Ph)-l,10-phen)3Cl2

(

Ru(Ph2phen)32+),

a

oxygen-quenched
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compound, in a siloxane copolymer. Before photopolymerization, the tip of the optical
fiber was silanized. With the silianized fiber submerged in the Ru(Ph2phen)32+ siloxane
copolymer solution, site-directed UV polymerization was applied such that four siloxane
polymer cones were deposited onto the fiber surface.

To prepare glucose sensitive

assays, GOx was mixed with poly(hydroxyethyl methacrylate) (HEMA), and an aliquot
placed over two siloxane cones.

Illumination times were varied such that different

thickness of the GOx-HEMA was polymerized to the siloxane cones. The additional two
cones were coated with HEMA containing no GOx, to allow the measurement of local
oxygen levels.

Glucose sensitivity experiments were performed under various bulk

oxygen concentrations, and the results showed that glucose sensitivity and operational
range could be affected - higher bulk oxygen levels extended the operational range since
the sensor became oxygen-limited at higher glucose levels.

Response experiments

showed sensitivity over the range of 0.6 - 20 mM glucose, with a response time of
approximately 20 sec.

Additionally, the authors found a dramatic difference in step

response properties o f the sensing arrays with varying GOx-HEMA layer thicknesses
(Figure 16).
However, it is unclear whether this change in response is generated by the
presence of a thicker diffusion barrier or the increase in enzyme concentration associated
with the thicker GOx-HEMA layer. The implications of this study are profound for
enzymatic smart tattoo applications, as they depict how enzyme concentration and/or
membrane thickness, along with bulk oxygen levels, could drastically affect sensor
response properties.
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Figure 16. Response time curves of glucose sensors with thicker (■) and thinner (•)
poly-HEMA layers compared to oxygen reference (o). Taken from Li et al. 1 2 7

Significant work was done by Rosenzweig and Kopelman to further the
development o f glucose sensitive optical fibers, by examining the dependence of
IQ 1

response properties on enzyme concentration and sensor size. ’

’

1JQ

In this work,

optical fibers with tip diameters ranging from 0.1 - 50 pm were prepared through the
precise application o f tension to the fiber, while the tip was heated with a CO2 laser. The
tips were acrylate-functionalized through a silanization procedure. The fimctionalized
fibers were dipped into a polyacrylamide cocktail containing Ru(Ph2phen)32+ and varying
concentrations of GOx.

UV illumination was used to crosslink the polymer matrix

containing the sensing components to the fiber tip.

To quantify the affect of GOx

concentration within the polymer cocktail, 10 pm sensors were exposed to 10 mM
j i

glucose and the response allowed to equilibrate. The final Ru(Ph2phen)3

intensity was

normalized to the intensity obtained in glucose-free buffer and plotted against the GOx
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dilution used to prepare the polymer matrix (GOx stock solution was 225 units/mg) as
shown in Figure 17.
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Figure 17. Effect of GOx concentration within the polyacrylamide cocktail on sensor
response. Taken from Rosenzweig et al. 3 8

Results indicate an optimized response was observed when a 1:50 dilution of GOx
to polyacrylamide was used during sensor fabrication. The data show and increase in
response until a 1:100 dilution was obtained.

In this region of operation, glucose

oxidation is kinetically limited, therefore the glucose and oxygen consumption is directly
proportional to the concentration of GOx within the polymer matrix. From 1:100 to 1:25,
the reaction kinetics are governed by mass transport of analytes from the bulk into the
sensor; therefore, an increasing concentration of enzyme has no effect on response
properties since the reaction is now diffusion-limited. The authors explain that at higher
GOx concentrations

(> 1:25), the buffering capacity of the sensor is overcome, resulting

in a local decrease o f pH, which in turn decreases enzymatic activity. This explanation is
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indeed possible; however, a more plausible explanation would be that the high levels of
enzyme rapidly consume glucose on the outer boundary of the sensor, resulting in an
insufficient decrease in oxygen levels within the sensors and subsequently, a loss of
sensitivity. It is important to state that a separate report showed a similar trend when the
effect o f enzyme concentration on device sensitivity within spherical sensors was
examined.41
A similar experiment was performed using fiber diameter as the independent
variable.

In this experiment, fibers with diameters ranging from 0.1 - 50 pm were

exposed to 5 mM glucose and the response allowed to equilibrate.

The final

Ru(Ph2phen)32+ intensity was normalized to the intensity obtained in glucose-free buffer
and plotted against fiber diameter (Figure 18).
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Figure 18. Dependence of sensor response on the fiber diameter of glucose (■) and
oxygen (□) sensors. Taken from Rosenzweig et al. 38

The results indicate that the oxygen response of the sensors is independent of
diameter; however, clearly the glucose response is dependent on sensor diameter. An
approximate 20% increase in intensity is observed when the fiber diameter is decreased
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from 5 to 1 (am. The authors attribute the intensity increase to an increase in enzymatic
activity per GOx molecule. For sensor diameters > 10 pm, the authors state that enzymes
trapped within the inner core o f the sensors only become “active” after enzyme molecules
toward the sensors’ surface become deactivated. However, the authors fail to show that
enzyme concentration was held constant throughout the experiments investigating the
size effect, making their results somewhat questionable.

Nonetheless, the authors

successfully iterate that sensor size and enzyme concentration can significantly influence
sensor properties, concepts indeed applicable to the work presented in this dissertation.
Thus far, glucose sensors based on oxygen transduction with optical fiber
substrates were reviewed.

These reports demonstrate the first successful attempts in

developing this type of sensor; however, for in vivo minimally-invasive monitoring, a
system with a decoupled sensor and excitation/collection apparatus is desired. Numerous
reports have demonstrated the ability to prepare functional glucose sensors by
immobilizing GOx and an O2 indicator within various species of gel slabs and use
external excitation/collection to monitor sensor kinetics.

However, Xu et al. was the

first to report on preparing nanoscale spherical particles comprising GOx and O2
indicators for use in intracellular monitoring of glucose.39 In this work, a glucosesensitive variant of their PEBBLE131,132 (Probes Encapsulated By Biologically Localized
Embedding) type sensors is prepared through a microemulsion polymerization technique.
The polyacrylamide based PEBBLES are polymerized in the presence of GOx, a
•
9+
sulfonated version of Ru(Ph2phen)3
( a water soluble compound used to enhance
loading in the polyacrylamide hydrogel), and an oxygen-insensitive fluorophore,
resulting in sensors with a mean diameter of 45 nm. The incorporation of an oxygen-
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insensitive fluorophore allows ratiometric intensity measurements of sensor response,
eliminating spectral artifacts caused by source fluctuations or changes in particle
concentration.

Several variants of glucose-sensitive PEBBLES were prepared: one

variant with Texas Red as the reference dye for excitation-based ratiometric
measurements and one variant with Oregon Green as the reference for emission-based
ratiometric measurements. The sensors showed a dynamic range of 0.3 - 8 mM, with a
linear deviation occurring at glucose levels greater than 5 mM. The sensors exhibit an
approximate 100% change in ratiometric intensity from glucose depleted to saturated
conditions. Additionally, the authors demonstrate that the sensors have an approximate
response time of 100 sec. Although this initial work is promising, there is one particular
shortcoming worth noting. Response properties were determined in a standard cuvette,
and it is unclear whether bulk oxygen levels were controlled throughout the experiment;
therefore, it is possible that spectral changes could have been influenced by changes in
bulk oxygen levels as well as glucose. If bulk oxygen levels are not fully replenished, as
glucose and oxygen are consumed locally within the sensors, the depletion of local
oxygen levels could be due to decreasing bulk oxygen levels from glucose oxidation,
resulting in erroneous observations. Nonetheless, this work represents an important step
in the development of an enzyme/oxygen indicator transduction scheme for glucose that
is decoupled from an excitation/collection apparatus.
In 2005, a significant advancement in the development of an enzyme/oxygen
indicator transduction scheme was described by Brown.133 This work represented the
first report in which a continuous bead-based fluorescent sensor for glucose designed for
transdermal implantation was demonstrated.

In this work, calcium alginate hydrogel
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microspheres doped with GOx were prepared using an emulsion technique. Following
particle preparation, GOx was covalently bound to the alginate matrix using EDC/NHSS
catalyzed

amide

bond

formation.

Ruthenium-tris(4,7-diphenyl-1,10-

phenanthroline)dichloride (Ru(dpp)) was subsequently loaded into the spheres using a
controlled precipitation technique.

A novel feature of this work entails the used of

fluorescent nanofilms deposited via the Layer-by-Layer (LbL) self-assembly technique to
provide a reference signal (provided by AF488) as well as control substrate mass
transport properties. Sensor response was quantified using a flow chamber apparatus,
which allowed bulk oxygen levels to be stringently controlled while acquiring real-time
response data. Results were indeed promising because these sensors exhibited a highly
reversible and linear response to glucose over 0 - 600 mg/dL range. However, a 10%
maximum percent change over the operation range was observed, leaving something to
be desired in terms of device sensitivity.
2.2.3.5

The “smart tattoo” concept
The smart tattoo concept is predicated upon the entrapment of a fluorescent

glucose assay within microscale containers, which are subsequently implanted into the
dermal region of the skin. The carriers are designed such that small molecular weight
molecules like glucose are able to freely diffuse into the container, while permanently
compartmentalizing the sensing assay. The tattoos freely interact with interstitial fluid,
and upon transdermal interrogation, emit glucose sensitive spectra that are collected and
analyzed to reveal interstitial glucose levels to the patient in a continuous or spot fashion
(Figure 19).26
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Figure 19. Schematic of the “smart tattoo” concept: implantation, interrogation,
and readout. Taken from McShane. 26

Ultimately, this approach could completely supplement the current standard
blood-draw measurement technique, with hopes of increasing management compliance
among diabetics. In this section, a brief history of the smart tattoo will be given, with
particular interest given to the encapsulation method, as well as transduction scheme.
Additionally, a brief summary of how the smart tattoo configuration addressed in this
work represents a significant advancement of the concept will be given.
These sensors extract glucose levels from the interstitial fluid; therefore, before
additional discussion, the relationship between glucose concentration in the interstitial
fluid and blood should be addressed.

Traditional glucose monitoring techniques and

subsequent therapies are based on blood measurements, thus the relevance of interstitial
measurements depends on the existence of a correlation between the two fluids. Under
normal physiological conditions, changes in the glucose levels within the interstitial fluid
and blood are highly correlated, given free mass transfer of glucose occurs between the
two compartments. Therefore, with the exception of a slight lag time (~ 5 min) reports
have shown a high correlation with glucose levels in the blood and interstitial fluid,
particularly within close proximity of capillaries. 47’ 48 Additionally, all FDA-approved
minimally-invasive devices currently available extract glucose levels through sampling of
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the interstitial fluid; thus, for the duration of this report, glucose measurements by means
of analyzing interstitial fluid will be considered an accurate method by which to manage
diabetic therapies.
Given that the success of smart tattoos is based on the ability to transdermally
interrogate and collect light, optical properties of the skin must also be considered. This
topic was briefly covered in an earlier section during which the wavelength dependencies
o f absorption and scattering properties were discussed (Figure 3); however, additional
detail concerning light propagation as a function of tissue depth was not covered and is
essential for understanding the location at which the implants should be placed. As light
enters the skin, an initial 4% is specularly reflected as a result of the refractive index
mismatch between the air and epidermis.62 The remaining 96% enters the tissue, where it
is attenuated due to successive absorption and scattering events, which contribute to
diffusing the incident beam. The scattering and absorption properties of skin are highly
dependent upon the wavelength of the incident light, such that light at UV (< 300 nm)
and IR (> 1000 nm) wavelengths are strongly absorbed, while wavelengths in between
tend to be strongly scattered (Figure 3).62 The scattering and absorption events attenuate
the light intensity as it propagates through the various skin layers (Figure 20). Therefore,
long wavelength fluorophores should be considered during sensor preparation.
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Figure 20. Total fluence rate as a function of skin depth. (577 nm incident radiation)
Taken from Van Gemert et al. 6 2

The question then arises: which location within the dermis is best suited for
implantation such that sensor performance is maximized? To answer this question, a
brief description of the microcirculation within the skin is necessary.134
Blood flow is supplied to the skin through two plexuses: the upper and lower
horizontal plexuses. The upper plexus is approximately 1 - 2 pm below the epidermis,
while the lower horizontal plexus is at the dermal-subcutaneous junction. Ascending
arterioles and descending venules are paired because they connect the two plexuses.
Ascending from the upper plexus is a series of arterial capillaries that form the dermal
papillary loops, which represent the main supply of nutrients to the skin. Sphincter-like
smooth muscle cells are at the capillary-arteriole junction of the upper horizontal plexus,
serving as a means to regulate the microcirculation. At the dermal-subcutaneous
junction, the upper plexus directly connects to the lower plexus, which supplies nutrients
to other structures in the skin such as hair follicles or sweat glands. A schematic of the
skin circulation can be seen in Figure 21.
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Figure 21. Skin circulatory system. Taken from Guyton and Hall. 1 3 4

Oxygen is supplied to the dermal tissue through uptake from the atmosphere, as
well as through oxygen transported through the capillaries.135 Recent work has shown
the contribution of oxygen from the atmosphere and the blood supply is highly dependent
upon depth within the dermis. In this work, the authors produced a depth dependent
profile of intracutaneous oxygen levels assuming 90 |lM and 0 pM (vasculature
occlusion) oxygen within the hematogenic supply and 277 pM (air-equilibrated oxygen
levels) oxygen at air-skin interface (Figure 22).
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By simulating the oxygen profile in the case of an occlusion within the
vasculature, the authors determined that tissue as deep as 400 pm receives a portion of its
oxygen supply from the atmosphere (Figure 22, trace B). However, at depths greater
than 230 pm a substantial portion of the oxygen is supplied by the vasculature. It is
additionally important to note that oxygen levels within the dermis are highly depthdependent, such that oxygen levels at the epidermal-dermal junction are approximately
215 pM, in contrast to the oxygen levels at the papillary-reticular dermis junction, which
are approximately 115 pM (overall, an approximate 50% variation). Given that the smart
tattoos addressed in this dissertation are based on indirect measurements though oxygen
transduction, bulk oxygen levels must be considered when selecting the appropriate
oxygen probe as well as when analyzing sensor performance (local oxygen levels
ultimately determine when the devices become oxygen-limited).

These concepts are
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critical to the success o f the work presented in this dissertation and will be revisited in
later chapters.
Therefore, in an attempt to maximize the efficiency of excitation and collection
efficiency o f the tattoos, while at the same time placing the tattoos in close proximity of
capillaries (so that chemical concentrations within the interstitial fluid closely match
those in the blood), it is proposed that such systems be implanted in the papillary dermis
at a depth of 150 - 200 pm below the skin surface, as suggested by previous work on
similar systems.23’133
History of the smart tattoo. The first known attempt at preparing smart tattoo type
sensors was in 1999.

-> ”3

In this work, Russell et al. described the encapsulation of FITC-

dextran and TRITC-Con A within millimeter sized PEG hydrogel spheres for use in a
RET-based glucose biosensor.

Before sphere formation, a PEG hydrogel precursor

solution was prepared by chemically conjugating TRITC-Con A to the PEG monomers.
This precursor solution, along with FITC-dextran, was then extruded through a 21-gauge
syringe into a bath o f mineral oil, resulting in spheres with an approximate diameter o f 2
mm.

The spheres were subsequently photopolymerized using UV illumination, then

separated and allowed to hydrate overnight.
Glucose sensitivity experiments were performed, and the percent change in
relative fluorescence at 514 nm was used to compare various sensor formulations. The
authors demonstrated that the maximum percent change in fluorescence was obtained
when a TRITC-Con A/FITC-dextran ratio of 100:1 was used during particle preparation.
Additional experiments also determined that the absolute concentration of the binding
pairs significantly affected device sensitivity.

The authors used a 500:1 TRITC-Con
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A/FITC-dextran ratio, which demonstrated optimum performance (i.e., highest relative
percent change), to construct an additional set of sensors.

Results were promising

because the sensors were shown to linearly respond to glucose levels up to 600 mg/dL.
At elevated glucose concentrations, non-linearities in the response profile were due to the
displacement o f the majority of FITC-dextran molecules and concentration quenching by
free FITC-dextran molecules.

The forward response time of these systems was

approximately 10-12 min; however, the reverse response time was significantly longer (~
20 min). Although leaching of FITC-dextran molecules over time as well as elevated
response time could prevent this system from being used in in vivo diagnostics, this work
represents an ingenious first attempt in smart tattoo development.
Additional work from the same group was focused on developing a software
package to simulate photon propagation through skin tissue.25 In this work, McShane et
al. used Monte Carlo simulation techniques to track excitation photons as they propagate
through the skin. Following the generation of a fluorescence event, the software tracks
the propagation o f the fluorescence photons throughout the tissue, ultimately producing a
spatial distribution o f sensor fluorescence at the skin surface, to aid in the design of an
excitation/collection apparatus.
ultimately dictated

transdermal

Simulation results pointed out that several factors
excitation/collection

efficiency:

(1)

geometrical

properties o f the sensors and/or implanted sensor population, (2) depth at which the
sensors were implanted, and (3) the separation distance between the excitation and
collection optics. Ultimately, the package only simulates the propagation of 488 and 520
nm photons, restricting applications. Nonetheless, simulation results did indeed indicate
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that transdermal excitation and collection of the implanted systems reported by Russel et
al.23 was feasible.
The Cote group eventually tested the efficacy of exciting and collecting emission
•
,
13a
data from PEG hydrogel sensors implanted in an in vivo rat model.

Transdermal

emission spectra were successfully collected from sensors implanted approximately 500
pm below the skin surface. Additionally, a bolus injection of glucose into the tail vein
resulted in measurable spectral changes. This important developmental step ultimately
proved that the smart tattoo concept could provide a feasible mean to fabricate
minimally-invasive glucose sensors.
More recently, Ibey et al. reported on a longer wavelength competitive-binding
assay, with hopes o f reducing the low signal-to-noise ratio observed in previous work.31,
136 In this work, a RET system based on AlexaFluor® 647 labeled Con A (AF647-Con
A) and a fourth-generation polyamidoamine (PAMAM) glycodendrimer labeled with
AlexaFluor 594 (AF594-dendrimer), which is hypothesized to increase assay sensitivity
to glucose was developed. The authors report that the alkalinic nature of the dendrimers
could ultimately cause pH-induced spectral fluctuations, resulting in artifacts; however,
no such artifacts were observed when using the reported fluorophores. Characterization
results indicated that the assay responded linearly to glucose up to 20 mM concentrations,
while responding to step changes in approximately 5 min. A total percent change of
approximately 100% was observed over the operational range of the assay, a considerable
improvement over the sensitivity observed with the TRITC-Con A/FITC-dextran system.
However, the assay was only characterized in solution phase; whether or not behavioral
changes will be observed when the assay is encapsulated has yet to be reported, but the
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authors indicate that encapsulation of the AF647-Con A/ AF594-dendrimer within a PEG
hydrogel is in progress.
Chinnayelka et al.27 recently reported on a novel competitive-binding assay based
on the deactivated form of GOx, apo-GOx, as the binding molecule. In this work, a RET
assay based on the competitive-binding between FITC-dextran and glucose with TRITCapo-GOx (TAG) is reported, a schematic of which is given in Figure 23.

TAG/Glucose
complexes

FAD removal &
TRITC conjugation

I Addition
I of glucose

Addition of FD
FITC t r it C
^

TRITC-Apo-GOx (TAG)

0 Absence of FAD
FITC-Dcxtran (FD)
Glucose

TAG/FD
complexes

Q FAD

Figure 23. Schematic of a RET assay based on the competitive-binding between
dextran and glucose. Taken from Chinnayelka et al.27

A distinguishing feature of this work is the encapsulation of the sensing assay
within hollow microscale capsules, thereby allowing the free movement of the ligand,
receptor, and analyte within the capsule during competitive displacement. To prepare the
capsules, a degradable MnC03 was used as a sacrificial template to which alternating
layers of PAH (a cationic polymer) and PSS (an anionic polymer) were adsorbed using
the LbL self-assembly technique. Additional multilayers comprised of PSS and DAR (a
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photocrosslinkable resin) were subsequently adsorbed to the particle surface. The core
template was removed through an acid treatment, resulting in hollow polymeric capsules
with semi-porous walls. The capsules were loaded with the assay using simple diffusion,
after which a brief exposure to UV radiation crosslinked the DAR and PSS molecules,
permanently entrapping the assay within the capsule. In this report, several key results
were emphasized, the most notable of them is that the molecular weight of the dextran
used in the assay, the FITC-dextran/TAG ratio, as well as the sensor concentration all
greatly affected the sensitivity and glucose dissociation constant, allowing the response
properties o f this system to “tuned.” Also, the author reported a 5-fold increase in
sensitivity over previously reported competitive-binding systems, as well as high
reversibility.

Additionally, unpublished work using NER-emitting fluorophores were

equally as impressive.106 All the work reported by Chinnayelka was completed using
steady-state fluorimetric analysis; however, future work includes dynamic testing as well
as lifetime analysis o f the system prior to in vivo analysis.
Most recently, the first smart tattoo based on enzymatic transduction was
demonstrated by Brown.

13 3

’

1 37

•

In this work, GOx was entrapped within calcium alginate

microspheres by the emulsion-conjugation technique.35 In this technique, GOx is initially
mixed with an alginate solution to form a precursor. Through an emulsion process, GOxdoped alginate spheres are prepared and stabilized with Ca2+ crosslinking. A covalent
amide linkage was formed between GOx and alginate, to stabilize the entrapment. A
methanol-induced controlled precipitation process was used to entrap the ruthenium
derivative, tris(4,7-diphenyl-l,10-phenanthroline)ruthenium(II), Ru(dpp)32+ throughout
the spheres. Additionally, a series of fluorescent nanofilms were adsorbed to the particle
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surface using the LbL technique, the purpose of which is two-fold: to provide an oxygeninsensitive reference signal (AF488) and arguably more important, to provide a means by
which to control the substrate mass transport properties.

The authors point out that

enzymatic sensors provide high selectivity as well as specificity, but require strict control
over reaction kinetics to ensure that the sensors operate in a glucose-limited regime.
Testing of the enzymatic smart tattoos was accomplished in a flow chamber
apparatus that allowed complete control of oxygen concentration in the testing solution.
Sensors were exposed to buffer, followed by exposure to a glucose step, during which
real-time emission data were collected. Results indicated that the sensors responded
linearly up to 600 mg/dL o f glucose, with a sensitivity of 0.02 % change per mg/dL
(approximately 10% change observed at saturation).

The report details that

approximately 50% o f the ratiometric signal was lost due to photobleaching within the
first hour of continuous illumination, requiring extensive data processing techniques to
extract usable calibration profiles.

Even though excessive photobleaching and poor

sensitivity were observed with these concepts, this work represents a significant
contribution in the development of enzymatic smart tattoos.
Smart tattoo configuration addressed in this work. In this work, an enzymatic smart
tattoo sensor based on oxygen transduction is presented. Specifically, GOx and platinum
porphyrin oxygen indicators are immobilized within mesoporous hybrid silica particles.
The hybrid silica particles are prepared through the sol-gel technique using an alginatemodified silanol as the precursor. Fluorescent nanofilms are implemented to provide a
reference signal as well as to control substrate transport, a technique proven crucial in the
success o f similar systems.41,133,137 Although previously reported results on these similar
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systems will serve as the basis of comparison for many results detailed throughout this
dissertation, a brief review on the following topics will indeed be useful for depicting
why the materials used in this work were selected: materials used to control substrate
diffusion and oxygen-sensitive fluorophores.
2.2.4

Mass Transport Controlling
Materials
In enzymatic glucose sensing schemes, mass-transport controlling materials can

ultimately dictate whether or not a particular design is successful. These sensor types
operate on the principle o f glucose-limited oxygen consumption within the local
environment o f the sensor. As glucose diffuses into the sensor, oxygen is consumed and
rapidly replaced, allowing indirect glucose monitoring through an oxygen reporter. To
achieve this fundamental condition, the relative diffusion rate of oxygen into the sensor
must be greater than that o f glucose; therefore, the local oxygen levels within the sensor
are in excess and the sensor is operating in a glucose-limited regime. As bulk glucose
levels are increased, the rate o f glucose delivery into the sensor begins to eclipse the rate
o f oxygen replenishment, preventing the relative recovery of oxygen levels within the
sensor. In this state o f operation, the sensor response begins to deviate from linearity,
thus implicating the onset of oxygen-limited glucose consumption. Further increases in
glucose levels elicit no sensor response, due to complete internal depletion of oxygen
levels (oxygen is readily consumed upon diffusion into the sensor). This condition is
elicited by the surplus of local glucose within the sensor and signifies absolute oxygenlimited catalysis and response saturation. Therefore, mass-transport limiting materials
could effectively control the operational range of enzymatic-based sensors.
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Previously, researchers have employed several mechanisms by which to control
substrate transport. One o f the simplest methods involves the use of thin films, which
can be comprised o f a variety of synthetic or naturally occurring polymer materials.
Wolfbeis’ group made use o f a simple dialysis membrane to construct a sensor, whose
sensitivity was quite unimpressive (1.5 - 2 mM).107 Others have used the so-called
“sandwich conformation” to control diffusivities, where GOx was entrapped between two
membranes; however, results implicated that product buildup within the enzyme layer led
to rapid sensitivity losses under continuous operation.138

As previously reviewed,

Rosenzweig et al. used a polyacrylamide thin film to control substrate diffusivities and
achieved notable results.38 Additional work by other researchers have shown that sol-gel
derivatives could be implemented as diffusion-limiting films.139’141 All this work has
proved successful, but to an extent, these techniques do not provide a highly precise
means to control substrate transport.
Thin films fabricated using LbL self-assembly allow the construction of complex
nanocomposites through simple adsorption of oppositely charged molecules in a
sequential fashion. In this technique, a charged substrate is introduced to oppositely
charges molecules that electrostatically self-assemble on the substrate surface, forming a
nanometer scale thin film. Subsequent molecular layers are adsorbed in a similar fashion,
ultimately resulting in a film with the desired molecular arrangement (Figure 24).
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Figure 24. Layer-by-Layer nanofabrication process. Taken from McShane. 2 6

This general technique has been applied to various charged species, including
linear polyions, proteins, viruses, ceramics, lipid tubules, lipids, and charged
nanoparticles.142 Therefore, this technology affords a practically endless variety of
nanocomposite materials to be constructed through an extremely simple procedure.
Through the careful selection of materials and deposition conditions, precise nanometerscale thin films can be deposited in a regular, consistent fashion. This technique has also
allowed the realization of complex microscale three-dimensional structures, namely
microcapsules.143

Polymeric microcapsules are obtained through the sequential

adsorption of polyelectrolyte multilayers onto sacrificial spherical templates (inorganic or
organic). After the desired film architecture is obtained, the core templates are dissolved,
resulting in stable hollow polymeric microcapsules comprised of nanocomposite walls.
Such containers have already been exploited to successfully prepare RET-based smart
tattoo sensors.27,106
The Bruening group published a series of manuscripts studying the transport of
various molecular species through polyelectrolyte multilayers.144' 149 In one report, the
transport of uncharged solutes such as glucose, glycerol, and sucrose through
polyelectrolyte multilayer with various film architectures was explored.144 In this work,
multilayers comprised of PSS and PAH were deposited onto porous alumina substrates
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and the diffusivities of the uncharged solutes through the films determined.

Results

demonstrated that the glucose diffusivity through 7 bilayers of PS S/PAH [demarked
(PSS/PAH)?] was 9.87 x 10"14 m2 sec’1, a decrease in four orders o f magnitude when
compared to the glucose diffusivity in water (6.9 x 10' 10 m2 sec' 1 ), proving that
polyelectrolyte films could adequately be applied as diffusion-limiting coatings. This
result is remarkable, given that a typical (PSS/PAH)7 film has an approximate thickness
of 28 nm (4 nm per PSS/PAH bilayer).
Brown and McShane devised a model based on reaction-diffusion kinetics to
simulate how polyelectrolyte films would influence the performance of enzymatic smart
tattoos 41 In this work, the authors present a mathematical model of previously reported
sensors concepts,137 in which a ruthenium derivative and GOx were encapsulated within
calcium alginate microspheres coated with polyelectrolyte multilayers to control substrate
diffusivity. Various simulations were used to observe the effect of sensor parameters,
such as sphere diameter, film thickness, and enzyme concentration. By varying nanofilm
thickness through simply adjusting the amount of bilayers adsorbed onto the surface, the
diffusivity o f glucose relative to oxygen is modulated, thereby adjusting the average
steady-state oxygen levels observed within the sensor (Figure 25).
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Figure 25. Average oxygen concentration at steady-state within alginate enzymatic
smart tattoo sensors with varying glucose levels and nanofilm thicknesses.
Taken from Brown et al. 4 1

The authors highlight that these nanofilms drastically affect the sensor response,
such that 12 nm nanofilms deposited onto the surface can significantly improve device
response when compared with uncoated sensors. However, it is important to note that the
model used in this work assumed that the substrate diffusivities throughout the nanofilms
were independent of thickness, an assumption that is not likely to hold in reality.
Nonetheless, the utility o f these nanofilms in engineering the response properties of
enzymatic smart tattoos cannot be understated. Further simulations using experimental
parameters were performed and the output directly compared to experimentally
determined results.

Excellent agreement between simulated response and the

experimental response were observed, further validating the accuracy of the model
(Figure 26).
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Taken from Brown et al.

Therefore, the high precision and controllability afforded by LbL films, as well as
the proven ability to successfully modulate substrate diffusivities in similar enzymatic
sensors (as proven in experimental and simulation studies

41 133 137

’

’

), make this technique

highly attractive for the work presented in this dissertation.
2.2.5

Luminescent Oxygen
Indicators
Oxygen is one o f the best known collisional quenchers of fluorescence.

In

collisional quenching, the quencher contacts the fluorophores while in the excited state,
returning the fluorophore to ground state without photon emission.

QQ

The process of

collisional quenching is typically characterized by the Stem-Volmer equation:

F

=

T

= i + *qt , { Q ] = l + K DlQ]

In this equation, F0 and F are the fluorescence intensities in the absence and presence of
the quencher, To and t are the lifetimes of the fluorophore in the absence and presence of
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the quencher, kd is the biomolecular quenching constant, and [Q] is the concentration of
the quencher (in this case, molecular oxygen). The Stem-Volmer quenching constant is
Kd, and is calculated as the product of kd and x0. The Smoluchowski equation describes
the biomolecular quenching constant, kd, and is given by:
kq - 4nNp(Df + Z>9) -103,
where Df

and Dq are the diffusion coefficients of the quencher and fluorophore,

respectively, N is Avogadro’s number, and p is the probability of collision. Therefore,
for oxygen indicators to be sensitive to low concentrations of oxygen, long lifetimes in
the absence o f the quencher (xo) must be exhibited (most oxygen indicators typically
exhibit lifetimes greater than 100 ns). In the context of this dissertation, the indicators
will be physically immobilized; thereby, the diffusion of oxygen through the
immobilization matrix will to some degree affect sensitivity.

This concept will be

revisited later in this section.
There are two main classes of luminescent oxygen indicators: organic luminescent
probes and organometallic compounds.150 The first class includes polycyclic aromatic
hydrocarbons and decacyclene compounds; however, most of these fluorophores require
high UV excitation, making transdermal applications difficult and will therefore not be
considered for further review in this text. Additional reading on organic luminescent
probes can be found in the recent review by Amao.150
The majority o f research in luminescent oxygen probes has focused on
organometallic

compounds,

comprised

of

transition

metal

complexes

and

metalloporphyrins. Metal ligand complexes (MLCs) refer to transition metal (Ru2+, Re,
1 I

1 I

Os , and Ir ) complexes containing one or more diimine ligands.

QQ

These compounds
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are rendered fluorescent through electron promotion from the metal to the ligand - the socalled metal-to-ligand charge transfer transition (MLTC) state upon photon absorption,
where an intersystem crossing from the singlet to the lowest-energy triplet state
(requiring an electron-spin inversion) proceeds.

Given that the conversion from the

triplet state to the ground state requires an additional electron-spin flip, the triplet state of
MLCs has an intrinsically long lifetime prior to photon emission.

08

Upon contact with molecular oxygen (while in the excited triplet state), the
energy o f the MLC is non-radiatively transferred to oxygen, resulting in the formation of
singlet oxygen. This highly reactive form of oxygen can either spontaneously return to
ground state or consume oxygen from another molecule (oxidation). Should this occur to
the MLC itself, irreversible damage can result (termed “photo-oxidation”).
O f the transition metal complexes, ruthenium metal ligand complexes have been
extensively researched for applications in biosensors.38,103,129,137,151-153 O f the various
ruthenium

complexes,

ruthenium(II)-2,2’-bipyridine

and

tris(4,7-diphenyl-1,10-

phenanthroline)ruthenium(II) and have been studied the most. Both these compounds
exhibit lifetimes in the low ps range and are excited with approximately 450 nm light,
with subsequent emission around 590 - 605 nm. This relatively long Stokes shift allows
a reference fluorophore with emission in the 500 - 570 nm range (and excitation in the
range of 450- 500 nm) to be readily incorporated into the optical transduction scheme.137
Although

biosensors

utilizing

ruthenium

complexes

have

been

successfully

demonstrated, metalloporphyrins typically have longer lifetimes and are therefore more
sensitive to oxygen levels than ruthenium complexes.44
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Metalloporphyrins, like MLCs, have unique electron transfer properties, resulting
in luminescent properties. Typically porphyrin molecules have three distinct absorption
peaks, the first o f these is the Soret band, which results from the electronic excitation
from the ground state to a vibration level of the second excited state. Two additional
absorption bands (usually between 500 and 600 nm) result from the promotion of ground
state electrons to the lowest vibration state level of the first excited singlet state and one
moment o f vibrational energy at the first excited singlet state.44 Therefore, porphyrin
molecules tend to have a variety of excitation options, allowing more versatility when
designing optical transduction schemes, but the highest relative excitation efficiency is
observed with UV excitation. Upon contact with molecular oxygen, a similar photo
oxidation schemes unfolds; however, porphyrins undergo different electron orbital
transitions when compared to ruthenium complexes.
Two o f the more popular porphyrin compounds are Pt(II) and Pd(II)
octaethylporphines, both of which exhibit lifetimes on the order of 100 ps, with
excitation peaks at ca. 375, 500, and 535 nm and emission at 640 - 660 nm.46 For the
application described within this dissertation, Pd(II) porphyrin complexes will not be
further considered due to lack of sensitivity over dermal physiological levels described
earlier. Pt(II) complexes are highly sensitive over physiological oxygen levels in the
dermis (as will be detailed later in this text); however, these complexes are poorly soluble
in water, making aqueous application difficult. To overcome this difficulty, surface
adsorption to a carrier, usually silicon, organic glassy, cellulose derivatives, or
fluoropolymers is common practice; in these cases, the immobilization matrix has been
shown to significantly affect O2 sensitivity.44, 45 Generally, researchers agree that the
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difference in sensitivities observed in various immobilization media are due to the
solubility and diffusivity of oxygen in the host matrix.46 Given this observation, the
highest O2 sensitivities with Pt(II) complexes been reported with Pt(II) porphyrin
adsorption onto silica-containing matrices.42, 46 It is theorized that oxygen molecules
adsorb to the surface substrate then rapidly diffuse across the surface, the so-called
Langmuir-Hinshelwood, and silica containing substrates exhibit high oxygen binding
affinities and surface diffusion rates45’46 Thus, silica containing matrices often excel as
platforms upon which highly-sensitive oxygen sensors are built.
This result was observed in the work of Koo et al., where and oxygen-sensitive
variant o f optical PEBBLE nanosensors was presented.42 In this work, organicallymodified silicate nanoparticles containing Pt(II) octaethylporphine (PtOEP) as the
oxygen indicator and octaethylporphine (OEP) as the oxygen-insensitive reference were
prepared through the sol-gel process. Using the percent change in PtOEP/OEP peak ratio
observed at oxygen depleted and saturated conditions, the authors calculated the overall
sensitivity. A sensitivity of 97% was calculated, significantly greater that those observed
for ruthenium-based sensors. A similar sensitivity was observed using a ketone-modified
variant o f PtOEP. Table 1 details the findings of the authors in terms of a comparison of
sensitivities observed with ruthenium based schemes immobilized in various matrices:
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Table 1. Comparison of sensitivities (Qdo) of Pt(II) porphyrin and ruthenium
complexes immobilized in various silica-containing matrices.
Taken from Koo et al.42
probe

sensor type

[(Ru(dpp)3]2+
[(Ru(dpp)j]2+
IdM dppW 24
PtOEP
PtOEPK

silica film
ormosil film
silica nanoparticle
ormosil nanoparticle
ormosil nanoparticle

(bom
30

56-80
80
97
97

Therefore, for the work detailed in this dissertation, highly sensitive Pt(II)
porphyrin complexes immobilized within silica-containing matrices will provide highly
sensitive oxygen sensors as platforms for enzymatic smart tattoos.
In summary, many methods have been employed in an attempt to provide
sustained minimally- and non-invasive glucose monitoring techniques. Techniques based
on fluorescence-sensing schemes have advantages (high sensitivity, as well as selectivity)
over other techniques, but challenges to realize in vivo diagnostic devices may be faced.
Recent work in the area of enzymatic smart tattoos has indeed been promising,26,133 but
problems with sensitivity and photodegradation have raised efficacy questions. In the
following chapters, a similar approach (enzymatic transduction) will be employed
utilizing highly sensitive oxygen-sensitive indicators dyes and silicate immobilization
matrices in an attempt to produce more sensitive, photostable devices. These devices
could potentially be integrated into a transdermal glucose monitoring system to provide
continuous and spot monitoring to diabetics, with hopes of increasing compliance with
suggested monitoring frequencies.
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CHAPTER 3

PORPHYRIN-BASED SPHERICAL OXYGEN
SENSORS AS PLATFORMS FOR
ENZYMATIC SMART TATTOOS
3.1

Introduction

Optical glucose sensors19, 154 particularly “smart tattoo” type sensors23'26 implantable luminescent particles that may be transdermally interrogated with light - are
being pursued as minimally-invasive diabetic monitoring devices. While work in this
field has primarily focused on systems exploiting competitive-binding assays,28"30’ 155,156
critical steps toward realizing enzymatic smart tattoos have also been reported.
Enzymatic smart tattoos are typically comprised of an oxygen-quenched phosphorescent
dye and glucose oxidase (GOx), an enzyme which specifically catalyzes the oxidation of
P-D-glucose. Under conditions where this reaction is glucose-diffusion-limited, local
glucose concentrations can be extracted from 02-dependent emission spectra or
luminescence lifetimes.34 Therefore, overall performance of such sensors is directly
related to oxygen sensing properties.

For this reason, long-lived oxygen-quenched

phosphorescent heavy metal ligand complexes are commonly used for such
applications 43 Most work in this area has focused on using ruthenium complexes as the
reporter dye.36, 153' 157 However, metalloporphyrin-based sensors, particularly Pt(II)

86

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

87

complexes, exhibit significantly greater sensitivity to O2,44 due in part to a longer
fluorescence lifetime; however, these have received only minimal attention for
biosensing applications.

•yn

Pt(II) porphyrin complexes are poorly soluble in water, making aqueous
application difficult. To overcome this difficulty, surface adsorption to a carrier, usually
silicon, organic glassy, cellulose derivatives, or fluoropolymers is common practice; in
these cases, the immobilization matrix has been shown to significantly affect O2
sensitivity.44,45 Overall, the highest O2 sensitivities have been observed with porphyrin
adsorption onto silica-containing matrices.42,46
An additional consideration when attempting to combine the oxygen indicator
with an enzyme is the need for co-immobilization of these two active elements. For
GOx, the immobilization environment is preferably hydrophilic, and the enzyme must
further be accessible to both oxygen and glucose.

We recently introduced a facile

approach to produce mesoporous silicate particles comprising homogeneously distributed
hydrophilic and hydrophobic domains using sol-gel-induced self-assembly. These hybrid
structures are being studied as a platform for optical enzymatic biosensor technology.158
The hybrid functionalities allow simple homogeneous adsorption of both hydrophobic
and hydrophilic species like dyes and enzymes, respectively; however, maintaining
sufficient functionality o f the immobilized materials is paramount. Thus, the effect of
this carrier material on the immobilized O2 indicator must first be evaluated. As a first
step in designing highly sensitive glucose-sensitive materials, we report on the
immobilization o f a Pt(II) porphyrin complex, namely Pt(II) octaethylporphine (PtOEP),
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onto hybrid mesoporous silicate particles and characterization of the 02-induced
quenching effect.

3.2
3.2.1

Experimental Details

Materials
Sodium alginate (low viscosity, 250 cps, MW 12-80 kDa), (3-glycidyloxypropyl)

trimethoxysilane (GPTS), and ammonium hydroxide were obtained from Sigma and used
for the synthesis o f mesoporous alginate-silica particles. Platinum(II) octaethylporphine
(PtOEP, Frontier Scientific) and tetrahydrofuran (THF, Fluka) were used to prepare
PtOEP-doped alginate-silica particles. Poly(allylamine hydrochloride) (PAH, MW = 70
kDa, Aldrich), poly(sodium 4-styrene sulfonate) (PSS, MW = 70 kDa, Aldrich), and
sodium chloride (Sigma) were used during the deposition of multilayer thin films.
Additionally, rhodamine B isothiocyanate (RITC, Aldrich) was conjugated to PAH and
used in thin film deposition. O2 (Air Liquide), N2 (Air Liquide), and phosphate-buffered
saline (PBS, Sigma) were used during testing. All necessary titrations were performed
using 1.0 M HC1 and 1.0 M NaOH, which were obtained from Fluka. All chemicals
listed above were reagent grade and used as received.

Throughout all experimental

procedures, ultra pure water with a resistivity of greater than 18 MQ was used.

Unless

otherwise stated, all experimental processes were conducted at 25 °C.
3.2.2

Preparation of Mesoporous
Alginate-Silica Particles
Alginate-silica (“algilica”) particles were prepared using a procedure similar to

that which was previously reported.35,159 Briefly, the precursor was prepared by stirring
a solution comprised o f 1.5 wt% aqueous alginate solution and glycidyl silane (GPTS) in
a 1:1 volumetric ratio for at least 4 hours, resulting in an alginate-modified silanol.
88
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While stirring, 2 mL of the precursor silanol was added to 3 mL of water. To initiate the
sol-gel process, 1.25 mL o f 10 M

N H 4O H

was added and stirred for 20 min, followed by

the addition o f 10 mL of water and an additional stirring time of 40 min. An extra 40 mL
of water was added and the suspension stirred for at least an additional 4 hours. The
resulting particle suspension was rinsed with DI water using four sequential
centrifugation cycles and diluted to a total aqueous suspension volume of 1.5 mL. A
Beckman Coulter counter (Z2) equipped with a 100 pm aperture was used to obtain the
mean diameter and concentration of particles comprising the stock suspension.
3.2.3

Preparation of PtOEPDoped Particles
Approximately 250 pL of stock particle suspension was placed in a

microcentrifuge tube, the supernatant removed via centrifugation, and 250 pL of a 750
pM PtOEP solution prepared in THF was added. The container was sealed to prevent
volatilization of THF and stirred for 30 min, after which 30 pL of water was added and
the suspension stirred for an additional 30 min. The water added to the suspension
initiated a solvent-mediated controlled precipitation of PtOEP into the mesoporous
particles, a technique used in previous reports to aid in the immobilization of desired
molecules.160 The suspension was subsequently rinsed with DI water four times.
3.2.4

Adsorption of Nanofilm
Surface Coatings
RITC was conjugated to PAH (PAH-RITC) according to a standard amine

conjugation protocol.161 Before multilayer film deposition, respective solutions of PSS,
PAH, and PAH-RITC were prepared in 0.2 M NaCl at a concentration of 2 mg/mL. The
supernatant o f the particle suspension was removed and the particles were resuspended in
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PAH-RITC.

Following a 15 min adsorption time, during which the particles were

continuously shaken using a Vortex Genie-2 (Fisher Scientific) and protected from light
with aluminum foil, the particles were rinsed three times with DI water and subsequently
resuspended in PSS solution.

To determine the overall number of PAH-RITC/PSS

bilayers to be deposited on the particle surface, fluorescence emission spectra were
acquired using the sample chamber detailed in the following section after each bilayer
deposition. When the PtOEP emission maxima (645 nm) was approximately 75% of the
RITC emission maxima (580 nm), which in this case was three bilayers of PAH-RITC
and PSS (denoted {PAH-RITC/PSS}3), PAH-RITC deposition was halted.

The

completed oxygen sensors were imaged using confocal microscopy with 543 nm He/Ne
excitation and a 63x oil immersion lens.
3.2.5

Testing Apparatus
A custom-designed software suite (LabVIEW, National Instruments) and testing

apparatus was developed to monitor changes in sensor response to varying levels of
dissolved oxygen (Figure 27).
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Figure 27. Schematic of testing apparatus used to quantify oxygen response
properties of self-referenced oxygen sensors.

This system allows control of bulk oxygen concentration by means of regulated
mixing of oxygen and nitrogen through a pair of individually addressable pressure
controllers (Model 00122QA, Cole-Parmer Instrument Company) entering the buffer
reservoir. Equilibration of oxygen levels within each reservoir was hastened with a gas
diffuser (ChemGlass, fine frit) and magnetic-assisted stirring (Dylastir, VWR).

A

peristaltic pump (MasterFlex L/S 7550 pump drive with MasterFlex Easy Load 3 pump
heads) extracted the oxygenated buffer from the reservoir and into the sample chamber.
Prior to entering the sample chamber, the dissolved oxygen level of the solution was
recorded using an in-line oxygen microelectrode and picoammeter (OX 500 and PA2000,
Unisense). The sample chamber consists of a custom-designed garolite flow cell, which
accepts a standard microscope slide (25x75x1 mm, VWR) with the sensors immobilized
to the surface. Additionally, the reaction chamber contains a port to interface the sample
slide with a custom optical fiber. The optical fiber probe was comprised of one delivery
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fiber (400 (am multi-mode, ThorLabs) and six collection fibers - a so-called “6-around-l”
fiber - and delivered excitation light from a Hg-Xe arc lamp (Model 68811, Oriel)
containing a 530 ± 5 nm interference filter (ThorLabs).

Sensor emission was

subsequently delivered to a diode array spectrometer (USB 2000, OceanOptics) through
the collection bundle. Following passage through the sample chamber, the solution was
recycled into the reservoir vessel. Tubing (Norprene® , MasterFlex) in direct contact
with solution exhibited negligible oxygen permeability, thereby minimizing convectiveinduced changes in oxygen levels as the solution traveled through the apparatus. It is
noteworthy to state that all o f the equipment, except the stir plates, used in the testing
apparatus are either individually addressable (i.e., directly controlled) or report (i.e.,
output collected and processed in real-time) through the custom software suite, allowing
increased user-control o f the experimental environment and minimized data processing
times. Details on experimental parameters, including sample preparation techniques, will
be detailed in the next section.
3.2.6

Oxygen Sensitivity Testing
The testing apparatus was set up to pump buffer (0.01 M PBS, pH = 7.4) into the

sample chamber (Figure 27). To prepare a sample for testing, double-sided pressuresensitive polyacrylate adhesive (3M) was placed onto the surface of a standard
microscope slide, followed by the addition of 10 pL (~ 106) of sensors onto the adhesive
surface. The sample was dried under streaming N2 and fixed into the sample chamber.
Randomized oxygen levels ranging from oxygen depleted to oxygen saturated conditions
were obtained by bubbling O2 and N2 at varied partial pressures into the buffer reservoir.
With the solution flow rate set at 4 mL/min, the oxygen-dependent emission spectra of
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the sensors were collected when the oxygen level at the reaction chamber inlet reached
steady-state, as indicated by the in-line oxygen microelectrode.

3.3
3.3.1

Results and Discussion

Sensor Fabrication
To allow compensation for instrumentation fluctuations and changes in

illuminated particle numbers, it is common practice to include an 02-insensitive reference
probe, allowing ratiometric analysis of sensor response. To provide such a reference
signal, rhodamine isothiocyanate (RITC)-tagged nanofilms were deposited onto the
particle surface using electrostatic layer-by-layer assembly,40 a technique allowing
multilayer polyelectrolytes to be deposited with nanometer precision on threedimensional structures.

Following deposition of RITC-doped nanofilms, the emission

spectrum o f the dissolved oxygen sensors was acquired using the testing apparatus
detailed in the above section (Figure 28). Additionally, it is important to state that these
data were collected at air-equilibrated conditions.
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Figure 28. Emission spectrum of self-referenced dissolved oxygen sensors acquired
using 530 nm excitation.

From inspection o f the emission spectrum of the sensors, it is clear that a bimodal
distribution exists.

Upon 530 nm excitation, both RITC and PtOEP are efficiently

excited and emit with maxima around 580 nm and 645 nm for RITC and PtOEP,
respectively. A schematic of this concept is given in Figure 29, where h vex, h V r i t c , and
h vptoEP represent the 530 nm excitation and simultaneous emission of RITC and PtOEP,
respectively.
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hv e x
PtOEP

Figure 29. Schematic of single-excitation/dual-emission ratiometric oxygen sensor.

The spatial distribution of dyes within the particles was analyzed using confocal
microscopy with 543 nm HeNe excitation and emission collection over 560-600 nm and
630-660 nm for RITC and PtEOP, respectively (Figure 30). Line scan analysis of the
acquired images indicated PtOEP adsorption was uniform throughout the particle, while
RITC was limited to the surface, as expected (Figure 30).
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Figure 30. Confocal images of self-referenced oxygen sensors with corresponding
line scan data depicting the spatial distribution of
RITC (red) and PtOEP (blue).
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3.3.2

Oxygen Response Properties
Characterization of the 02-quenched properties of the particles was performed

using steady-state fluorimetric analysis with particles immobilized in a custom flow
through chamber.

Upon 530 nm excitation with a filtered arc lamp, intense stable

emission spectra were acquired (Figure 28). The steady-state response of the sensors was
obtained by pumping buffer from a reservoir set at a desired oxygen concentration, in
random order. Spectral measurements were performed in parallel with measurements
collected from a calibrated O2 microelectrode. The ratiometric response was obtained by
normalizing the corrected intensity spectra to the RITC maximum at 575 nm (Figure 31),
where the 645 nm peak decreased with increasing oxygen concentration. The PtOEP
peak ratio vs. O2 concentration was plotted to determine regions of high sensitivity
(Figure 31 - inset). Before ratio calculations, the PtOEP peak ratio (645/575 nm) was
corrected for spectral overlap from the reference peak, which was determined to be
approximately 17%.
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Figure 31. Oxygen-dependent emission spectra of sensors, depicting strong decrease
in emission at 645nm when moving from oxygen depletion to saturation. Inset:
Peak ratio vs. O2 concentration.

An important feature o f these nanocomposite materials is the high sensitivity to
oxygen levels between O2 depleted and atmospheric (277 pM) levels, such that 95% of
the total change in ratiometric intensity per pM of O2 occurs for O2 concentrations less
than 277 pM. Given the reported intradermal O2 level of 90 pM,162 these sensors would
be highly sensitive in the physiologically relevant range. For enzymatic smart tattoo
applications, high sensitivity to O2 within this region is critical, as reported reactionkinetic simulations o f enzymatic smart tattoo behavior show that local O2 levels within
the sensor can be reduced to 10 pM when elevated blood-glucose levels (350 mg/dl) are
present., 41
It is well-known that environmental properties can influence the quenching
properties of luminescent oxygen probes, affecting the Stem-Volmer relationship, which
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relates fluorescence intensities in the absence and presence of the quencher, F0 and F,
respectively, to the quencher concentration. Other reports have observed a downward
curvature in the Stem-Volmer relationship, attributed to indicator exposure to multiple
environments o f varying O2 diffiisivity.163’ 164 However, we observed highly linear
quenching behavior (Figure 32), indicating that PtOEP is distributed within a highly
homogeneous environment throughout the immobilization matrix, such as has been noted
in other silica-based systems.42

ll

LL

y = 0.0146x + 1
R2 = 0.997
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[0 2] (pM)

1000
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Figure 32. Stern-Volmer plot for ratiometric PtOEP sensors, including linear fit.
Error bars indicate one standard deviation («=3).

Additionally, it is common to quantify sensitivity by calculating the overall
quenching response to dissolved oxygen (QDO) using the following equation:
QDO = Rdeoxy~ Roxy x 100,
^ deoxy
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where Rdeoxy and Roxy represent the PtOEP peak ratio during exposure to oxygen depleted
and saturated conditions, respectively. The sensitivity was determined to be 95%, among
the highest reported sensitivity for luminescent dissolved-oxygen sensors reported to
date.42

High oxygen sensitivity, coupled with the protein-friendly amphiphilic

mesoporous immobilization matrix, makes these systems ideal for enzymatic smart tattoo
development.
3.4

Conclusion

Highly sensitive, internally-referenced phosphorescent oxygen sensors using
hybrid mesoporous silicate microparticles were prepared, in which homogenous
adsorption o f PtOEP was achieved throughout the particle structure, while reference
emission was localized to the surface.

The sensors respond linearly to oxygen

concentration while exhibiting 95% sensitivity.

These results form a basis for

development o f enzymatic glucose sensors for use in diabetic monitoring by integrating
glucose oxidase into the reported oxygen-quenched system. Thus, in the next chapter, the
co-immobilization of PtOEP and GOx is presented and the glucose sensitive response
properties evaluated.
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CHAPTER 4

PORPHYRIN-BASED ENZYMATIC
SMART TATTOO SENSORS
4.1

Introduction

In the previous chapter, a ratiometric oxygen sensor comprising algilica matrices,
platinum porphyrin indicators and fluorescent nanofilms was described.

The results

indicated high oxygen sensitivity within the expected range of operation (< 90 pM);
therefore, algilica matrices and PtOEP indicators provide a platform upon which to
develop smart tattoo type sensors.

In this chapter the feasibility of co-immobilizing

PtOEP and glucose oxidase within algilica matrices to produce glucose sensitive devices
is explored, with particular emphasis on using fluorescent nanofilm coating to modulate
response characteristics, namely sensitivity and range. Ultimately, devices with a high
degree o f controllability would be an attractive solution to provide diabetics with
monitoring technology customized to their individual needs.
In the United States alone, it is estimated that 20.8 million residents (7% of the
population) are afflicted with diabetes mellitus, a group of diseases characterized by
hyperglycemia elicited from defects associated with insulin secretion, insulin action, or
both.1 A recent clinical trial proved that proper care and management o f blood glucose
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levels is critical in preventing or delaying the progression of complications, which
include

cardiovascular

disease,

stroke,

hypertension,

retinopathy,

nephropathy,

neuropathy, periodontitis, gingivitis, cataract formation, and pregnancy complications. 2 ’ 8
•

•

Proper disease management is centered around effective control o f blood glucose levels
using one or more of the following therapies:

changing high-risk lifestyle habits,

consuming prescription medications, and administering supplemental insulin.7 However,
to effectively manage therapy dosages, particularly supplemental insulin, patients must
frequently evaluate blood glucose levels. Currently, the gold-standard method for self
monitoring blood glucose levels is the “finger-prick” test, which involves lancing the skin
and extracting a blood sample that is subsequently placed in a portable device to extract
glucose levels.

This method, although proven highly accurate, is both painful and

bothersome for the patient, especially if the recommended testing frequency - at least 3
times per day - is practiced.7 However, according to several studies, only 40% of
diabetics requiring insulin therapy and 5% of diabetics requiring prescription medications
monitor their blood glucose levels at least once per day, citing excessive pain and
inconvenience as the principle reason for lack of compliance. 11-13 Therefore, it is
reasonable to conclude that the development of a simple and painless method would
increase patient observation o f the recommended self-monitoring guidelines, which in
turn would reduce their overall complications. The development of such a minimally- or
non-invasive technique which can provide continuous and spot measurements has long
been considered one o f the “holy grails” of diabetes research.14
Optical monitoring techniques, including fluorescence,

10

absorbance,

on

raman,

'j

i

and polarization spectroscopy22 have been heavily researched as a minimally-invasive
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means to measure blood glucose levels. However, the high sensitivity and selectivity
associated with fluorescence-sensing techniques have led to increased interest by many
groups.19 A particularly interesting technique which has the potential to provide both
spot and continuous measurements of glucose levels are “smart tattoo” type sensors,
which consist o f micron-scale glucose-sensitive luminescent particles that could be
implanted into the dermis and transdermally interrogated with light.23'26 Most of the
work in this field has primarily focused on the development o f competitive-binding based
assays, which rely on changes in fluorescence emission properties modulated by
fluorescence resonance energy transfer (FRET) to optically transduce glucose levels.27'31
FRET is driven through the competitive binding of a fluorescent ligand and analyte to
receptor sites on lectins, glucose-binding proteins, or deactivated glucose-specific
enzymes, such that the ligand is displaced from the receptor when in the presence of the
analyte causing measurable changes in emission spectra.32, 33, 165 However, recent
successes with enzymatic-based smart tattoo sensors have been reported.26,166
Enzymatic-based smart tattoo sensors typically entail of an oxygen-quenched
luminescent dye and glucose oxidase (GOx) entrapped within a microscale container. As
glucose diffuses into the sensor, local oxygen levels are proportionally reduced through
GOx-initiated catalysis. The glucose-dependent oxygen levels are then relayed through
the fluorescence emission of the oxygen reporter, providing an indirect means to monitor
glucose levels.34 Although the integration of GOx into the sensing scheme provides
innate selectivity to the sensor as well reversibility, controlling the reaction-diffusion
kinetics o f both glucose and oxygen are key to the realization of optimized sensors.35
Initial work in this field was done using optical fibers with sensor components
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immobilized in transport limiting matrices.36’37’167 While these devices exhibit desirable
sensor properties, in practice they would require a permanent connection to external
measurement devices, providing a potential infection pathway.

Additional work by

Kopelman’s group showed that sensor components immobilized within nano-scale
polyacrylamide particles reversibly responded to physiological glucose levels.

39

Brown

et al. advanced the concept using calcium alginate hydrogel microspheres, which
contained GOx and an oxygen-quenched ruthenium compound, and diffusion-limiting
nanofilms adsorbed to the surface using layer-by-layer self assembly.26,40,41 By altering
the physical properties o f the nanofilms, the analyte transport properties into the
microsphere could be altered, resulting in control of overall response characteristics, such
as sensitivity and linear range.41 Although the results reported to date are promising,
most work has focused on using phosphorescent ruthenium complexes as the reporter
molecules, which have a lower sensitivity than other oxygen probes, such as
phosphorescent metalloporphyrins.37,42,43,44
Since the overall response properties of enzymatic smart tattoo sensors are
dependent on the oxygen probe, it is hypothesized that the integration o f a more sensitive
Pt(II) porphyrin dye should result in an overall increase in sensitivity to glucose. To our
knowledge only one report has used Pt(II) porphyrins in enzymatic glucose sensors.37
The lack of work with porphyrin indicators could be due to extreme hydrophobicity,
causing difficulties in aqueous applications 43 To overcome this obstacle, researchers
have since developed immobilization matrices comprised of silicon, organic glassy,
cellulose derivative, or fluoro-polymers, to which Pt(II) porphyrins can be adsorbed,
thereby allowing dissolved oxygen measurements in aqueous environments.44, 45 It is
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well documented that the immobilization matrix can drastically affect the oxygen
sensitivity and that silica-containing matrices produce high sensitivities, although the
exact mechanisms are still debated.42,46
We recently introduced a simple method (performed at room temperature and
independent of surfactants) to self-assemble mesoporous silicate particles comprised of
homogeneously distributed hydrophilic and hydrophobic domains, so-called hybrid
structures, for use as a platform technology.

One application of this technology is the

use as an immobilization matrix for enzymatic smart tattoo components. As a first step in
preparing enzymatic smart tattoos, Pt(II) octaethylporphine (PtOEP) was adsorbed to
alginate-modified mesoporous silica particles, followed by characterization of the
oxygen-induced quenching effect, as detailed in Chapter 3.159 As a continuation o f that
work, this report focuses on the adsorption of both GOx and PtOEP into alginatemodified mesoporous silica particles subsequently coated with fluorescent nano-films
using the LbL technique. The loading characteristics of the sensor components into the
mesoporous substrate were characterized using confocal microscopy and fluorescence
spectroscopy. The response dynamics - stability, response time, reversibility, sensitivity,
and analytical range - o f the sensors to varying bulk glucose levels were characterized
using a custom flow chamber. Potentially, these systems or similar systems may be
integrated into minimally-invasive diabetic monitoring devices, allowing diabetics to
perform continuous and spot measurements of blood glucose levels without the pain and
bother associated with “finger pricking”. More important, this work lays the foundation
for the development o f additional highly sensitive biochemical monitors, which may be
obtained by simply integrating other enzyme species specific to the target analyte.
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4.2
4.2.1

Experimental Details

Materials
Sodium alginate (low viscosity, 250 cps, MW 12-80 kDa), (3-glycidyloxypropyl)

trimethoxysilane (GPTS), and ammonium hydroxide were obtained from Sigma and used
for the synthesis o f mesoporous alginate-silica particles. Platinum(II) octaethylporphine
(PtOEP, Frontier Scientific), tetrahydrofuran (THF, Fluka), glucose oxidase (GOx, type
VII from Aspergillus niger, 198 k units/g solid, Sigma), V-(3-dimethylaminopropyl)-Ar’ethylcarbodiimide hydrochloride (EDC, Fluka), V-hydroxysulfosuccinimide sodium salt
(NHSS, Toronto Research Chemicals Inc.), and sodium bicarbonate (Sigma) were used to
prepare PtOEP/GOx-doped alginate-silica particles.

Poly(allylamine hydrochloride)

(PAH, MW = 70 kDa, Aldrich), poly(sodium 4-styrene sulfonate) (PSS, MW = 70 kDa,
Aldrich), and sodium chloride (Sigma) were used during the deposition of multilayer thin
films.

Additionally, rhodamine B isothiocyanate (RITC, Aldrich) was conjugated to

PAH and used in thin film deposition.

p-D-glucose (MP Biomedicals, Inc.), O2 (Air

Liquide), N2 (Air Liquide), and phosphate buffered saline (PBS, Sigma) were used during
dynamic testing. All necessary titrations were performed using 1.0 M HC1 and 1.0 M
NaOH, which were obtained from Fluka. All chemicals listed above were reagent grade
and used as received. Spectroscopic grade potassium bromide (KBr, Thermo Electron)
was used to prepare infrared spectroscopy samples.

Throughout all experimental

procedures, ultra-pure water with a resistivity of greater than 18 MO was used.
otherwise stated, all experimental processes were conducted at 25 °C.
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4.2.2

Particle Preparation and
Characterization
Alginate-silica (“algilica”) particles were prepared using a procedure similar to

that which was previously reported.35’ 159 Briefly, the precursor was prepared by stirring
a solution comprised o f 1.5 wt% aqueous alginate solution and glycidyl silane (GPTS) in
a 1:1 volumetric ratio for at least 4 horns, resulting in an alginate-modified silanol.
While stirring, 2 mL o f the precursor silanol was added to 3 mL of water. To initiate the
sol-gel process, 1.25 mL of 10 M NH4OH was added and stirred for 20 min, followed by
the addition o f 10 mL o f water and an additional stirring time of 40 min. An extra 40 mL
of water was added and the suspension stirred for at least an additional 4 hours. The
resulting particle suspension was rinsed with DI water using four sequential
centrifugation cycles and diluted to a total aqueous suspension volume of 1.5 mL. A
Beckman Coulter counter (Z2) equipped with a 100 pm aperture was used to obtain the
mean diameter and concentration of particles comprising the stock suspension. Fourier
transform infrared spectroscopy (FTIR, Nexus 470) was used to characterize the chemical
makeup o f the particles. Samples for FTIR analysis were prepared by using a hand press
with accompanying die and anvil (Thermo Electron) where approximately 1 mg of dried
particles were mixed with 15 mg of KBr and pressed into pellet form.

After the

spectrometer was purged with N2, IR spectra were acquired using the prepared pellets.
4.2.3

pH Effect on GOx
Immobilization
For use in fluorescence imaging, FITC labeled GOx (FITC-GOx) was prepared

using 1:1 molar ratio during the labeling reaction, which was performed using a standard
amine labeling protocol.161 The final solution was diluted to a final concentration of 2
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mg/mL in 0.05 M sodium acetate. Separate FITC-GOx solutions were titrated to the
following pH values: 3.0, 4.0, 5.0, and 6.0, using an electrochemical pH meter (270 A+,
Thermo Orion) to monitor the titrations. Approximately 5 mg of dried alginate-silica
particles were added to 250 pL of the respective FITG-GOx solutions. Solutions were
allowed to equilibrate overnight before analysis.

Samples were prepared for image

analysis by placing 10 pL o f each particle suspension onto a coverslip (24x60 mm No.
1.5, VWR).

Image analysis was performed on a Leica TCS 2 (Leica Microsystems)

confocal imaging system equipped with a 63x HCX PL APO oil immersion lens (1.4 0.60 NA) and 488 nm Ar/Kr excitation.
4.2.4

Preparation of PtOEP and
GOx-Doped Particles
Approximately 250 pL of stock particle suspension was placed in a

microcentrifuge tube, the supernatant removed via centrifugation, and 250 pL of a 750
pM PtOEP solution prepared in THF was added. The container was sealed to prevent
volatilization o f THF and stirred for 30 min, after which 30 pL of water was added and
the suspension stirred for an additional 30 min. The water added to the suspension began
a solvent-mediated controlled precipitation of PtOEP into the mesoporous particles, a
technique used in previous reports to aid in the immobilization of desired molecules.160
The suspension was subsequently rinsed with DI water four times. Following the last
rinse cycle, the supernatant was removed and 300 pL of 35 mg/mL GOx prepared in 0.05
M sodium acetate (pH = 4.0) was added and the pH value experimentally determined
from the results obtained in the previous section. The suspension was stirred for 1.5
hours, followed by two rinsing cycles with DI water. The supernatant was subsequently
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removed and replaced with 250 pL o f solution comprised of 30 mg/mL and 10 mg/mL of
EDC and NHSS in 0.05 M sodium acetate (pH = 5.0) to catalyze amide bond formation
between amine and carboxylic acid functionalities on GOx and alginate, respectively.35
Finally, the suspension o f PtOEP/GOx-doped particles was stirred for 4 hours then rinsed
two times with DI water. The Lowery method was used to determine the concentration
o f GOx immobilized in the particles,

indicating that approximately 720 pM of GOx

per particle was immobilized. For imaging purposes, a separate batch of PtOEP/GOxdoped particles were prepared using FITC-GOx and imaged using the confocal scanning
system detailed above, set in sequential scanning mode with 488 nm Ar/Kr and 543 nm
He/Ne excitation, respectively.
4.2.5

Adsorption of Nanofilm
Surface Coatings
RITC was conjugated to PAH (PAH-RITC) according to a standard amine

conjugation protocol.161 Before multilayer film deposition, respective solutions of PSS,
PAH, and PAH-RITC were prepared in 0.2 M NaCl at a concentration of 2 mg/mL. The
supernatant o f the PtOEP/GOx-doped particles was removed and the particles were
resuspended in PAH-RITC.

Following a 15 min adsorption time, during which the

particles were continuously shaken using a Vortex Genie-2 (Fisher Scientific) and
protected from light with aluminum foil, the particles were rinsed three times with DI
water and subsequently resuspended in PSS solution. To determine the overall number of
PAH-RITC/PSS bilayers to be deposited onto the particle surface, fluorescence emission
spectra were acquired using the sample chamber detailed in the following section after
each bilayer deposition. When the PtOEP emission maxima (645 nm) was approximately
75% o f the RITC emission maxima (580 nm), which in this case was three bilayers of
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PAH-RITC and PSS (denoted {PAH-RITC/PSS}3), PAH-RITC deposition was halted.
An additional seven PAH/PSS bilayers were deposited using the same protocol, making
the total film architecture deposited on the PtOEP/GOx-doped particles [{PAHRITC/PSS}3/{PAH/PSS}7] and completing sensor fabrication.

The complete sensors

were imaged using confocal microscopy with 543 nm He/Ne excitation.
4.2.6

Dynamic Testing Apparatus
A custom-designed software suite (LabVIEW, National Instruments) and dynamic

testing apparatus were developed to monitor real-time changes in sensor response (Figure
33). The system allows control of bulk oxygen concentration by means of regulated
mixing of oxygen and nitrogen through a pair of individually addressable pressure
controllers (Model 00122QA, Cole-Parmer Instrument Company) for the buffer and
glucose reservoir, respectively. Equilibration of oxygen levels within each reservoir was
hastened with gas diffusers (ChemGlass, fine frit) and magnetic assisted stirring
(Dylastir, VWR). Peristaltic pumps (MasterFlex L/S 7550 pump drive with MasterFlex
Easy Load 3 pump heads) extract glucose and buffer from the reservoirs at a relative rate
that when mixed prior to entering the reaction chamber, the glucose concentration was
equivalent to a user-defined value.

Prior to entering the reaction chamber, the bulk

oxygen level of the glucose solution was recorded using an in-line oxygen microelectrode
and picoammeter (OX 500 and PA2000, Unisense).
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Figure 33. Schematic of dynamic testing apparatus used to quantify sensor response
properties.

The reaction chamber consists of a custom-designed garolite flow cell, which
accepts a standard microscope slide (25x75x1 mm, VWR) with the sensors immobilized
to the surface. Additionally, the reaction chamber contains a port to interface the sample
slide with a custom optical fiber. The optical fiber probe had one delivery fiber (400 pm
multi-mode, ThorLabs) and six collection fibers - a so-called “6-around-l” fiber - and
was used to deliver excitation light from a Hg-Xe arc lamp (Model 68811, Oriel)
containing a 530 ± 5 nm interference filter (ThorLabs).

Sensor emission was

subsequently delivered to a diode array spectrometer (USB 2000, OceanOptics) through
the collection bundle. Following passage through the reaction chamber, outlet solution
oxygen levels were recorded using an additional in-line microelectrode chamber prior to
being collected as waste and discarded.

Tubing (Norprene® MasterFlex) in direct

contact with solution exhibited negligible oxygen permeability, thereby minimizing
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convective-induced changes in oxygen levels as the solution traveled through the
apparatus. It is noteworthy to state that all of the equipment, with exception of the stir
plates, used in the testing apparatus are either individually addressable (e.g. directly
controlled) or report (e.g. output collected and processed in real-time) through the custom
software suite, allowing increased user-control of the experimental environment and
minimized data processing times. Details on experimental parameters, including sample
preparation techniques, will be detailed in the next section.
4.2.7

Oxygen Sensitivity Testing
The testing apparatus was set to pump only buffer (0.01 M PBS, pH = 7.4) into

the reaction chamber (Figure 27). To prepare a sample for testing, double-sided pressuresensitive polyacrylate adhesive (3M) was placed onto the surface of a standard
microscope slide, followed by the addition of 10 pL (~ 106) of sensors onto the adhesive
surface. The sample was dried under streaming N2 and fixed into the reaction chamber.
Randomized oxygen levels ranging from oxygen-depleted to oxygen-saturated conditions
were obtained by bubbling O2 and N2 at varied partial pressures into the buffer reservoir.
With the solution flow rate set at 4 mL/min, the oxygen-dependent emission spectra of
the sensors were collected when the oxygen level at the reaction chamber inlet reached
steady-state, as indicated by the in-line oxygen microelectrode.
4.2.8

Dynamic Glucose Sensitivity
Testing
Large volume reservoirs (4 L) supplied the testing apparatus with buffer and

glucose, respectively. The buffer reservoir contained 0.01 M PBS (pH = 7.4), while the
glucose reservoir contained 600 mg/dL of P-D-glucose dissolved in 0.01 M PBS (pH =
7.4). The oxygen levels in both reservoirs were equilibrated to air saturated conditions.
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Sample preparation was performed as described above. Random triplicate glucose levels,
ranging from 25 mg/dL to 300 mg/dL in 25 mg/dL increments, were flowed through the
reaction chamber at a rate of 4 mL/min for approximately 8 min, which was
experimentally predetermined to allow response equilibration. To show reversibility of
the sensors and assess baseline stability, buffer was flowed at the same rate between the
glucose step changes for the same time allotment. Spectral data were collected in real
time throughout the course of the experiments.
4.2.9

Glucose Response at Various
Bulk Oxygen Levels
Using the setup described in the previous section, sensor response to glucose was

evaluated at different bulk oxygen levels. Dissolved oxygen levels were varied through
the adjustment o f nitrogen and oxygen pressures of the gas mixture used to aerate the
glucose and buffer reservoirs. Dissolved oxygen levels were monitored at the reaction
chamber inlet, and upon stabilization, glucose sensitivity testing proceeded as described
above. Additionally, it is noteworthy to state that the same sample was used throughout
this experimental procedure.

4.3
4.3.1

Results and Discussion

Preparation of Ateilica
Particles
Following particle fabrication, the infrared spectrum of the particles were

acquired using FTIR spectroscopy, and compared to previously reported spectra.35 As
expected, the spectrum confirmed alginate-GPTS conjugation indicated by absorbance
bands present at 1630 cm'1 - contributed by the carboxylic acid groups on alginate - and
1730 cm'1 - contributed by the conversion o f carboxylic acid groups into ester bonds
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during the conjugation. Additionally, the particle spectrum showed a very strong Si-0
bond absorbance band between 1100 and 1000 cm'1, confirming successful condensation
of the silanol and formation of the silicate structure.
4.3.2

Sensor Component
Immobilization
With enzymatic smart tattoos, it is important to have a uniform distribution of the

enzyme and indicator dye so that a homogeneous sensing environment is achieved. For
the reported case, that involved achieving a uniform distribution of GOx and PtOEP
throughout the microparticle matrix. During preliminary experimentation, the pH of the
GOx loading solution was observed to have a profound effect on whether or not the
enzyme was uniformly distributed throughout the particle. To characterize this effect,
GOx immobilization within algilica particles was performed at various pH levels and
imaged using confocal microscopy (Figure 34).
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Figure 34. Confocal micrographs of GOx loading at different pH levels. Insets for
the respective micrographs depicts the intensity profile along the given line.
Note that bars used for line scan analysis represent 10 |im.

The distribution profile of GOx within the particles was obtained through line
scan analysis of the confocal micrographs (Figure 34—insets). By inspecting the relative
fluorescence intensities of the line scan data corresponding to the particle center and
comparing those with the intensities at the surface, one sees that the solution pH does
influence whether GOx is uniformly (Figure 34, pH 3 and 4) or non-uniformly (Figure
34, pH 5 and 6) distributed within the microparticle. However, to quantifiably compare
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the distribution profiles, the following equation was introduced to calculate a distribution
index, Dr.
D. =

v

,(D

where v is the average fluorescence intensity of the center 10% of the particle and a
and (3 are the average fluorescence intensities of the outer 10% of the distribution
profile, located at the right and left boundaries of the particle surface, respectively. As
the value of Dr approaches unity, GOx is uniformly distributed throughout the particle,
and as Dr approaches zero, the distribution of GOx becomes inhomogeneous, with bias
toward the surface boundaries. The calculated Dr values were plotted versus solution pH
(Figure 35).
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Figure 35. Distribution indices calculated for GOx loading at various bulk pH levels.
Error bars donate one standard deviation of three measurements.
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Dr values close to unity were observed for pH 3.0 and 4.0 with no statistical
difference (Student’s t-test, with a = 0.1) between the two, indicating that uniform
distributions were obtained when GOx was loaded under these conditions. Conversely,
the Dr values significantly decreased when the bulk pH was increased to 5.0 and 6.0,
respectively, signifying an increased bias for GOx adsorption to the outer surface o f the
particle.

This observed trend could be explained through pH-induced modulation of

attractive and repulsive electrostatic forces. As the solution pH is reduced below the pi
of GOx (4.2)169 and above the algilica pi (estimated to be 2 from reports on similar
organically-modified silicates).170 172 GOx exhibits a cationic surface potential, while the
net surface potential o f algilica remains anionic.

Opposite surface potentials elicit

attractive electrostatic forces between GOx and algilica, allowing GOx to readily
penetrate and adsorb throughout the microparticle. Such behavior was observed at bulk
pH levels o f 3.0 or 4.0. However, as bulk pH values are elevated above the GOx pi, the
surface potential o f both GOx and algilica become increasingly anionic, inducing an
increased electrostatic repulsion.

These repulsive forces incrementally reduce GOx

penetration throughout the particle, while progressively confining adsorption to the
particle surface, as seen in loading solutions of pH 5.0 and 6.0, respectively. Similarly,
other reports have observed the same phenomenon and have used pH-induced
electrostatic loading as a means to immobilize enzymes.173 Therefore, to obtain a
uniform distribution of GOx within the sensors, a pH 4.0 loading solution was used.
Additionally, it is important to note that post-loading exposure to elevated pH levels
resulted in no significant changes of the GOx distribution profile.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

117

Following the controlled precipitation of PtOEP, algilica particles were doped
with GOx, and subsequently imaged using confocal microscopy (Figure 36A and B).

Figure 36. Typical confocal micrographs of algilica particles loaded with FITC-GOx
(A) and PtOEP (B) and complete self-referenced sensors comprising RITC-doped
nanofilms (C), PtOEP (D), and unlabeled GOx.

Dr values calculated for GOx (Figure 4A) and PtOEP (Figure 4B) were 0.87 ±
0.11 and 0.86 ± 0.08, respectively, suggesting that the precipitation technique used to
adsorb PtOEP has no significant effect on GOx immobilization. We also observed that
the distribution profiles of GOx and PtOEP remained unchanged if the order of
immobilization was reversed (i.e., GOx loaded before PtOEP). The ability to obtain
uniform immobilization of both GOx and PtOEP is due in part to the unique chemical
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and structural properties of the mesoporous algilica matrix, comprised of a homogeneous
arrangement

of

hydrophilic

and

hydrophobic

functionalities

thermodynamically stable environments for both GOx and PtOEP.

that

provide

35

In fluorescence-sensing application, it is common to incorporate a reference dye
which is non-sensitive to the measured analyte into the sensor, allowing a ratiometric
read-out. Ratiometric monitoring of sensor response provides a signal independent to
instrumental drift, namely light source fluctuations, and the number of sensors
interrogated.

To provide a reference signal, RITC-doped multilayer nano films were

adsorbed to the outer surface of the GOx/PtOEP-doped particles using the well
established layer-by-layer technique. The completed ratiometric sensors were imaged
using confocal microscopy (Figure 36C and D), and the resulting line scans used to
calculate Dr.

The Dr value calculated for the RITC-nanofilms was 0.22 ± 0.03,

confirming surface limited adsorption o f the nanofilms.
4.3.3

Component Immobilization
Stability
The stability o f component immobilization is of utmost importance when

designing sensors o f this type. A loss o f PtOEP over time would cause negative drift
(decrease) in the PtOEP signal over time, which would in turn affect the ratiometric
response via increased noise and gradual loss of sensitivity.

To determine the

immobilization stability o f PtOEP, sensors were prepared without nano film coatings and
placed in an aqueous suspension. Fluorescence measurements were made by removing
the supernatant after the particles precipitated via centrifugation and normalizing the
PtOEP emission maxima to a separate RITC standard to account for source fluctuations.
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The supernatant was subsequently replaced and the measurement repeated again every 24
hours. The data obtained are presented in Figure 37.
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Figure 37. PtOEP leaching profile. Error bars denote one standard deviation of
triplicate measurements.

Upon analysis of these data, no statistically significant trend depicting an increase
in normalized PtOEP emission with time is observed, indicating that an insignificant
amount o f PtOEP leaches from the particles during this time period.

This result is

expected, given the hydrophobic nature of PtOEP. Following the controlled precipitation
procedure used to immobilize PtOEP, the particles are suspended in aqueous solution
from that point on, deterring PtOEP leaching.
Leaching o f GOx over the lifetime of the smart tattoo would also have a drastic
affect on sensor dynamics. Should GOx leach from the sensors, fewer enzymes would be
available to consume oxygen and glucose, thereby causing less of a change in the average
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steady state oxygen level within the sensor for a given glucose concentration, leading to
decreased sensitivity over time. The leaching properties of GOx were monitored via a
similar experiment, but in this case FITC-GOx was used and an Oregon-Green solution,
which has similar excitation and emission properties, was employed as a separate
intensity reference. The leaching data obtained over 6 days are presented in Figure 38.

w
o
c o <D
ffi
2 ^
N
ro 0
E

4
Time (days)

Figure 38. GOx leaching profile. Error bars denote one standard deviation of
triplicate measurements.

The data presented in Figure 38 indicate that over the first 24 hours, weaklyimmobilized GOx does leach from the sensor.

GOx is soluble in aqueous solution;

therefore, some degree o f leaching can be expected from enzyme molecules not
covalently bound to the algilica matrix. It is also important to note that previous work on
enzyme immobilization within alginate hydrogels shows covalent attachment of GOx to
alginate moieties (via amide linkages) provides a stable system with minimal leaching.35
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Additionally, these experiments were performed without nanofilm coatings, which have
been shown to stabilize encapsulation;35 therefore, these data represent a “worst case”
scenario. Since all the data presented in this work were obtained at least 48 hours after
GOx immobilization, including the experiments to determine the concentration of GOx
immobilized per particle, it can be concluded that GOx leaching is negligible in the
experiments presented herein. Therefore, calibrations to determine the percent of initial
immobilized GOx leached from the microparticles were not performed.
4.3.4

Sensor Response to Bulk
Oxygen Changes
The reported sensors indirectly measure local glucose levels by monitoring

changes in local oxygen levels elicited through GOx-catalyzed glucose oxidation.
Therefore, it is critical to quantify the oxygen response characteristics of the sensors
before performing glucose sensitivity experiments. To quantify the oxygen response, the
dynamic testing apparatus (Figure 27) was used to vary bulk oxygen levels and collect
emission spectra after the establishment of concentration equilibrium.

To depict the

oxygen-induced quenching effect observed at extreme oxygen levels (oxygen and
nitrogen saturated conditions, respectively) with air saturated conditions as a reference,
selected spectra normalized to the RITC emission maxima at 585 nm are presented in
Figure 39.
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Figure 39. Sensor response to variations in bulk oxygen levels: spectral response to
air, nitrogen, and oxygen saturated environments.

A more concise view of the oxygen-quenching effect is demonstrated by plotting
the PtOEP/RITC peak ratio, obtained by normalizing the intensity observed at the PtOEP
maxima (645 nm) to that of the RITC maxima (585 nm), versus bulk oxygen
concentration Figure 40.
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Figure 40. Peak ratio response to randomized oxygen levels ranging from oxygen
depleted to oxygen saturated conditions. Error bars denote one standard deviation
from triplicate measurements.

These data suggest the sensors are highly sensitive to oxygen levels between
depleted and atmospheric (277 pM) levels, such that approximately 95% of the total
change in ratiometric intensity per pM of oxygen occurs within this region.

For

enzymatic smart tattoo applications, high oxygen sensitivity within this region is critical
to optimal sensor performance. Reported reaction-kinetic simulations of similar systems
under physiological conditions show that local oxygen levels within the sensor can be
reduced to 10 pM ( assuming intradermal oxygen levels of 90 pM) when elevated blood
glucose levels (350 mg/dL) are present.41,162
To quantify the sensitivity of the overall oxygen-induced quenching response
( Qdo )> the following relationship is commonly used:
Rn - R 0
Q do =

’

Rm

2 x 100, (2)
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where RN and R 0i are the PtOEP/RITC peak ratios observed under nitrogen and oxygen
saturated conditions, respectively.

Surprisingly, QD0 was calculated as 95%, a

sensitivity equivalent to that observed with algilica based dissolved oxygen sensors,
which did not contain GOx, as reported in Chapter 3. This result indicates that GOx
adsorption does not function as an impenetrable barrier that prevents fractal diffusion o f
oxygen and quenching o f PtOEP, but allows oxygen to readily diffuse throughout the
matrix. Although the steady-state transport o f oxygen is not affected by GOx adsorption,
current studies are underway to examine whether or not the transport rate of oxygen is
affected.

Additionally, a linear Stem-Volmer relationship (R2 = 0.99) was observed

(Figure 41), confirming PtOEP adsorption within a homogeneous environment, a
characteristic also observed in our previous work.42’159
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Figure 41. Stern-Volmer quenching characteristics. Error bars denote one standard
deviation from triplicate measurements.
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These data show high sensitivity to oxygen levels within predicted sensor
operation limits, while exhibiting linear quenching characteristics.
4.3.5

Sensor Response to Bulk
Glucose Changes
Although the reported system demonstrated high sensitivity to oxygen, a response

to glucose is not inherent. Since the sensors are designed to indirectly measure glucose
levels through monitoring glucose-limited consumption of local oxygen, the system must
adequately control glucose diffusion relative to that of oxygen to be glucose responsive.
The glucose response characteristics were monitored using the dynamic testing apparatus
(Figure 33), which allowed real-time monitoring of sensor performance as step changes
in bulk glucose levels were introduced.

In this report, dynamic testing was used to

efficiently evaluate critical sensor characteristics such as stability, response time,
reversibility, sensitivity, detection limit, and analytical range.
Dynamic response data collected during sensor exposure to random bulk glucose
levels ranging from 0 to 300 mg/dL are shown in Figure 42. It is important to note that
the data displayed in Figure 42 are only of the initial 150 min of the experiment, which
totaled 500 min. The data shown in Figure 42 are the respective peak intensities of RITC
and PtOEP, displayed to highlight the advantages of ratiometric monitoring. The data
presented in Figure 42 depicts three key properties about the sensor fluorimetrics: (1) step
changes in glucose concentration elicit a significant increase in PtOEP emission (Figure
42, demarked “Glucose step”), (2) flushing the system with buffer (Figure 42, demarked
“Buffer flush”) caused the PtOEP intensity to return to the baseline value, and (3) RITC
emission intensity remains independent of modulations in glucose concentration.
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Figure 42. Dynamic sensor response data shown in raw intensity units.

Using ratiometric analysis, it is possible to account for source fluctuations and
changes in sensor concentration. One such case can be observed in Figure 42, where
after 10 min had elapsed, the peak intensities of PtOEP and RITC began to decline as a
result of sensor detachment (Figure 42, demarked as “Sensor detachment”), causing a
decrease in sensor concentration; however, after normalizing the peak intensities, the
concentration-dependent artifact is eliminated and the baseline prior to glucose step
introduction (/ = 0 - 45 min) becomes stable (Figure 43). Additionally, it is noteworthy
that after approximately 50 min, the RITC peak becomes stable (Figure 42), signifying
the removal of weakly adhered sensors.
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Figure 43. Dynamic sensor response data shown in ratiometric intensity.

4.3.6

Sensor Stability
In this report, the sensors were immobilized on a glass slide and continuously

illuminated for approximately 500 min, during which approximately 5000 spectra were
acquired. The power density of the excitation source at the sample was measured to be
36 mW cm' . Baseline values were defined as the average ratiometric intensity values
occurring at 0 mg/dL glucose throughout the experiment. A statistical comparison of the
baseline values indicate insignificant drift (p < 0.1) had occurred throughout the course of
the experiment.
Photostability o f the sensors was subsequently characterized via continuous
exposure of the sensors to the excitation source over approximately 4 days.

It is

noteworthy to state that this experiment was performed in the dynamic testing apparatus
with continuous buffer flow (4 mL/min). A profile of the ratiometric intensity versus
time is given in Figure 44.
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Figure 44. Photobleaching of sensors under air-equilibrated conditions.

These results indicate an approximate 30% loss in ratiometric intensity over the
course of 4 days o f continuous illumination (~ 7.5% per day). Over the course of this
experiment approximately 162,000 spectra were obtained, one every 3 seconds. In light
of this observation, photobleaching seems to be insignificant, since in a practical setting,
relatively few measurements will be acquired each day.

To put these data into

perspective, let us assume that in a clinical setting, the average of three measurements
will be used to determine an average glucose value and glucose levels will be monitored
6 times/day; therefore, the sensors will be optically interrogated on average 18 times per
day.

Assuming that it would require approximately 3 seconds to record each

measurement, the sensors would be irradiated for a total of 54 seconds per day - it would
take 24.5 years to degrade the ratiometric intensity by 30%. However, additional effects
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like fluctuations in oxygen levels (elevated oxygen levels increase photodegradation) and
exposure to sunlight would be expected to greatly contribute to photodegradation. More
specifically, the bulk oxygen concentration was kept at air-equilibrated conditions (277
pM), but in physiological conditions, bulk oxygen levels are expected to be significantly
lower (approximately 90 pM). Additionally, when in the presence of normoglycemic
levels ( > 7 0 mg/dL and < 1 8 0 mg/dL) oxygen levels within the sensors would be
expected to be further reduced to approximately 60 pM.41 Under these conditions, it is
expected that the affects o f photodegradation would be further reduced, given that less
oxygen present would result in less singlet oxygen produced, which would in turn reduce
the probability o f photoxidation.

QO

Thus, to obtain a more accurate photostability profile,

a similar experiment should be performed with continuous exposure to a normal
physiological glucose level. Nonetheless, as a point of comparison, the photodegradation
rate of similar enzymatic smart tattoo concepts was reported to be 2.3% per hour,
approximately lOx’s greater than the RITC/PtOEP based concepts.133, 166 Therefore, the
current RITC/PtOEP based enzymatic smart tattoos show great promise as being highly
photostable systems.
4.3.7

Response Time and
Reversibility
Response time is a critical figure of merit for diabetic monitoring, as sensors must

respond within the physiological time scale of glucose fluctuations to ensure accuracy.
Using the dynamic data acquired, sensor response time was defined as the time required
for the PtOEP/RITC peak ratio to reach 95% of its maximum value in response to a step
change in glucose concentration. The average response time was determined to be 86 ±
12 seconds, making these sensors adequate to monitor fluctuations in blood glucose,
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which usually occur over a period of 30 min.174 Upon comparison, the measured
response time is similar to other systems based on optical oxygen transduction of glucose
•
levels. 39 It is
noteworthy that in Chapter 6, the response time for individual sensors was

determined to be approximately 30 seconds less than that observed in the dynamic testing
apparatus.

This observation indicates that the response time determined with the

dynamic testing apparatus may be due a combination of fluidic latency and equilibration
time within the immobilized sensor population.
Reversibility is a figure of merit that assesses baseline change before and after
exposure to the analyte. Reversibility was quantified by flushing the reaction chamber
with buffer before subsequent glucose step changes, then calculating the baseline
variation.

Figure 45 shows sensor response to several step changes in glucose

concentrations.
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Figure 45. Sensor response to step changes in glucose concentration. Sensors were
exposed to a step change in glucose at (A) and the chamber subsequently flushed
with buffer to remove glucose (B). Notice the peak ratio returns to initial values
following glucose removal.
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It is important to note that after glucose is flushed from the bulk solution (Figure
45, marked “B”), the PtOEP/RITC peak ratio returns to the baseline value observed prior
to the glucose step (Figure 45, marked “A”). The average percent change in the baseline
value before and after a step change in glucose concentration was determined to be 0.75 ±
0.6%, indicating a high degree of reversibility.

This result is not surprising, as

enzymatic-based sensors usually display a high degree of reversibility due to consistent
analyte consumption.26’39
4.3.8

Sensitivity
Sensitivity is a critical sensor performance characteristic that characterizes the

change in analyte signal with a corresponding change in analyte concentration.

A

sensitivity curve was generated by plotting the percent change in PtOEP/RITC peak ratio
versus bulk glucose concentration (Figure 46), using the following equation to calculate
percent change:
% Change = ——— xlOO,
Ro
where R and Ro are the PtOEP/RITC peak ratio obtained at incremental glucose levels
and 0 mg/dL glucose, respectively.
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Figure 46. Percent change in PtOEP/RITC peak ratio values following step changes
in bulk glucose levels. Regression line used to depict linear operation range, while
analytical range demarks a 10% response deviation from linearity. Error bars
denote one standard deviation of random triplicate measurements.

The response sensitivity was determined by taking the slope of the linear region,
which was defined as the region within the sensitivity curve that exhibited an R2 value
greater that 0.95. Using linear regression, with the y-intercept forced to 0, the response
sensitivity was determined to be 4.16 ± 0.57 % change / mg dL'1 (assuming 95%
confidence bounds, Figure 46), which is greater by at least one order of magnitude than
those o f similar systems.27,37,39 However, it should be noted that high sensitivity is often
associated with a reduction o f the analytical range; therefore, the sole objective is not
high glucose sensitivity, but to obtain the highest sensitivity while staying within the
confines of the desired analytical range. Additional discussion on the analytical range
and how multilayer thin films can be used to tailor the response sensitivity will be given
later.
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4.3.9

Detection Limits
Detection limits are used to quantify the lowest concentration of analyte that can

be readily detected.

Several types of detection limits commonly characterize sensor

performance; the first o f them is the limit of detection, which is the lowest analyte
concentration that is detectable (assuming 66% certainty). The identification limit is the
lowest analyte concentration that can be detected with a reasonable degree of certainty,
commonly 83%. For this work, the detection limit used is the quantification limit, which
is defined as the lowest analyte concentration in which there is at least 90% certainty that
the analyte is present. The quantification limit,
/-<

^QL ~

C ql,

is defined as

baseline
g

/o\

>W

where Gbaseime is the standard deviation of the baseline (e.g. glucose concentration equal
to 0 mg/dL) and S is the response sensitivity defined above.

C ql

was determined to be

1.5 ± 0.2 mg/dL. The low Cql is a result of the high signal-to-noise ratio, which was
determined to be 175, and the high response sensitivity of the sensors.

Given that

hypoglycemic comas are commonly observed when blood glucose levels drop below 30
mg/dL,175 the low detection limit of these devices are not advantageous for diabetic
monitoring devices; however, other applications requiring low detection limits could find
this characteristic useful.
4.3.10

Analytical Range
The analytical range is one of the most critical figures of merit when evaluating

the feasibility of a sensor. The analytical range was defined as the concentration range
over which glucose levels can be statistically differentiated. Typically the lower limit of
the analytical range is defined as

C ql,

while the upper limit is the analyte concentration
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observed when the response profile deviates 10 % from linearity (Figure 46), making this
figure of merit a function o f response sensitivity (for the upper limit) and baseline noise
(for the lower limit).

Using this definition, the analytical range of the sensors was

determined to be 2 - 120 mg/dL of glucose, which does not cover the entire accepted
range of 40 - 350 mg/dL for self-testing systems.

17 ft

However, the reported system could

adequately monitor hypoglycemic events (blood glucose levels below 70 mg/dL), which
according to one report, is the most critical aspect of diabetic care.

i nn

The fundamental operating principles of the sensors can be described through
further analysis of Figure 46, in conjunction with Figure 47.
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Figure 47. Average steady-state oxygen concentration within the sensors as a
function of bulk glucose concentration.

It should be noted that these data were obtained by using the calibration data
relating oxygen concentration to PtOEP/RITC peak ratio, as presented in Figure 40.
Prior to analysis it is important to note that linear ranges of the data presented in Figure
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46 and Figure 47 differ significantly, arising from the nonlinear relationship between
PtOEP/RITC peak ratio and oxygen concentration.

Given that oxygen sensitivity

increases as oxygen levels approach 0 p.M, slight changes in reduced local oxygen levels
result in significant changes in ratiometric intensity increasing the glucose sensitive range
of the sensors, as described in the following text.
As previously mentioned, these sensors operate on the principle of glucoselimited oxygen consumption within the smart tattoo. As glucose diffuses into the sensor,
oxygen is consumed and rapidly replaced, allowing indirect glucose monitoring through
an oxygen reporter. To achieve this fundamental condition, the relative diffusion rate of
oxygen into the sensor must be greater than that of glucose, such that local oxygen levels
within the sensor are in excess, resulting in glucose-limited oxygen consumption. This
condition can be observed in the linear response region ([glucose] < 90 mg/dL, Figure
46), where peak ratio changes resulting from the depletion in steady-state oxygen levels
are proportionally reduced in response to increasing bulk glucose levels. As bulk glucose
levels are increased, the rate o f glucose delivery into the sensor begins to eclipse the rate
of oxygen replenishment, preventing the relative recovery of oxygen levels within the
sensor. In this state o f operation, the sensor response begins to deviate from linearity
with bulk glucose levels between 90 and 150 mg/dL (Figure 46), thus implicating the
onset o f oxygen-limited glucose consumption.

With additional increases in glucose

levels above 150 mg/dL, the sensor does not respond to changes in bulk glucose
concentrations (Figure 46). This phenomenon is due to internal depletion of oxygen
levels, such that oxygen is readily consumed upon diffusion into the sensor, a condition
elicited by the surplus of local glucose within the sensor and signifies absolute oxygen-
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limited catalysis and response saturation. Therefore, to extend the analytical range to
cover both hypoglycemic and hyperglycemic events, the mass transfer properties of
oxygen and glucose must be altered to limit the glucose delivery rate into the smart
tattoo.

Limiting glucose diffusion allows oxygen levels within the sensor to remain

relatively elevated, allowing the sensor to operate under glucose-limited conditions over a
greater range o f bulk glucose levels.41
To control glucose flux relative to oxygen, previous work on enzyme-based
sensors have found that mass transfer limiting surface coatings could successfully
modulate sensor response properties.166, 178

In our approach, we utilize surface-

immobilized multilayer nanofilm technology to control the analyte mass transfer and
induce glucose-limiting kinetics. This technology allows exquisite control over substrate
diffusivities through nanoscale changes in film thickness.5,26,41’ 147 We hypothesize that
the analytical range of these sensors can de tuned by simply altering the thickness of the
nanofilms, the results o f which will be presented later in this chapter.
4.3.11

Accuracy
Accuracy is arguably the most critical figure of merit of sensor performance and

ultimately clinical efficacy.

For this work, accuracy is defined as the degree of

conformity o f the predicted (measured) glucose level to the actual value. To quantify
accuracy, a set o f standards must be initially determined.

For this exercise, the

calibration standard was determined to be the first and last PtOEP/RITC peak ratio values
obtained at each glucose concentration (three measurements at each glucose
concentration were obtained during each dynamic testing experiment). The average and
standard deviation was obtained, and glucose concentration was related to the mean

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

137

PtOEP/RITC peak ratio and plotted (Figure 48). Since this is a not an attempt to model
any physiological process (i.e., a model describing the underlying physical and chemical
mechanisms), the data were fitted to a model yielding the highest correlation coefficient,
which in this case was a rational function of the following form:
r ,
t
(a + b -PR)
[glucose] = --------------------- 7 ,
1+ c-PR + d - P R 2
where PR is the PtOEP/RITC peak ratio and a, b, c, and d are fitting coefficients
determined through a least-squares fitting algorithm. Given that the same form of this
model will be used to fit additional data, the exact values of the fitting parameter will not
be given. The resulting fitted data were plotted and compared with the experimental data
(Figure 42).
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Figure 48. Experimental data and rational function fit used to construct calibration
model.
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Upon comparison of the experimental and fitted data, Figure 48 shows that the
rational function provides a good prediction of glucose concentration when the
PtOEP/RITC peak ratio is used as input (R2> .99).
Using the rational model, the experimentally determined peak ratio data were
used to predict glucose concentration. The predicted values were then compared with
actual values assigned by the calibration standards.

The “unknown” sample was

considered to be the second mean PtOEP/RITC peak ratio obtained at each glucose
concentration, and was subsequently used to predict glucose concentration using the same
rational model, followed by comparison to the calibration standards.

These data are

presented in Figure 49.
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Figure 49. Calibrated comparison of sensor accuracy using first and third mean
PtOEP/RITC peak ratios obtained at each glucose concentration as calibration
standards.

When analyzing these data, it is common to include a linear regression fit (with
the y-intercept forced to 0) to the data so that the slope, which related the predicted and
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actual glucose levels, can be analyzed. As the slope approaches 1 and the correlation
coefficient approaches 1, the sensors are highly accurate as actual and predicted glucose
levels are statistically the same. As the slope deviates from 1, several insights on sensor
behavior can be extrapolated.

For instance, the data having a slope greater than 1,

indicates that the sensor over predicts or overshoots the actual analyte concentration. On
the other hand, when the slope decreases below 1, the sensor under shoots the actual
analyte concentration. A high correlation between the actual and predicted glucose levels
is expected in the calibration model, since these data were used to define actual glucose
levels, and that is indeed what is observed in Figure 49 (m = 0.96 ± 0.035). Additionally,
the “unknown” sample depicted in Figure 49 as “predicted” also exhibits a high degree of
accuracy (m = 1.06 ± 0.154).
As an additional exercise, a second calibration was performed, this time using the
first and second mean PtOEP/RITC peak ratios obtained at each glucose concentration as
calibration standards, and the third mean PtOEP/RITC peak ratios obtained at each
glucose concentration as the unknowns. In both cases, the data were fitted to the rational
function previously discussed. The data obtained are presented in Figure 50.
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Figure 50. Calibrated comparison of sensor accuracy using first and second mean
PtOEP/RITC peak ratios obtained at each glucose concentration as calibration
standards.

As expected, the calibration data show a high degree of accuracy (m = 1.00 ±
0.018). On the other hand, the unknown sample shows significantly lower accuracy (m =
0.8181 ± 0.128), indicating a loss of sensitivity (~ 20% deviation of accuracy) over time.
It is again important to note that these data were acquired in a random triplicate fashion to
eliminate hysteresis. When preparing the calibration standard using the average peak
ratios obtained during the first and third glucose measurements, time-based fluctuations
were averaged; however, in the later case, these fluctuations were exposed. There are
several explanations for the loss of sensitivity over time, one of which is leaching of the
enzyme; however, earlier in this chapter, data were presented indicating that after the
initial day of immobilization, GOx is stably immobilized within the particle (Figure 38).
A second and more likely scenario would be the temporal deactivation of GOx. This
well-known phenomenon can spontaneously occur over time, or could be poison-induced
by reaction byproducts, namely hydrogen peroxide and hydronium ions.179, 180 This

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

141

scenario will be reviewed in depth later in this dissertation through the careful
examination o f response properties obtained continuously over several days.
4.3.12

Response Stability over
Extended Periods
of Time
To assess response stability over extended periods of time, dynamic response

experiments were performed on samples obtained from the same stock suspension of
sensors over a period o f 21 days. The sensor suspension was stored in glucose-free
buffer at 3 °C until needed. It is important to note that these data do not reflect response
stability under a continuous mode o f operation. Upon completion of the experiment, the
temporal response profiles were used to determine sensitivity over the examined time
range, the results o f which are presented in Figure 51.
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Figure 51. Stability of device sensitivity over time. Note that these data were not
collected under a continuous mode of operation.
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These data indicate a somewhat erratic stability profile. Interestingly, the last
three data points (collected at 10, 13, and 21 days after sensor fabrication) indicate no
statistical difference, revealing that no significant change in sensitivity over this given
time period is observed. However, a statistical difference lies between the first and the
last three data points, indicating that a slight increase in sensitivity is observed after the
initial week of preparation. This seemingly improbable occurrence could be explained in
the variation o f the samples themselves, which could in turn influence the response
profiles collected. Although great care is taken to ensure that a similar concentration of
sensors is used throughout the sample preparation procedure, it is difficult to maintain a
consistent number o f immobilized sensors through out each experiment.

Inevitably,

sensors will be detached by the shear force exerted by the flowing bulk solution, a
parameter difficult to keep constant throughout all prepared samples. This topic will be
covered in great depth in the later section o f this chapter.
It is important to state that a stable response (i.e. sensitivity vs. time) was
expected given the experimental conditions. Previously in this chapter, it was shown that
in the days following GOx immobilization, insignificant leaching was observed,
indicating the enzyme was stably immobilized within the sensor (Figure 38).
Additionally, it was also shown that PtOEP immobilization was stable (Figure 37).
Therefore, the possibility that the sensors would lose sensitivity due to component
leaching was deemed insignificant.

Given that the sensors were stored in ambient

conditions (i.e. no glucose), the enzymes were assumed to be dormant, thus eliminating
the possibility o f poisoning due to peroxide and/or pH drop (no glucose present = no
production o f byproducts). Given these assumptions, the most obvious path by which
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sensitivity reduction could occur would be the spontaneous deactivation of the enzyme
over time, but given that the sensors were stored at near-freezing temperature, the
deactivation rate would be reduced substantially. Additionally, the rigid structure of the
algilica particles could provide structural support181 to the enzyme such that the rate of
spontaneous denaturing (i.e. unfolding) and denaturing due to byproduct poisoning is
reduced. In a report on the stabilization of creatine kinease within a sol-gel matrix, it was
found that the enzyme retained 50% activity 10 times longer than that of free enzyme,
attributing the decreased inactivation to the rigid structural support of the matix.182 It is
also noteworthy to state that a more accurate assessment of response stability would be to
repeat the experiment using a single sample, thus removing error due to sample
variations.

To reduce drift associated with spontaneous enzyme inactivation, the

immobilized sensors should be stored in buffer at refrigerated temperatures.
Additionally, a more practical exercise would be test stability at normal physiological
temperatures over extended periods of time, as the results of which would provide insight
on how the spontaneous deactivation of GOx would affect sensor performance.
4.3.13

Effect of Bulk O? Variations
on Glucose Response
As mentioned in Chapter 2, the local oxygen supply within the dermis has been

shown to be highly dependent on atmospheric conditions as well as depth, with
concentration fluctuation from 215 pM (near the epidermis-dermis junction) to 90 pM
(near vasculature).

1TC

Therefore, it is informative to examine the overall effect of sensor

performance when exposed to varying bulk oxygen levels. Following stabilization of
bulk oxygen levels at oxygen levels below, at, and above atmospheric concentration,

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

144

sensors were exposed to random step changes in bulk glucose levels. The response data
obtained are presented in Figure 52.
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Figure 52. Sensor response to glucose at various bulk 0 2 concentrations. Error bars
denote one standard deviation of random triplicate measurements.

These data do indeed indicate a significant shift in sensitivity. To enhance clarity
of the effects of bulk oxygen concentration on sensor performance, the sensitivity and
analytical ranges were calculated for each sample set (Figure 53).
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Figure 53. Effect of bulk 0 2 levels on sensitivity and analytical range of glucose
response.

As expected, these data suggest that the glucose response significantly varies with
fluctuations in bulk oxygen levels, a observation noted in similar enzymatic systems.127,
183 First, it is important to note that these data indicate reaction-limited consumption is
not obtained, such that at higher bulk oxygen levels, the glucose-limited rage is extended
when compared to that obtained with 95 pM bulk oxygen. Additionally, at oxygen levels
above atmospheric, in this case 540 pM, the sensors exhibit a sensitivity and analytical
rage of 0.455 ± 0.03 % change / mg dL'1 and 295 ± 55 mg/dL, respectively. When
compared to the response properties obtained at 95 pM - 1.3 ± 0.145 % change / mg dL'1
and 98 ± 14 mg/dL - an approximate 65% decrease in sensitivity and a 200 % increase in
analytical range is observed. This occurrence can be simply explained by variations in
local oxygen levels induced by changes in the bulk. At elevated bulk oxygen levels, the
average steady-state oxygen concentration within the sensors is elevated;41 therefore,
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higher incremental glucose levels are required to significantly reduce the elevated
average oxygen level within the sensor.

This occurrence ultimately results in an

extension of glucose-limited range, which in turn results in decreased device sensitivity
and increased analytical range as shown in Figure 53. A more physiologically relevant
demonstration would be to compare response properties acquired at 95 pM and 257 pM
oxygen levels. Under air saturated conditions, response properties were determined to be
0.826 ± 0.07 % change / mg dL"1 and 182 ± 40 mg/dL, which when compared with those
obtained at 95 pM, represent a 36% decrease in sensitivity and a 54% increase in
analytical range. These findings, although expected, indicate the importance of having an
internal oxygen reference to monitor bulk oxygen levels.

Such a reference would

determine absolute changes in oxygen levels within the sensor that are directly due to
glucose oxidation, allowing for the compensation of response artifacts due to fluctuations
in bulk oxygen levels. Therefore, for this approach to ultimately be successful in in vivo
applications, direct oxygen monitoring functionality will need to be incorporated to allow
compensation for fluctuations in bulk oxygen levels within the dermis. This topic will be
revisited later in the text.
4.3.14

Effect of Sensor Concentration
on Glucose Response
Additionally, it is a constructive exercise to examine the effect of sensor

concentration on overall response properties, as this understanding would enhance the
ability to design clinically viable implantation schemes (implants would ultimately be
comprised o f a population o f sensors, not a single sensor). In this series of experiments,
suspensions o f various sensor concentrations were used during sample preparation. After
drying, the samples were subjected to dynamic testing. The following data represent
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sensor response profiles acquired from samples prepared with various concentrations
(Figure 54).
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Figure 54. Sensor response profiles acquired with varying sensor concentrations.

Remarkably, samples prepared with a high concentration, in this case 6.1 x 108
sensors/mL, exhibit a total percent change of over two fo ld greater than those with lower
concentrations.

Additionally, samples prepared with concentrations below 6.1 x 108

sensors/mL exhibit lower sensitivities and increased ranges when compared with those
obtained with 6.1 x 10 sensors/mL (Figure 55).
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Figure 55. Sensor concentration effect on overall sensitivity and analytical range.

These observations can be explained through careful analysis
environmental conditions surrounding individual sensors.

of the

For this discussion, the

environment around a single sensor will be initially considered, followed by increasing
sensor concentration in a packed-bead fashion. For a single-sensor scenario, the sensor is
surrounded by solution containing a supply of glucose and oxygen, and since the solution
is continuously replaced (replenishment is greater than consumption), it is assumed that
the sensor surface is exposed to a constant supply of both substrates. As glucose diffuses
into the sensor, glucose and oxygen are consumed (oxygen is rapidly replenished),
resulting in a decrease in the steady-state level of oxygen within the sensor; however, the
steady-state concentration of oxygen within the sensor is dependent on the oxygen
concentration within the bulk. Higher bulk oxygen levels result in higher steady-stale
levels within the sensor and vise versa with lower bulk oxygen levels, which in turn
affect sensor dynamics (as described in the previous section).

As the particle

concentration is increased, the sensors become tightly packed together (small interparticle
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distances), and the environment surrounding individual sensors becomes drastically
different than that of the single sensing microsphere. At greater sensor concentrations, a
higher rate of substrate consumption would be expected, such that substrate
concentrations at the sensor surface may be considerably less than those in the bulk.
Lower substrate levels at the sensor boundaries would affect sensor performance.
Therefore, it is hypothesized that this phenomenon is not due solely to increased
concentration but due instead to decreased interparticle distances associated with
increased sensor concentrations.
The experimental data presented in Figure 54 and Figure 55 seem to corroborate
o

the above scenarios. At the highest concentration tested (6.1 x 10 sensors/mL), the
analytical range was determined to be 65 ± 5 mg/dL, indicating early onset of an oxygenlimited regime. This result could be explained by reduced oxygen levels at the sensor
surface due to rapid consumption by the sensor population (consumption from the sensor
population is greater than replenishment from the bulk); therefore, average steady-state
oxygen levels within the sensors are reduced such that oxygen-limited catalysis occurs at
relatively low glucose levels. This event would also explain the high total percent change
O
t
obtained with 6.1 x 10 sensors/mL, as decreasing oxygen levels would result in an
increased percent change from baseline. As the concentration is reduced by a factor of 5
(1.2 x 108 sensors/mL), the sensor population consumes bulk substrates at a lower rate,
thereby allowing more rapid replenishment of substrates at the sensor surface than
compared with those of the highest concentration. This reduction in sensor concentration
results in an extending the glucose-limited operation range, effectively increasing the
analytical range. The same observation was observed with a 15x dilution, resulting in a
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concentration of 4.1 x 107 sensors/mL, such that the analytical ranges and sensitivities
were similar (Figure 55). This observation indicates that substrate diffusivities within the
bulk solution were able to overcome substrate consumption of the sensor population at a
o

similar rate to those of the 1.2 x 10 sensors/mL sample set.
To further analyze this situation, changes in bulk oxygen levels at the entrance
and exit o f the reaction chamber were monitored during the experimental procedure
(Figure 56).
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Figure 56. Bulk oxygen levels at sample chamber outlet for various sensor
concentrations.

These data indicate that there is indeed a mean reduction of oxygen levels at the
chamber outlet; however, the oxygen level fluctuations observed under 0 mg/dL glucose
make statistical conclusions difficult. In an attempt to account for fluctuations of oxygen
at the chamber inlet, the absolute difference between the inlet and the outlet was
calculated (Figure 57).
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Correction for fluctuations of bulk oxygen at the chamber did not enhance
statistical viability o f the data, given the standard deviations observed at 0 mg/dL of
glucose are not statistically different than measurements acquired over non-zero glucose
levels. Statistical significances aside, it is noteworthy to point out that the mean changes
•

•

in bulk oxygen levels observed with the lowest particle concentration (4.1 x 10

7

sensors/mL) are greater that those observed with the highest tested concentration. These
data seem counterintuitive, as it would be expected that samples prepared with a higher
concentration of sensors would consume more oxygen and would therefore result in a
greater oxygen differential. In an attempt to explain this anomaly, a closer inspection of
the sample preparation technique was warranted. As detailed in the methods section of
this chapter, 10 p.L of the sensor suspension are placed on double-sided pressure-sensitive
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polyacrylate adhesive and dried under streaming nitrogen. After testing, the samples were
removed, dried under streaming nitrogen, and imaged using a SEM (Amray 1830, 20kV).

Figure 58 Scanning electron micrograph of immobilized sensor sample prepared
with 6.1 x 108 sensors/mL.

From this image, it is apparent that multiple sensor layers (approximately 3)
comprise the tested sample. Thus, it is plausible that underlying sensor layers “see”
different substrate concentrations at their respective surfaces. It is important to note that
the non-spherical matter could be due to salt crystal formation as a result of PBS presence
during the drying process.
Additionally, tested samples were examined on a more global scale using UV
illumination (BlackRay), while collecting PtOEP emission with a digital camera (Figure
59).
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Figure 59. Images of sample with varying concentration after testing - left (6.1 x 108
sensors/mL), middle (1.2 x 108 sensors/mL) and right (4.1 x 107 sensors/mL).
Sensors are identified by red/pink color.

Shear forces exerted at the sample-solution interface removed weakly adhered
sensors (red/pink color), resulting in immobilization patterns observed in Figure 59.
When compared with an image of a sample obtained before testing, a significant
difference between the immobilization patterns can be observed (Figure 60).

Figure 60. Image of sample prior to dynamic testing (6.1 x 108 sensors/mL).

These images indicate that the distribution profile of the sensors can significantly
change as the shear forces are exerted on the sensors (this event takes approximately 45
min to equilibrate as shown in Figure 42). Therefore, the initial number of immobilized
sensors can not be assumed to be constant throughout the experimental procedure, but it
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is apparent that the absolute quantity of sensors immobilized when using 6.1 x 10

sensors/mL is indeed greater than that observed for the two lower concentrations.
Therefore, there is no current explanation as to why mean decreases in bulk oxygen
levels are greater for a lower number o f sensors present on a sample. It is believed that
lowering the flow rate would result in an increased amount of oxygen consumed from the
bulk, which should exaggerate the oxygen differential and possibly reduce the noise
observed in Figure 56 and Figure 57, allowing statistically significant measurements of
the oxygen differential between glucose-containing solution and buffer. Additionally, it
is important to recognize that the sample geometry tested is similar to that of a disk,
where in in vivo situations, the sensor implant geometry may more closely resemble that
o f a sphere. Nonetheless, it is a practical concept to consider when designing the in vivo
functionality of the system.
4.3.15

Effect of Flow Rate on
Glucose Response
A critical variable o f the testing apparatus used in this work is flow rate. It was

hypothesized that the solution flow rate through the reaction chamber could indeed cause
changes in the dynamic response properties of the sensors. An experiment was devised
during which a sample was exposed to varying glucose levels at several flow rates. Data
were collected and the % change in PtOEP/RITC peak ratio was plotted versus glucose
concentration (Figure 61).
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Figure 61. Effect of solution flow rate on mean sensor response.

It should be noted that since the same sample was used throughout this
experiment, that random duplicate exposures to each glucose concentration were
performed (as opposed to triplicates in the previous experiments), with the samples being
exposed to random flow rates. These data indicate that solution flow rate does have an
effect on the response properties of the sensors. In order to further interpret the data in
Figure 61, the sensitivity and analytical ranges determined for each flow rate were
calculated.
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Figure 62. Flow rate effect on sensor sensitivity and analytical range.

In contrast to previous data sets, there is no clear trend (i.e. continuously
increasing or decreasing) of how flow rate affects sensitivity and analytical range. For
instance increasing the flow rate from 0.75 mL/min to 2 mL/min results in an increase in
sensitivity, but increasing the flow rate from 2 mL/min to 4 mL/min results in a
subsequent decrease in sensitivity. Given that these data are indeed more chaotic than
previous data detailing a parameter’s effect on sensitivity and analytical range of the
sensors, conclusions are more difficult to draw. Therefore, it is desirable to formulate a
quantitative relationship between device sensitivity and analytical range such that a
single coefficient is extracted and compared with those obtained from other values of the
independent variable, in this case, flow rate. To relate device sensitivity and analytical
range, the following “fitness” function (F) is introduced:
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F ( m , R 2) = —

1
max A ,
1 - A * m * -----------—---- b B * R
m a x A %Change

The fitness value is obtained from the overall sensitivity (m) and linearity (R2) of
the response. It should be noted that in this case, the sensitivity is not defined as before
(the slope o f the linear region of the response), but is defined as the overall sensitivity
(average slope, m) o f the entire response, which is obtained by simply performing a leastsquares linear regression to the entire response profile.

The overall sensitivity was

subsequently normalized to the maximum possible slope over the range of interest. The
overall linearity o f the response is defined as the correlation coefficient obtained through
the linear regression; this R2 value is synonymous with analytical range, such that as R2
approaches 1, the linearity (i.e., range) of the response over the range of interest is
increased. It is noteworthy to state that the fitness function assigns weights to m and R2
given by A and B, respectively, allowing one to assign varying levels of importance to
either parameter. It should be noted that summation of the weighting factors is equal to
unity. For the work presented in this section, an equal weighting of 0.5 was assigned to
each variable (i.e., sensitivity and linearity are of equal importance). Before instating this
function to analyze the data, presented in Figure 61 and Figure 62, it is a useful exercise
to examine how profiles with varying sensitivity and range affect the fitness. To compare
the effect steady-state response profiles on fitness values, several sets of dummy response
profiles were generated and a fitness value calculated for each case (Figure 63).
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Figure 63. Response profile effect on fitness value (F ). Note that these data were not
experimentally determined.

The data presented in the black trace represent the “ideal” response, with the
highest obtainable sensitivity and linearity over the defined response range (0 - 300
mg/dL), thereby warranting the “infinite” fitness value of 4 x 1015. The data presented in
the red and blue traces represent similar deviations in sensitivity and linearity,
respectively, such that the resulting fitness values are similar in magnitude. Therefore,
elevated fitness values represent increasing conformity of the response data to the “ideal”
response.
Using this approach, the fitness values were calculated for each response profile
obtained at various flow rates (Figure 61) and displayed in Figure 64.
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The first noteworthy point is that flow rate can indeed affect the glucose response
of the sensors. Additionally, these data indicate a “sweet spot” between sensor response
and flow rate, as observed by the maximum fitness value occurring at 4 mL/min. This
result is not surprising, as at low flow rates (0.75 mL/min), it is possible that substrate
replenishment from the bulk cannot match consumption of the sensors. As flow rate is
increased, more rapid delivery of substrates allows extension of the oxygen limited
response, resulting in an increased fitness value. However, at extreme flow rates (i.e. 10
mL/min), forced mass transfer due to convection may occur, resulting in sensitivity loss
and a reduced fitness value. Under the premise that oxygen has a greater diffusivity than
that glucose through the nanofilm coatings,144 convection would result in elevated
average steady-stage oxygen levels within the sensor, causing decreased sensitivity
similar to that observed in Figure 52 (540 pM sample set). It is also important to state
that normal physiological interstitial fluid flow rates are on the order of mL/hour,
significantly lower than those obtainable with the current experimental setup.184 When
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tested under physiological flow conditions it is expected the response will exhibit a poor
analytical range due sensor consumption being greater than bulk replenishment;
therefore, changes in sensor concentration, as well as nanofilm thickness (as discussed in
the next section), may be required to obtain a desirable clinically viable response
properties.
4.3.16

Effect of Nanofilm Thickness
on Glucose Response
One o f the key hypotheses o f this dissertation is that modulation of substrate

diffusivities into the sensor would result in alterations of response properties, namely
sensitivity and analytical range. More specifically, limiting glucose diffusivity (relative
to oxygen) would decrease the drop of steady-state oxygen levels within the sensors for a
given bulk glucose level, ultimately reducing sensitivity and extending the glucose
sensitive range of the sensors.41

Previously, substrate transport was controlled via
•JO

component immobilization within diffusion limiting polymer supports,
derivatives, 139-141 and dialysis membranes.107

sol-gel

Although these reports have shown

successful response properties to glucose, a simple means to modulate response
properties (i.e. customize sensitivity and analytical range) is difficult to achieve with the
reported fabrication techniques.
In this work, the surface adsorption of thin films fabricated using LbL selfassembly has been selected as substrate diffusion limiting membranes in part due to the
ability to create complex nanocomposite thin films through the sequential adsorption of
oppositely charged molecules.

This general technique has been applied to various

charged species, including linear polyions, proteins, viruses, ceramics, lipid tubules,
lipids, and charged nanoparticles, 142 thus providing a means to engineer a practically
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endless variety of nanocomposite materials via an extremely simple procedure. Previous
work has shown that glucose diffusivity through PAH/PSS thin film (the film architecture
used in this work) could decrease glucose diffusivity by four orders o f magnitude when
compared with the glucose diffusivity in water, proving that LbL films could indeed
provide diffusion limiting capabilities.144 This result is indeed remarkable, given that a
typical (PSS/PAH)7 film has an approximate thickness of 28 nm (4 nm per PSS/PAH
bilayer).
Additionally, a reaction-diffusion model was developed to examine the effect of
physical parameters on enzymatic smart tattoo function, comprising LbL nanofilms as a
substrate diffusion barrier.41 By varying nanofilm thickness (through simply adjusting
the number of bilayers adsorbed to the surface), the authors demonstrated that the
diffusivity o f glucose relative to oxygen could be modulated, thereby adjusting the
average steady-state oxygen levels observed within the sensors. Additionally, optimal
response properties (sensitivity and range) were obtained with 9 PAH/PSS bilayers
adsorbed to spherical immobilization matrix in which the oxygen diffusivity is
approximately 6-fold greater than that of the glucose diffusivity. Given that theoretical
predictions of sensor dynamics showed excellent agreement with experimental
observations, the utility of these nanofilms in preparing successful enzymatic smart tattoo
concepts was demonstrated, making LbL films a model thin film technology to use in an
attempt to engineer smart tattoo response properties.41’133,137
To examine the effect of nanofilm thickness on sensor response properties,
sensors with varying numbers of PAH/PSS bilayers were prepared as previously
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described, and the response properties acquired using the dynamic testing apparatus
(Figure 65).
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Figure 65. Effect of the number of PAH/PSS bilayers on glucose response
properties.

From these data, it is apparent that the number of PAH/PSS bilayers (i.e.,
thickness of the PAH/PSS film) can effect the response sensitivity and analytical range.
To quantify the effect of nanofilm thickness on response properties, the sensitivity and
analytical range were determined for each sample set and presented in Figure 66.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

163

7

300

_ 6
"D

- 250

'U

E 5

)
200 ®O
E

0)
c 4

o>
CD

CD

-£=

150 |

o

5? 3 -

aj
o
100 %

£ 2
<n
c

C
CD

<

CD

to

50

10

15

20

25

30

Number of PAH/PSS Bilayers

Figure 66. Effect of PAH/PSS bilayer number on device sensitivity and analytical
range.

To begin this discussion, the increase in sensitivity observed between sensors
coated with {PAH/PSS}3 and {PAH/PSS}5, respectively, will be considered.

This

observation is indeed unexpected, as it was hypothesized that sensors comprised of a
lower number of PAH/PSS bilayers would exhibit a higher relative sensitivity. This
hypothesis stems from the ideology that films comprised of a low number of bilayers
would provide an insufficient barrier to glucose; hence, steady-state glucose levels within
the sensors would be greater than those observed with a higher number of bilayers for a
given bulk glucose level.

This phenomenon would in turn elicit increased oxygen

consumption within the sensor, resulting in decreased steady-state oxygen levels that
would ultimately cause the rapid onset of an oxygen-limited reaction scheme (i.e. high
device sensitivity and low analytical range) when compared with that of sensors with a
greater number of bilayers.

Nonetheless, the opposite behavior is observed between
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{PAH/PSS}3 and {PAH/PSS}5 coated sensors.

One potential explanation for this

occurrence could be that the algilica matrix itself provides an efficient diffusion limiting
effect, allowing the sensor to operate in an extended glucose-limited range. Given that
this explanation ignores the contribution of the LbL film, it is somewhat controversial;
however, it has been documented that several bilayers of LbL films are necessary to
ensure complete surface coverage, 185 suggesting the possibility that {PAH/PSS}3.5 may
not be sufficient to achieve complete coverage o f the sensor. With a “leaky” diffusion
barrier, the reaction-diffusion kinetics would be governed to a greater extent by the
algilica matrix.
Given that the transport properties of glucose and oxygen through the algilica
matrix remain unknown, extensive speculation is impractical. However, it is well known
that silica-containing matrices exhibit glucose diffusivities similar to those observed in
water, while having increased oxygen diffusivities (approximately 2 order of magnitude
greater) when compared with hydrogel matrices, whose oxygen diffusivities are similar to
that of water.170, 186 Should the algilica matrix have similar diffusivities to that of
mesoporous silica, it is plausible that the rapid replenishment of oxygen with respect to
glucose could result in a glucose-limited response without the aide of diffusion limiting
coatings. Nonetheless, this finding indicated that surface adsorption of 20 nm thin films
(typical bilayer thickness of a PAH/PSS film is 4 nm) could drastically influence the
behavior of these sensor prototypes.
Following the initial increase in

sensitivity between

{PAH/PSS}3 and

{PAH/PSS}5 coated sensors, the hypothesized trend (i.e. decreased sensitivity with
increased nanofilm thickness) becomes apparent.

To emphasize the effect of
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polyelectrolyte films on device sensitivity as well as analytical range, the percent change
of these figures of merit observed in sensors comprising greater than five PAH/PSS
bilayers was determined (Figure 67).
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Figure 67. Percent change in sensitivity and analytical range resulting from an
increasing in nanofilm bilayers.

The first point of note is that these data indicate the remarkable ability of
PAH/PSS nanofilms to control device response properties. Overall, the sensitivity was
reduced by approximately 80% and the range extended approximately 150% through the
adsorption of {PAH/PSS}25 coatings to the particle surface. It is important to highlight
that there is an approximate linear relationship between the percent change in sensitivity
and analytical range observed with sensors comprising 5, 10, and 15 PAH/PSS bilayers.
By performing linear regression between these data sets, it was determined that the
percent change in sensitivity per bilayer was -7.26 ± 0.3% and the percent change in
analytical range was 10 ± 0.35% - a total percent change of 70 and 100%, respectively.
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However, this trend was significantly dampened between sensors coated with 15, 20, and
25 bilayers, such that sensitivity was only reduced by approximately a 10% change (~
0.7% per bilayer). This result can be explained by the incremental reduction of glucose
flux (relative to oxygen) observed with 5, 10, and 15 bilayer coatings, such that the
sequential adsorption o f 5 bilayer increments linearly retards glucose flux into the
catalytic region of the sensor. However, after the adsorption of 15 bilayers, the transport
rate of glucose into the sensing region of the sphere begins to be less affected by the
nanofilms, resulting in a dampened response, as predicted in previous work.41 Given this
analysis, it is hypothesized that a further increase in the number of nanofilm bilayers
would continue to reduce the sensitivity and increase the analytical range, albeit at a less
effective rate. Nonetheless, it is important to restate that the sequential adsorption of
PAH/PSS films onto the particle surface does allow the sensitivity and the analytical
range o f these devices to be tailored using an extremely simple technique. Additionally,
future applications are not limited to PAH/PSS nanofilms, but a variety of nanocomposite
films could be applied to this platform, such that more dense films could reduce the
thickness (i.e. number of bilayers) needed to obtain a similar response.
Following the analysis of bilayer effect on sensor response properties, it is only
logical to speculate about the number of PAH/PSS bilayers required to obtain an
optimum response. To determine the optimum number of bilayers, the fitness function
(as described earlier in this chapter) is employed.

As previously stated, the fitness

function allows the relative importance of sensitivity and linearity of the response to be
assigned through weighting factors over a designated range of operation. As an initial
exercise, the glucose range over which the fitness values were calculated was varied from
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0 - 300 mg/dL to 0 - 150 mg/dL assuming equal weighting of sensitivity and linearity
(Figure 68).
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Figure 68. Fitness of sensor response versus number of PAH/PSS bilayers at various
ranges of interest. Note that these data were obtained with equal weighting of
sensitivity and linearity.

These data indicate that by decreasing the range of interest to 0 - 150 mg/dL, the
fitness values of the sample set are similar, in part due to the high linearity of the sample
sets in this range, whereas, when using 0 - 300 mg/dL as the range of interest, sensors
comprising 5 nanofilm bilayers (range = 90 ± 5 mg/dL) produce the highest valued
response.

Although this exercise is somewhat impractical (undoubtedly a glucose

monitor with such a limited range would not be viable), it is nonetheless interesting to
examine the effect of varying the analytical range of interest on the calculated fitness
value.
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A more practical exercise would be to study the effect of the weighting factors on
the fitness output. In Figure 69 the fitness values with equal and unequal weighting
factors were calculated for the sensor response properties given in Figure 65.
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Figure 69. Fitness of sensor response versus number of PAH/PSS bilayers at various
sensitivity (m ) and linearity (R2) weightings, assuming a 0 - 300 mg/dL
range of interest.

As expected, these results indicate that weighting factors can influence the fitness
of response.

The red trace yields the fitness values obtained when equal weighting

(A=5=0.5) was used, and indicated that the optimum response (given by the largest
fitness value) is obtained through the adsorption of {PAH/PSS}5 to the particle surface.
If the weighting values are skewed such that more importance is given to sensitivity
(A=0.75 and 5=0.25), the resulting fitness values place more emphasis on {PAH/PSS}5as
the optimum bilayer number. The analytical range of sensors with {PAH/PSS}5 coatings
was determined to be 90 ± 5 mg/dL, which does not cover the accepted range (up to 350
mg/dL) of monitors for home use.

17 ( \

Hence, it can be said that these devices are too
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sensitive (greater than those of similar systems by at least one order of magnitude).27,37,39
Therefore, more importance was assigned to response linearity (A - 0.25 and B = 0.75).
These data are depicted in the blue trace and indicate that the optimum response is
obtained with {PAH/PSS}25 coatings, which provided the greatest analytical range (225 ±
15 mg/dL) o f all tested sample sets. Although these sensors do indeed have an extended
range when compared with sensors coated with a lower number of PAH/PSS nanofilm
bilayers, the analytical range is still not within clinical standards. It is hypothesized that
films with increased resistance to glucose diffusion (as compared to PAH/PSS
nanofilms), such as self-assembled lipid bilayers would allow a more efficient means to
extend the glucose sensitive range of these devices.187
4.3.17

Response Properties of
Uncoated Particles
As shown in the previous section, a precise means to modulate sensitivity and

analytical range o f these sensor prototypes is to adsorb polyelectrolyte multilayer films of
varying thickness to the sensor surface. By modulating the flux of glucose relative to
oxygen, the glucose-limited range can be engineered.

However, it is interesting to

consider sensor function without surface-adsorbed nanofilms. In the previous section, it
was hypothesized that uncoated algilica particles would have a glucose-sensitive
response, since reports have shown that silica based matrices have greater oxygen
diffusivities than that o f glucose by approximately 2 orders of magnitude. 170,186 This
hypothesis was tested by preparing sensors without fluorescent nanofilm coatings and
tracking the change in PtOEP intensity as a function of bulk glucose concentration over
time.
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It is important to note that in these data, no reference signal was used; therefore,
the data had to be corrected for any drift resulting from source fluctuations and decreases
in sensor concentration. Figure 70 depicts the raw data and the curve fit used to correct
baseline drift.

— Intensity data
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Figure 70. Raw PtOEP peak intensity obtained during dynamic glucose testing of
sensors without nanofilm surface coatings and baseline fit used to correct
for signal drift over time.

It should be noted that to obtain the baseline fit, the dynamic sensing data
obtained at 0 mg/dL were fitted to a second-order polynomial.

After the data were

corrected for drift by subtracting the baseline drift, the profile in Figure 71 was obtained.
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Figure 71. Corrected PtOEP peak intensity obtained during dynamic glucose testing
of sensors without nanofilm surface coatings.

From these data, it evident that a stable baseline was obtained through the
baseline correction procedure. The corrected data were then used to obtain the following
response profile.
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Figure 72. Glucose response profile of uncoated sensors.
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The first point of note is that the uncoated sensors are indeed sensitive to changes
in bulk glucose levels.

Using the data presented in Figure 72, the sensitivity and

analytical range of the uncoated sensors can be obtained and subsequently integrated into
the data presented in Figure 66 to create the graph in Figure 73.
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Figure 73. Comparison of uncoated to coated sensor response properties.

It should be noted that the behavior responsible for the decrease in sensitivity
observed with sensors coated with {PAH/PSS}5.25 was discussed in the previous section;
therefore, the discussion here will focus on the increasing sensitivity trend observed with
sensors comprising {PAH/PSS}0-5.
One explanation for the initial increase in response sensitivity could lie in the
hindrance of oxygen adsorption to the algilica surface by the incomplete surface coverage
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o f initial nanofilm bilayers. In previous reports, it is hypothesized that the rapid oxygen
diffusivity observed in silica based matrices occurs due to surface adsorption of dissolved
oxygen followed by diffusion across the surface.46 Thus, if incomplete polyelectrolyte
multilayers are deposited to the surface, it is possible that glucose diffusion may be
minimally effected, but oxygen adsorption to the algilica surface and subsequent
diffusion may be significantly hindered. This phenomenon would ultimately decrease
oxygen flux relative to that o f glucose entering the catalytic region of the sensor. As a
result, the rate o f oxygen replenishment would be eclipsed by the rate of glucose supplied
from the bulk, resulting in increased sensitivity and reduced analytical range, as shown in
the transition from 0 to 3 nanofilm bilayers. If the adsorption of additional bilayers fails
to provide a significant barrier for glucose but provides additional hindrance to oxygen
surface adsorption, the effect would be compounded, resulting in a sequential increase in
sensitivity and decrease in analytical range, as seen in the transition from 3 - 5 nanofilm
bilayers. Additional support for this theory could be found by analyzing the response
profile of sensors coated with 0, 3, and 5 nanofilm bilayers, respectively (Figure 74).
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Figure 74. Glucose response profile comparison of sensors coated with 0,3, and 5
PAH/PSS bilayers.

If oxygen flux (relative to glucose flux) is reduced by the deposition of 3 nanofilm
bilayers, then the internal oxygen levels would be expected to be lower for a given bulk
glucose concentration, when compared with those sensors without nanofilm coatings.
This event would result in an increased percent change in the PtOEP/RITC peak ratio
(less oxygen = increased PtOEP emission) for a given bulk glucose level when compared
with those obtained with uncoated sensors, which is indeed what is observed in Figure
74.

The adsorption of an additional 2 nanofilm bilayers (5 total) also results in an

increased percent change in peak ratio for a given bulk glucose level, when compared
with those of 0 and 3 nanofilm bilayers, respectively. These data support the theory that
the initial 5 nanofilm bilayers have a profound effect on the oxygen flux, while additional
nanofilm bilayers dominantly affect the flux of glucose into the sensor.

Further

experimental work investigating the oxygen response may provide additional support for
this theory. More specifically, examining oxygen response time of the sensors versus the
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number of nanofilm bilayers may allow the quantification of relative differences in
oxygen flux throughout the sphere.
The lack o f some details on the underlying phenomena not withstanding, these
data indicate that glucose-sensitive prototypes using algilica matrices can be obtained
without polyelectrolyte nanofilms, a stark contrast to theoretical simulation using alginate
as the immobilization matrix, the results of which indicated that nanofilms were a critical
aspect in obtaining a glucose sensitive response.41’ 133 It is of critical importance to state
that although nanofilm coating are not required to obtain a glucose-sensitive response
fo r algilica matrices, they are indeed useful in providing a means to regulate device
sensitivity and analytical range, thus allowing these prototypes to be engineered to
individual specifications.

Therefore, the efficacy of polyelectrolyte nanofilms in this

application cannot be understated.

4.4

Conclusion

A highly sensitive microparticle-based enzymatic glucose sensor technology has
been demonstrated. As a first step, techniques were developed to allow the homogeneous
immobilization o f GOx and PtOEP within algilica microspheres, following which,
fluorescent nanofilms were deposited onto the particle to provide a reference signal and
obtain glucose-limited oxygen consumption within the sensor by controlling glucose
transport.

The oxygen-dependent response of the sensors was quantified, indicating

linear quenching characteristics and high sensitivity to oxygen within the expected range
o f physiological operation. Upon the addition of glucose, these self-referencing systems
rapidly responded (tgs = 84 sec) to step changes in glucose concentration, while
exhibiting excellent baseline stability, photostability, and reversibility between alterations
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of bulk glucose levels. It was found that these systems are highly sensitive to glucose,
with sensitivities approximately an order of magnitude greater that those o f similar
systems.

As a key point of this work, it was shown that through the subsequent

adsorption o f polyelectrolyte multilayers, the reaction-diffusion kinetics within sensors
could be modulated, ultimately resulting in the ability to control the sensitivity and
analytical range and design a sensor sensitive within a range of interest. These results are
undoubtedly promising indicators of the efficacy of these sensors as potential implants
for diabetic monitoring.

However, given that the response properties are highly

dependent on bulk oxygen concentration, as well as the concentration o f immobilized
sensors, these factors need to be addressed to enhance the practicality of the systems for
in vivo use. Future work will investigate the feasibility of incorporating bulk oxygen
sensors into the implanted sensor population to correct for fluctuations in oxygen levels
seen under normal physiological conditions, as well as oxygen fluctuations due to
substrate consumption from the enzymatic smart tattoo population. Additionally, the
effect o f polyelectrolyte nanofilms on the oxygen diffusivity through algilica should be
investigated, as additional insight could enhance future designs. Moreover, a critical
aspect o f clinical viability remains to be characterized - long-term response properties.
Thus, in the following chapter, a mathematical model describing the effect of long-term
operation on sensor function is presented and the output compared to experimentally
determined results.
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CHAPTER 5

MODELING AND EXPERIMENTAL VALIDATION
OF ENZYME DEACTIVATION
KINETICS
5.1

Introduction

In the previous chapter, the preparation and characterization of enzymatic smart
tattoo concepts were successfully demonstrated.

These sensors rely on the co

immobilization o f glucose oxidase and platinum porphyrin complexes to indirectly report
glucose levels through changes in local oxygen levels resulting from glucose
consumption. A particularly novel feature of these concepts is the use of fluorescent
polyelectrolyte nanofilms to provide an internal reference signal, as well as to modulate
substrate transport into the catalytic region of the tattoo. A schematic of the sensor
prototype, as well as confocal micrographs of actual prototypes are given in Figure 75.
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

178

Enzyme +
0 2-sensitive
fluorophore

Reference
fluorophore

Algilica
UJ
sphere
t
Multilayer film
(transport barrier)

Figure 75. Schematic of enzymatic smart tattoo sensor and accompanying confocal
micrograph depicting indicator (blue) and reference (pink) dye location.

While the results reported thus far are undoubtedly promising, sensor
performance under extended periods of continuous operation has yet to be characterized.
Since the ultimate goal of this work is to provide a clinically viable technology to
enhance the quality of life for diabetic patients, it is desirable for these transdermal
devices to exhibit long lifetimes (> 6 months). Constant removal/replacement of the
tattoos, as well as increased calibrations required to ensure readout accuracy would
ultimately detract from the “minimal invasiveness” of this technology and potentially
eliminate application in long-term situations. Although previously reported in Chapter 4,
photodegradation of fluorophores could also contribute to decreased sensor life span, but
has been shown to be minimal over the projected sensor lifetime.
It is also important to recognize that host-mediated inflammatory responses could
potentially be detrimental to sensor longevity.188

Inflammation serves to contain,
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neutralize, reduce, and wall off the foreign body.

Through the initial steps of this

process, the implant would be attacked by the host immune system, with full attention
focused on removing the implants via oxidative processes or phagocytosis, ultimately
resulting in a loss o f implant function over time. However, it should be noted that this
phenomenon is most likely dependent on surface structure and chemistry, and may be
controlled via the deposition o f different surface coatings, as previous work suggests.

1SO

Additionally, fibrous capsule formation around the implants may prove more detrimental
to long-term function stability, as most likely the substrate mass transport properties
through the capsule would be significantly less that those in the subcutaneous space.
This phenomenon may lead to increased lag times104 as well as performance alterations
due to variations in the bulk conditions “seen” by the implants. Additionally, the fibrous
capsule is expected to alter the excitation and collections efficiency of transdermal
irradiation, making the spectral acquisition more challenging.

However, the detailed

consideration of these factors is out of the scope of this work.
Additionally, one particular phenomenon which could greatly influence the long
term response properties o f enzymatic smart tattoos is the temporal deactivation of
glucose oxidase. Loss o f enzymatic activity would ultimately result in decreased device
sensitivity over time, causing diminished accuracy and ultimately requiring device
replacement. Being that GOx is used in a broad range of applications, a copious amount
of work has been dedicated to understanding its kinetic properties, as well as factors
affecting kinetic properties.179,190-193 in these reports, several key factors that affect the
long-term stability of GOx have been determined, including inactivation due to time,
temperature, pH, and hydrogen peroxide poisoning.

Of these factors, inactivation
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(unfolding) resulting from hydrogen peroxide poisoning has been shown to be the most
grave, such that one report showed > 95% loss of enzymatic activity after 50 hours of
continuous operation, while other factors such as pH and thermal inactivation have been
reported to have little effect on enzyme activity at physiologically regulated values.

1 7Q

’

1 Oft

193 Despite the understanding of GOx deactivation kinetics, there has been little effort in
integrating inactivation kinetics into a spatio-temporal reaction-diffusion model, possibly
due to the computationally intensive processes required to obtain a solution. Even so,
one report proposed a dimensionless model to investigate the effect of GOx deactivation
on glucose-sensitive response properties of planar electrochemical glucose sensors.179
Although simulation results were not experimentally validated, model output predicted
significant loss o f device sensitivity (~ 45%) due to enzyme inactivation after only ten
days of continuous operation.

Nonetheless, a dimensional model with spherical

coordinates is desired to describe the devices detailed in this work (Figure 75). More
recently, a model describing the reaction-diffusion kinetics within spherical enzymatic
smart tattoos was proposed.166 However, the model proposed in this report was solely
used to examine the effect of physical parameters on sensor response properties to
prepare functional first-generation prototypes; therefore, drift in response properties due
to enzyme inactivation was not considered.
Given that functional prototypes have been demonstrated in the previous chapter,
emphasis is shifted to engineering sensors with sustainable response properties. Hence,
there is a need to combine these efforts to develop a spatio-temporal reaction-diffusion
model which includes the ability to monitor long-term operation, while considering the
effect o f enzyme inactivation on device function. Such a model could be used to examine
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the effect of physical properties on long-term sensor function, providing a tool to
rationally design enzymatic smart tattoos for optimal response over extended periods of
continuous operation, thus alleviating the need for frequent calibration and/or
replacement. The scope o f this chapter is to develop such a mathematical model, while
experimentally validating the results.

5.2
5.2.1

Methods

Instrumentation
A numerical solution o f the sensor model was obtained with the PDEPE function,

which solves initial-boundary value problems for systems of parabolic and elliptic partial
differential equations in one space variable and time, in MATLAB 7.0 (Mathworks).
Stand-alone C applications were created using MATLAB compiler v3.0 and executed on a
Windows XP Professional-equipped workstation with dual 2 GHz Xenon® processors
and 2 GB o f RAM (Dell).
5.2.2

Theory
Glucose oxidation as catalyzed by glucose oxidase in the presence of oxygen can

be described by the following reaction scheme:

Eo ^ G ^ j ^ X , - ^ E r + P
E r + 0 2 < k^ kl >X2

( 1)

— >Ea + H 20 2

where G and O2 represent the reactants, glucose and oxygen, respectively, while P and
H 2 O2 represent the products, gluconic acid and hydrogen peroxide, respectively. The
oxidized and reduced forms o f the enzyme are represented by Ea and Er, and the enzymesubstrate complexes are given by Xj and X 2 . The forward and reverse reaction rate
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constants are given by ki, L j, k2, k3, k.3, and k4. Additionally, the following scheme
describes the first-order inactivation kinetics due to hydrogen peroxide poisoning:

e 0 + h 2o 2 -

^

ie o

X j + H 20 2 —^ - ^ I X x

Er + H 20 2

(2)

k , >IEr

X 2 + H 20 2^ + I X 2

where K 1, K2, K3, and K4 represent the inactivation rate constants o f the respective
enzyme forms, and IE0, IXh IEr, and IX2 represent the inactivated enzyme forms.
Applying a mass balance in the r direction to a spherical shell averaged in (/>and
6, seven equations describing the reaction-diffusion kinetics within an individual
spherical sensor are obtained:
~ = D c ~ ( r , G) + r 2(-k,G E , +k_,X ,)
dt
or

ot
^

or
~

= D h X

^

„

ot
dr
BE
- J L ^ S i - k ^ G + k ^ + k 4X 2 —K xE0H 20 2 - K 0E o)
ot
BX
— ± = r 2(k1E 0G - ( k _ 1 + k 2) X , - K 2X 1H 20 2 - K ° X x)
dE
~ ^ = r 2(k2X x - k 3Er0 2 +k_3X 2 - K 2E rH 20 2 - K ° E r)
dt
—j X = r 2(k3Er0 2 ~(k_3 + k 4) X 2 - K 4X 2H 20 2 - K ° X 2)
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where the diffusivities o f glucose, oxygen, and hydrogen peroxide are given by Do, Do,
and D h, respectively. It should be noted that K° represents the spontaneous deactivation
rate constant for each enzyme form and was assumed
K° = 0.25Kr ,
where K Tis the total spontaneous inactivation rate constant, stating the respective enzyme
forms spontaneously inactivate at an equivalent fraction of the total rate constant.
Additionally, the total active enzyme concentration, E t, at any time t and space r is
defined as
E t (r, t) = Ea(r,t) + X x( r,t) + Er(r,t) + X 2( r , t ) ,
where E0, Xi, Er, and X 2 represent the concentration o f the active enzyme forms.
Therefore, the simultaneous solution of the above series of partial-differential
equations with boundary and initial conditions appropriate for the structure of Figure 75
would result in the spatio-temporal profile of reaction substrates within the sensor, while
considering the effect o f enzyme inactivation. Thus, the effect of enzyme inactivation on
sensor function over extended periods of continuous-operation could be predicted, as well
as the effect o f varying physical parameters to minimize response drift.

Simulation

output could provide critical information in the development of sensor prototypes with
sustainable response properties.
5.2.3

Assumptions
Using the schematic in Figure 75, the model assumes homogeneous distribution

o f active enzyme and indicator within the algilica particle, from 0 < r < r l . It should be
noted that near-homogeneous distributions of enzyme and indicator dye were achieved in
the previous chapter and depicted in Figure 36, validating a shell balance averaged (/) and
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0. Given the stable immobilization of enzyme within the sensor after 24 hours (Figure
38), the enzyme components were assumed to have respective diffusivities of zero (i.e.
non-mobile). It is also assumed that the nanofilms are homogeneously adsorbed to the
particle surface from rl < r < r2, and substrate diffusivities through the nanofilms
remain constant irrespective o f film thickness. Additionally, for model output to describe
a population o f implanted sensors, it must be assumed that individual sensors within a
population are exposed to the same bulk conditions regardless of the sensor concentration
(the model simulates the reaction-diffusion kinetics within a single sensor). It should be
noted that this assumption will not hold under all conditions (i.e. high particle
concentration and small interparticle distances); however, given the intense computation
processes required to solve the model, this simplification is warranted for the work
presented herein.
The following assumptions are applied for the initial and boundary conditions:
1. The oxygen concentration in the bulk for all t remains constant at 90 pM, the
accepted value for intradermal oxygen tension near a constant hematogenic source.135
Similarly, glucose and hydrogen peroxide concentrations within the bulk remain
constant for all t. No enzyme is present in the bulk.
2. At time t —0, the concentrations of glucose and oxygen are equivalent to those in the
bulk for all r. Additionally, the initial enzyme concentration is 1 mM and there is no
hydrogen peroxide for all r at time t - 0.
3. Glucose, oxygen, hydrogen peroxide, and enzyme concentrations remain constant for
all t at r = r2.
4. There is no component flux at r = 0 for all t.
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The mathematic description of these conditions is summarized in the following
table.

Table 2. Initial and boundary conditions for sensor model.
G(r,0) = G(bulk)
O2(r,0) = 90 pM
H20 2{r,0) = 0 mM
Ej(r, 0) = 1 mM
G(r2,t) = G(bulk)
0 2(r2,t) = 90 pM
H20 2(r2,t) = 0 mM
Ej(r2,t) = 0 mM

Initial
Conditions

— G(0,t) - 0
ot
~ 0 2(0,t) = 0
Ot

Boundary
Conditions

— H 2OJ0,t) = 0
8t 2 2
| ot

5.2.4

(0, 0 = 0

Simulations
The model described herein predicts the effect of enzyme inactivation on long

term sensor function and determine if alterations in physical parameters could enhance
sensor longevity. In a typical simulation, a step increase in glucose concentration is
generated at time t = 0, and the temporal and spatial distribution of reaction substrates
(namely glucose and oxygen) and active enzyme components within the sensor are
tracked. It should be noted that the initial conditions assume that the glucose and oxygen
levels within the sensor are equilibrated with bulk levels, such that at time t = 0, the
enzyme is activated and substrate consumption is initiated. This condition allows the
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time required for the sensor to operate in steady-state (i.e. a balance between substrate
consumption and replenishment within the sensor) to be determined.

After the

achievement o f steady-state operation, the true average oxygen levels within the sensor
can then be used to indirectly monitor bulk glucose levels. To determine the true average
oxygen concentration, 0 2 , within the sphere, a weighting operation is performed on the
oxygen concentration calculated at each r, as previously described.41

r- 0

“

sphere

where the parameters [Orf, VSheii, and Vsphere, represent the oxygen concentration at r, the
shell volume with boundaries r and r +Ar, and the total volume of the sphere at r = rl,
respectively. It should be noted that this operation is necessary to obtain the true average
oxygen concentration within the sphere, since at greater r (i.e., r approaches rl) the shell
volume is larger and thus contains more oxygen indicator molecules, which inherently
contributes more to the overall fluorescence signal.
In these simulations, the effects of enzyme inactivation due to spontaneous
inactivation, hydrogen peroxide poisoning, and the combined effects of both on sensor
function (i.e. sensitivity) over time were characterized. The effect of enzyme inactivation
on sensor function was characterized through analysis of predicted device sensitivity over
time, which was defined as the average slope of 0 2 versus bulk glucose concentration at
each time t. Table 3 contains the model input parameters, which were experimentally
determined or obtained in previous work describing glucose oxidase, mesoporous silica,
and polyelectrolyte multilayers.41,144,170,179,180,186 It should be noted that the diffusivities
for hydrogen peroxide through algilica (0 < r < rl) and the polyelectrolyte nanofilms (rl

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

< r < r2) were estimated, as values were unreported in the literature. These values were
estimated by comparing previously published diffusivities for glucose and peroxide.194
Additionally, glucose and oxygen diffusivities for algilica were assumed to be equal to
those of mesoporous silica, an assumption requiring additional experimental work to
validate.

Table 3. Input parameter values used in simulations.
Parameter
ki
k-i
k2
k3
k-3
k4
K°
K‘
K2
K2
K4
0 2(bulk)
G(bulk)
E t (r,0)
rl
tfilm
D g-s
Dos
D h-s
D g-f
D o-f
D h-f

Value (unit)
105 (M '1 sec'1)
3x103 (se c 1)
300 (sec1)
10b (M '1 sec'1)
150 (sec'1)
50 (sec'1)
9.2x1 O'8 (sec'1)
6.8xl0'5 (M '1 sec'1)
1.97x1 O'2 (M '1 sec'1)
2x1 O'2 (M '1 sec'1)
7.6x1 O'1 (M '1 sec'1)
90 (pM)
0:2:30 (mM)
1 (mM)
10 (pm)
32 (nm)
2.5 xlO'11 (m2 ' sec'1)
2 xlO '^m 2 sec'1)
5 x l0 'lu(m2 sec'1)
9.87 x l0 'l4(m2 sec'1)
1.15 x l0 'lu(m2 sec'1)
4.15 x l O'10(m2 sec'1)

Unless otherwise stated, the parameter values given in Table 3 were used in all
simulations herein.
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5.2.5

Fluorescence Predictions and
Experimental Validation
In the previous chapter, the oxygen response of the enzymatic smart tattoos was

characterized by exposing the sensors to buffer of various oxygenation levels and
recording the corresponding PtOEP/RITC peak ratios, the results of which provided
calibration curves (Figure 40 and Figure 41). Using these calibration data, the average
oxygen concentration within the sensor, as given in the model output, was converted to
predicted fluorescence peak ratio values, allowing direct comparison to experimental
data.
Sensors comprising 10 PAH/PSS bilayers were prepared as described in Chapter
4 and used during continuous operation experiments.

Characterization of sensor

performance under continuous operation was performed with the dynamic testing
apparatus (Figure 33), where sensors were exposed to random glucose levels, ranging
from 50 mg/dL to 300 mg/dL in 50 mg/dL increments, for approximately 25 min each,
with buffer flushing between each glucose step. This process was repeated continuously
over a period o f 4.5 days, while the sensors were subjected to continuous irradiation.
Results obtained were subsequently compared to model output.

5.3
5.3.1

Results and Discussion

Steady-State Response to
Step Input of Glucose
Before analyzing the effect of inactivation on sensor performance, it is a useful

exercise to consider sensor performance ignoring enzyme inactivation, as these data will
serve as a baseline to which additional results are compared.

The averages oxygen
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concentration with the sensor for different step concentrations in bulk glucose is given in
Figure 76.
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Figure 76. Average steady-state oxygen concentration within the sphere versus step
glucose concentration.

From these data, the fundamental operating principles of enzymatic tattoos can be
determined by analysis o f Figure 76. At glucose concentrations ranging from 0 to 300
mg/dL, steady-state oxygen levels are linearly reduced in response to increasing bulk
glucose levels, indicating the sensor is operating in an absolute diffusion-limited regime.
A deviation from linearity is observed with increasing bulk glucose levels (300 - 600
mg/dL), resulting from an increased rate of glucose delivery (higher concentration
gradient) into the sensor.

Given that significant levels of oxygen remain within the

sensor, this deviation from linearity may be attributed to the onset of reaction-limited
consumption as opposed to the onset of oxygen-limited consumption.
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A particularly useful activity afforded by model output is to convert internal
average steady-state oxygen levels into ratiometric values using experimentally
determined calibration data.

Given the experimental data presented in the previous

chapter, the predicted ratiometric values can be simply converted into the expected
percent change of the PtOEP/RITC peak ratio and plotted against bulk glucose levels
Figure 77.
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Figure 77. Predicted percent change in PtOEP/RITC peak ratio for different bulk
glucose levels.

These data can then be directly compared to experimental results presented in
Figure 46, yielding the following plot.
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Figure 78. Comparison of model output to experimental data.

From the data presented in Figure 78 it is apparent that the sensor model grossly
underestimate actual response characteristics, as the percent change at 300 mg/dL is
predicted to be approximately 5, while experimental observations show approximately
500. Given that excellent agreement between theoretical predictions and experimental
outcomes were achieved using a similar model, it is logical to contemplate the
discrepancy observed in Figure 78.41 In previous unpublished work, it was shown that
the diffusivities of glucose and oxygen through the sensor immobilization matrix can
greatly affect the predicted response properties of the sensor.133 Such an insight is indeed
expected, and indicates the importance of knowing the substrate diffusivities through all
sensor components to produce a more accurate model.

Nonetheless, the substrate

diffusivities through algilica were estimated to be equivalent to those of mesoporous
silica, but given that algilica is a unique material containing hydrophilic and hydrophobic
domains, known substrate diffusivities through more hydrophilic media were used as
input parameters and compared with experimental data:
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Figure 79. Comparison of theoretical and experimental results assuming sphere
diffusivities of several materials.

The data presented in Figure 79 indicate that by changing the substrate
diffusivities from those of mesoporous silica to alginate (DG-s = 4x1 O'10 and D0-s =
2.45xl0'9 m2 sec'1) and water (Dos = 6.9xlO'10 and D0-s = 2xl0'9 m2 sec'1), little
improvement in theoretical-experimental agreement is observed. An effort was made to
“fit” algilica substrate diffusivities to experimental data in an attempt to extract
reasonable values that produced better agreement (Figure 80).
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Figure 80. Comparison of model agreement to experimental data using fitted values
for substrate diffusivities through algilica.

The glucose and oxygen diffusivities used to obtain these data were 8.8 lx l 0 '13
and 2x10 *1 m2 sec'1, respectively. Although good agreement was observed with this
particular experimental data set (Figure 52, 540 pM O2), it is difficult to speculate
whether or not these values are reasonable.
Despite the lack of understanding of substrate diffusivities through algilica, it is
paramount to restate that the sensor model only simulates the reaction-diffusion kinetics
within a single sensor and assumes constant bulk substrate concentration at the sensors
surface. As multiple sensor are immobilized, as is the case with this work, a higher rate
of substrate consumption from the bulk would be expected (more sensors = more
consumption); therefore, the substrate concentrations at the sensor surface may be
considerably less than those in the bulk. Lower substrate levels at the sensor surface
would affect sensor performance by decreasing the average steady stale levels within the
sensor, ultimately affecting sensor dynamics, as shown in Figure 54. O f important note is
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that if the experimental data are scaled to allow comparison to the theoretical profiles
(Figure 81), it is apparent that the theoretical predictions (regardless of the sphere
diffusivities) do not represent the experimental profile.
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Figure 81. Comparison of experimental (scaled by 1/30) and theoretical response
profiles using sphere diffusivities of various media.

Given that the model profiles are reaction-limited, while the experimental profiles
are oxygen-limited (as was proven in 4.4.13). it may be inferred that the kinetic constants
used as input parameters, which were derived from solution-phase experiments, are
significantly lower than those of the immobilized enzyme. A comparison of immobilized
and free enzyme kinetics was reported in a recent study, where enzymes immobilized
within mesoporous silica exhibited a 2 fold greater activity per mass than those in
solution phase.195 The authors attributed this observation to the increase in structural
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support provided by the mesoporous silica matrix. Thus, additional experiments should
be performed to examine kinetic parameters of GOx immobilized within algilica
substrates, as such may improve the correlation between simulation and experimental
data. Moreover, it is hypothesized that an additional and perhaps more considerable
reason for the disagreement o f the theoretical and experimental results may be due to
disregarding the global effects of multiple sensors in the current model. A particularly
interesting paper detailing the derivation of a sorption kinetic model used to describe a
population o f polydispersed particles may be of particular use in expanding “group
functionality” to the current model and possibly improve theoretical-experimental
agreement.196
5.3.2

Effect of Spontaneous
Inactivation on Sensor
Function
It is a well known phenomenon that over time, enzymes will unfold, resulting in a

loss of activity. This phenomenon is sometimes referred to as spontaneous inactivation,
time-dependent inactivation, or substrate-independent inactivation and should be
considered when utilizing enzyme-based devices for extended periods of time. In order
to examine the individual effects of spontaneous inactivation on sensor function,
simulations were first executed by assuming K 1, K2, K3, and K4 were equal to zero. Thus,
the only inactivation component was K°, the rate constant for time-dependent inactivation
(i.e. independent o f reaction substrates). The following surface plots show the spatial
distribution o f active enzyme components within the sensor exposed to various bulk
glucose levels over time.
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Figure 82. Surface plots depicting the distribution of active GOx as a function of
time, space, and bulk glucose concentration. Note the respective figure titles,
indicating the time of continuous operation.

From these plots, it is important to note two key features, the first of which is that
enzyme inactivation is independent of glucose concentration, as well as location within
the sphere. This result is expected, given that spontaneous-inactivation is solely based on
operation time. Also, for rl < r < r2, the active enzyme remains at the initial value of 1
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mM.

This occurrence is a result of assuming homogeneous enzyme distribution

throughout the sensor (0 < r < r2), but assuming no reaction occurs within the nanofilm
layer (rl < r < r2). Therefore, enzymes within the nanofilm layer are assumed to be
dormant and thus have no consequence on substrate concentrations within the sensor or
on calculation determining the average active enzyme concentration within the sensor (0
< r < rl).

The average active enzyme concentration,^, was calculated through a

weighting operation similar in form to that used to determine the average oxygen
concentration within the sphere and plotted against time (Figure 83).
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Figure 83. Average active enzyme concentration within the sphere versus
operational time.

From these data, it is shown that over 30 days of continuous operation, 21% of the
initial enzyme population within the sensor is deactivated. The following figure shows
the effect o f spontaneous inactivation on sensor performance.
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Figure 84. Predicted effect of spontaneous inactivation on sensor steady-state
behavior after 30 days of continuous operation.

From these data, it is important to note that as the active enzyme concentration
decreases over time, the steady-state oxygen levels for a given bulk glucose concentration
are increased, as a result of decreased consumption of substrates within the sphere. This
event ultimately leads to decreased device sensitivity, as shown in Figure 84. A perhaps
more pertinent exercise would be to examine the change in overall sensitivity over the
operational period.
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Figure 85. Predicted percent change in device sensitivity over time arising from
spontaneous inactivation.

Before data analysis, it is important to note that the overall sensitivity is defined
as the average slope of the entire response, thereby allowing the overall decrease in
maximum percent change to be accounted for. These data indicate a near-linear decrease
in sensitivity over the operational time period. A useful exercise would be to compare
the predicted change in sensitivity to that which was experimentally determined (Figure
51). It is important to note that the data presented in Figure 51 were obtained by testing
device sensitivity over storage time (i.e., no contact with substrates).

To directly

compare these data, it is important that the calculations used to determine sensitivity are
equivalent. In the previous chapter, sensitivity was defined as the slope of the linear
operation range, whereas in this chapter, the overall sensitivity is defined as the slope of
the entire response. Using the sensitivity (not overall sensitivity) calculation, the loss in
sensitivity over a 21 day period was determined to be 3%. When comparing this value to
the change in sensitivity experimentally observed (44 ± 27%), it is difficult to determine
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if the experimental data and the theoretical predictions agree, given fluctuations in the
experimental data due to sample variations.

Nonetheless, the experimental and

theoretical data indicate that sensor function is not completely compromised by
spontaneous inactivation (over a 30 day operational period), such that periodic
calibrations could potentially be used to account for sensitivity drift.
5.3.3

Effect of Combined
Inactivation on
Sensor Function
O f more practical importance is the combined effect of enzyme inactivation

resulting from hydrogen peroxide poisoning and spontaneous inactivation on the
operational stability o f the sensor.179 In these simulations, input parameters given in
Table 3 were used, and the resulting spatial and temporal substrate profiles used for
analysis. The following surface plot depicts the active enzyme profile at a function of
radial distance and step glucose concentration. It is important to note that this profile was
obtained after only 24 hours of operation.
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Figure 86. Distribution of active GOx as a function of space and bulk glucose
concentration after 24 hours of operation.

Although it is quite obvious, it is important to highlight that enzyme inactivation
due to peroxide poisoning is much more dominant than spontaneous inactivation (Figure
82, t - 30 days). Therefore, the combined inactivation effects on sensor function were
investigated simultaneously.

The first point of note is that the distribution of active

enzyme is a function of time, space, and substrate concentration, as expected. O f more
importance is that for bulk glucose concentrations greater than lOOmg/dL, the vast
majority ( > 85 %) of enzyme molecules within 8 pm of the origin are denatured. This
distribution profile is a result of hydrogen peroxide buildup within the center of the
sphere, hastening the inactivation of enzyme located within that region. Additionally,
while peroxide production is highest near the sphere-nanofilm interface (where substrates
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first contact active enzyme), less inactivation is observed due to peroxide diffusion from
the sensor into the bulk. This behavior was observed in previous work, and may be
experimentally validated using a similar procedure reported by Stein et al.

170 107

’

It is also

important to note that at bulk glucose levels less than 100 mg/dL, this effect is not
observed.

In these cases, the bulk concentration of glucose is such that glucose

consumption occurs outside the sphere origin, resulting in peroxide buildup within the
region o f 6 pm < r < 8 pm and the observed active enzyme “trough.” The active enzyme
concentration at the surface remains the highest due to peroxide diffusion into the bulk,
as does for all bulk glucose levels (except 0 mg/dL).
Given that these sensors rely on enzymatic consumption of glucose and oxygen to
indirectly monitor bulk glucose levels, it is important to know the active enzyme
concentration within the sensor for a given time. The following plot shows the average
active enzyme concentration, E r , within the sensor versus time for a given bulk glucose
concentration.
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Figure 87. Average active enzyme concentration within the sphere with respect to
time and bulk glucose level.

The first point o f note is that enzyme inactivation occurring at 0 mg/dL bulk
glucose is due to spontaneous inactivation. O f more importance, this plot indicates quite
dire results, such that for normoglycemic levels (glucose levels in between 70 and 180
mg/dL) at least 40% o f the initial enzyme concentration is rendered inactive after only 5
days o f operation. It is also important to note that after 5 days o f continuous exposure to
hyperglycemic conditions (> 180 mg/dL), approximately 80% of immobilized enzymes
are rendered inactive. It is indeed quite obvious that this level of inactivation would have
a tremendous effect on the glucose dependent reduction of steady-state oxygen levels
within the sensors, as observed in Figure 88.
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Figure 88. Effect of inactivation of the average steady-state oxygen levels within the
sensor for a given bulk glucose concentration.

Before analysis, it is important to state that the time increments given in Figure 88
represent the total time at which the sensor was exposed to each bulk glucose level. The
first point of note is that following 12 hours of operation, as a result of enzyme
inactivation, the sensors ability to reduce the average local oxygen levels in response to
increasing bulk glucose levels is severely compromised. It is important to highlight that
at bulk glucose concentrations below 100 mg/dL (for all t), that the reduction in 0 2 is
comparable to the initial response. With low bulk glucose levels, the drop in 0 2 is
expected to be low relative to those expected with increasing glucose levels. Therefore,
even though a significant amount of enzyme is inactivated over 5 days of continuous
operation, the remaining enzyme population is capable of supplying the necessary
catalytic requirements, such that a response comparable to that of the initial is obtained
(i.e. the response remains glucose-limited). As more enzyme is deactivated through
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exposure o f higher bulk glucose levels, the rate of change in 0 2 versus bulk glucose
levels begins to decrease, as shown from 100 - 200 mg/dL (t = 0.5). Eventually, the
enzyme inactivation is such that no change in 0 2 is observed for a given range of bulk
glucose (225 - 250 mg/dL, t = 0.5). More seriously, for elevated ranges of glucose ( >
250 mg/dL, t = 0.5), inactivation is so severe that it results in an increase in 0 2 . As the
operational time is increased, this effect is compounded, such that the glucose level at
which increases in 0 2 are observed begins to occur at progressively lower bulk glucose
levels (due to progressive enzyme inactivation), until 0 2 approaches that of the bulk (90
pM).
Using the data presented in Figure 88, the predicted percent change in spectral
peak ratio was determined (Figure 89).
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Figure 89. Predicted effect of inactivation on the percent change in PtOEP/RITC
peak ratio.
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Similar to the data presented in Figure 88, it is important to note that a decrease in
active enzyme concentration results in increased 0 2 levels, ultimately eliciting decreased
percent changes in PtOEP/RITC peak ratios with respect to increasing glucose
concentration and time of operation (Figure 89). Although it is quite obvious that after
12 hours of operation, the overall device sensitivity has been severely reduced, it is
important to quantify the percent change in sensitivity over time.
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Figure 90. Predicted loss of overall device sensitivity resulting from enzyme
inactivation.

Figure 90 indicates that after 12 hours of continuous operation, the sensitivity of
the devices is decreased by 75%. After two days, the loss of sensitivity approaches 90%,
until day 5, when a loss o f 98 % sensitivity arising from enzyme inactivation is observed.
Clearly, these data indicate that the current design would be unacceptable for long-term
use.

It is also important to note that these simulations do not include inflammatory
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responses such as biodegradation and bioremediation, which may cause additional
sensitivity losses. However, it is important to state that the inactivation rate constants
used were derived from experiments in which enzyme-doped membranes were prepared
•

«

•

•

via glutaraldehyde crosshnkmg within a collagen membrane.

1cn

There are some

significant differences between this enzyme-doped membrane and the mesoporous
silicate microstructures used in the current work, most notably the rigid structure of the
algilica particles, which could provide structural support to the enzyme such that the rate
o f spontaneous denaturing (i.e., unfolding) and denaturing due to byproduct poisoning is
reduced.181 In a report on the stabilization of creatine kinease within a sol-gel matrix, it
was found that the enzyme retained 50% activity 10 times longer than that of free
enzyme, attributing the decreased inactivation to the rigid structural support of the
matix.182 Therefore, it is plausible that the inactivation rate constants for algilica may be
lower that than the input parameters used, resulting in a theoretical overestimation of the
inactivation effect. Additionally, it is important to reiterate that the hydrogen peroxide
diffusivities through the nanofilms, as well as algilica, were estimates. Therefore, it is
possible that actual values may differ. Should the actual diffusivities be greater, then
peroxide diffusion from the sensor into the bulk would be more rapid, indicating that the
model would exaggerate inactivation effects. On the other hand, if actual diffusivities are
lower that those used in the simulation, then hydrogen peroxide diffusion from the sensor
into the bulk would be retarded, thus increasing the onset of inactivation and indicating
underestimation o f inactivation effects by the model. Therefore, further experimental
work to extract hydrogen peroxide diffusivities through algilica and polyelectrolyte
nanofilms, as well as investigate enzyme inactivation kinetics within algilica supports,
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could provide more accurate model input parameters, which in turn may increase the
correlation between experimental and theoretical results.
5.3.4

Experimental Validation
In the previously described simulation, influence of enzyme inactivation on

device sensitivity over time was demonstrated, the results of which indicated that after 12
hours of continuous operation, approximately 75% of initial sensitivity was loss. In order
to determine whether or not the simulation output could adequately describe experimental
observations, sensors were exposed to bulk glucose fluctuations for a period of
approximately 4.5 days, while simultaneously collecting real-time ratiometric data. The
data obtained are presented in Figure 91.
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Figure 91. Glucose response under continuous operation.
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It is important to state that there is a progressive increase in noise throughout the
experiment and is a direct result of incremental detachment of the adhesive anchoring the
sensors to the slide surface, such that the collected intensities were decreased but the peak
ratio remained unchanged. Also, the sensors were exposed to the same array of glucose
concentrations for 12 times over the course of this experiment, with each glucose step
totaling 25 minutes in duration.

Given that continuous operation is the total time at

which the sensors were exposed to a particular step concentration, it can be said that over
the course of this experiment, sensors were continuously exposed to step changes in bulk
glucose levels for a total o f 5 hours (25 min/step * 12 steps) per concentration. For
reference, throughout the experiments detained in the previous chapter, sensors were
exposed to random triplicate glucose steps for 7 min, totaling 21 minutes of continuous
operation per glucose concentration.
Using the 12 repose profiles obtained over 4.5 days (Figure 91), the respective
sensitivities were determined.
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Figure 92. Experimentally determined loss of device sensitivity versus time of
continuous operation.

These data indicate that approximately 80% o f device sensitivity is lost over 5
hours of continuous operation.
sensitivity loss.

It is indeed intuitive to question the source of this

Earlier it was shown that enzyme and indicator immobilization was

stable over time (Figure 37 and Figure 38), and from the data presented in Figure 92, it is
apparent that a baseline shift is not responsible. Therefore, it is assumed that enzyme
inactivation mainly contributes to the observed decline in device sensitivity. A
particularly useful exercise would be to compare these experimental data with those
produced by the sensor model.

Using the values given in Table 3, the following

substitutions were made: E r = 720 pM , 02(bulk) = 277 pM, and tf,im = 40 nm; the
percent change in sensitivity was determined and directly compared with experimental
results. It is important to note that ET was experimentally determined using the Lowery
method, as described in Chapter 4.
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Figure 93. Experimental-theoretical comparison of inactivation induced changes in
device sensitivity.

Upon comparison of experimentally and theoretically obtained data, it is quite
obvious that significant disagreement is observed.

Interestingly, the theoretical data

underestimates the inactivation effect, such that after 5 hours of continuous operation,
10% of sensitivity is lost, while the experimental data indicate an 80% loss in sensitivity.
It is hypothesized that this discrepancy arises from the boundary conditions used in the
model, which state that peroxide concentration at the sensor-bulk interface remains at 0
|iM. In experimental conditions, this condition is not expected to hold, despite testing in
a flow chamber where the bulk solution is continuously replaced.

As the sensor

population is exposed to glucose, hydrogen peroxide is produced and diffuses into the
bulk, which may result in an increase in hydrogen peroxide concentration at neighboring
sensor surfaces, thereby reducing the concentration gradient of hydrogen peroxide from
the sensor into the bulk.

This event would ultimately result in elevated hydrogen
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peroxide levels within the sensors, thus yielding increased inactivation of the enzymes
and ultimately causing the sensors to lose sensitivity more rapidly than predicted. This
provides yet another example for the need of a model that accounts for the contributions
o f a sensor population on response properties. Nonetheless, regardless of theoreticalexperimental disagreement, it is important to reemphasize that 80% of device sensitivity
was observed after only 5 hours of continuous operation, a considerable discouragement
for devices which would ideally exhibit sustained sensitivity for at least 6 months. To
accentuate how this loss of sensitivity would impact change in device accuracy over the
continuous operation period, an accuracy profile using the initial response profile as the
calibration standard and the final response profile as the unknown was constructed
(Figure 94).
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Figure 94. Accuracy profile of sensors after 5 hours of continuous operation.

It is somewhat difficult to use these data in a practical example given that a
patient would be expected to be in a hyperglycemia-induced coma with blood glucose
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levels below 30 mg/dL,198 but it is important to note that the loss of sensitivity shown in
Figure 92 would result in a 90% decrease in accuracy, such that the sensor readout would
grossly underestimate true glucose levels. Additionally, it is common to evaluate the
significance o f clinical device inaccuracies using error grid analysis (EGA).54,199 EGA
assigns clinical outcomes arising from device accuracies by defining regions on a plot
similar to Figure 94. Using the data presented in Figure 94, EGA indicates that clinical
action resulting from device inaccuracies could have “significant and/or dangerous
medical consequences.”199 Hence, it is quite obvious that the current sensing scheme
would be overlookedfo r use in long-term diabetic monitoring situations.
Therefore, a significant change in the sensor design is indeed warranted. It is
hypothesized that increasing the immobilized enzyme concentration would increase
response stability over time, albeit at a cost of initial sensitivity. It is expected that a
drastic increase in enzyme concentration ( > lOx’s) would cause an initial decrease in
sensitivity, due to rapid substrate consumption near the sensor-bulk interface, resulting in
a lower 0 2 per bulk glucose level and extended linear range. However, this parameter is
indeed experimentally limited, such that once the sensor matrix is saturated with
enzymes, it is difficult to achieve concentrations above the saturation point while
maintaining stability. Also, the sensor radius could be altered, but it is important to note
that great effort was focused into developing a protocol to produce monodispersed
algilica particles of radii greater than 20 pm, but little success was made. Nevertheless,
increasing the sphere radius would allow a greater magnitude of enzymes to be
entrapped, which should retard the inactivation effect, while increasing initial sensitivity
(increased volume over which 0 2 can be reduced). Additionally, the nanofilm thickness
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could be increased, which would decrease the glucose flux (relative to oxygen) for
entering the catalytic region o f the sensor for a given bulk glucose concentration. This
would undoubtedly decrease the initial sensitivity, but may increase response stability
over time.

Although these modifications may reduce the complications of enzyme

inactivation, the problem source (hydrogen peroxide) is not directly addressed, making
these proposed modifications more of a “patch” to slow down inactivation. Therefore, a
means to eliminate hydrogen peroxide would be ideal in directly combating the effects of
enzyme inactivation.
5.3.5

Incorporation of Catalase
into Enzymatic Smart
Tattoos
The enzyme catalase has been used in previous work to consume hydrogen

peroxide and increase the longevity of glucose oxidase.193 More specifically, catalase
(Cat) consumes hydrogen peroxide and produces water and oxygen as byproducts as
indicated in the following reaction:
h 2o 2 —~
Cat

>\ o 2 + h 2o

When coupled with GOx catalyzed consumption of glucose and oxygen, the overall
reaction scheme may be written as:
glucose + ~ 0 2 — GOxiCat >gluconic acid
Therefore, incorporation o f catalase into the sensing scheme of the devices presented in
this work could reduce the effects of peroxide inactivation by the decreasing the
hydrogen peroxide concentration within the sensor, as well as reducing the onset of
oxygen-limited operation, thereby extending the glucose-limited range.
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To test this hypothesis, catalase and glucose oxidase were simultaneously loaded
into PtOEP-doped algilica particles using a solution of 0.05 M sodium acetate (pH = 4.0)
comprising a 2 : 1 mass concentration ratio of GOx to Cat, such that the total
concentrations of GOx and Cat were 23.3 and 11.65 mg/mL, respectively. The enzymes
were subsequently crosslinked, followed by the adsorption of fluorescent nanofilms (10
PAH/PSS bilayers in total), as detailed in the previous chapter.
In order to determine if the simultaneous loading of both enzymes was possible,
fluorescent variants were prepared (FITC-GOx and RITC-Cat) and imaged using
confocal microscopy (Figure 95).

A

B

Figure 95. Confocal micrographs depicting the distribution of GOx (A) and Cat (B)
within algilica particles after simultaneous loading.

From these images, it is important to note that the distribution index of GOx
remains approximately 0.9 (as was in Figure 36), indicating near homogenous
distribution, while the distribution index of Cat was determined to be approximately 0.7,
indicating preferential adsorption to the sphere surface. Further experimentation would
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be required to determine the optimum loading conditions, as well as immobilization ratio
of both GOx and Cat.
The bienzymatic smart tattoos were exposed to dynamic testing under airequilibrated conditions and the glucose response profile obtained and compared with the
response profile for similar non-catalase containing sensors displayed in Figure 46.
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Figure 96. Comparison of glucose response profiles of sensors compromising
immobilized GOx and co-immobilized GOx and Cat.

From these data, several important points are of note. The first of which is that
sensors comprising co-immobilized GOx and Cat are indeed responsive to changes in
bulk glucose concentration.

Secondly, the maximum percent change in PtOEP/RITC

peak ratio is approximately 500% and 230% for sensors containing immobilized GOx
and those containing GOx and a Cat supplement, respectively. It is also important to note
that the sensors containing co-immobilized enzymes have a more linear response over the
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tested range o f glucose concentrations. Using these data, the sensitivities and analytical
ranges for the respective response profiles can be acquired and displayed in the following
table:

Table 4. Comparison of sensitivity and analytical ranges of sensors loaded with GOx
and both GOx and Catalase.
Enzyme
Components
GOx
GOx + Cat

Sensitivity
(% change/ mg dL'1)
4.16 ±0.57
1.15 ±0.054

Analytical Range
(mg/dL)
120 ± 10
225 ± 20

As expected, the sensors containing co-immobilized GOx and Cat are less
sensitive than those containing solely GOx, such that an approximate 3.5 fold reduction
in sensitivity and 2 fold increase in analytical range is observed. This is a direct result of
oxygen production as a byproduct of peroxide breakdown, which causes elevated levels
of oxygen within the catalytic region o f the sensor, thereby extending the glucose
sensitive range and reducing the percent change in PtOEP/RITC peak ratio. These results
could also be a product of a reduced concentration of immobilized GOx within the
particle, which would result in the reduced consumption of substrates, but may also result
in a reduced range (early onset of reaction-limited catalysis).
The results presented in Figure 96 are indeed intriguing, but the true efficacy of
co-immobilized Cat in the ability to reduce sensitivity drift due to enzyme inactivation
has yet to be demonstrated. To examine whether or not the incorporation of Cat could
reduce the effects of inactivation, an experiment similar to that used to acquire the data in
Figure 91 was performed, the results of which are presented in Figure 97.
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Figure 97. Glucose response under continuous operation conditions of sensors
containing co-immobilized GOx and Cat.

From a visual comparison of the data presented in Figure 97 to those of Figure 91,
it is apparent that the sensors containing catalase exhibit a decreased loss in sensitivity
over time. To quantifiably compare the sensitivity drift over time, the sensitivity of each
respective response profile over time was determined and directly compared with the data
presented in Figure 92.
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Figure 98. Drift in device sensitivity over time due to enzyme inactivation.

From these data, several important findings are observed, the first of which is that
the incorporation of catalase into the sensing scheme does not completely eliminate
sensitivity drift. This observation could be a result of several phenomena, such as the
non-homogeneous distribution of catalase throughout the sensor (Figure 95).

Since

catalase is preferentially immobilized toward the surface, excess peroxide buildup within
the sensor core, which was shown to be most catastrophic (Figure 86), could inactivate
GOx and cause sensitivity drift. Also, it was shown in a previous report that catalase
itself can be inactivated by hydrogen peroxide, which would ultimately result in the
decreased ability to remove peroxide over time, thus leading to enzyme inactivation.179 It
is also highly likely that the ratio of immobilized GOx to catalase is non-optimized, such
that the rate of peroxide produced from glucose oxidation eclipses that of consumption by
catalase, resulting in enzyme inactivation and sensitivity drift.179 Nonetheless, it is
important to state that the incorporation o f catalase into the sensing scheme does indeed
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reduce sensitivity drift over time. Additionally, from the data presented in Figure 98, it is
important to state that after 5 hours of continuous exposure to glucose approximately
40% of initial sensitivity was lost with GOx and Cat containing sensors, while 80% was
lots with sensors containing solely GOx.

This result is quite remarkable, as an

approximate 2 fold-decrease in sensitivity loss is accomplished by simply coimmobilizing catalase. It is also important note that the rate of sensitivity drift is reduced
approximately 3.5 fold as well when co-immobilizing catalase, approximately -47 % /
hour with non-Cat containing sensors and approximately -14 % / hour with sensors
containing co-immobilized enzyme.
Therefore, the refinement of the co-immobilization of catalase and glucose
oxidase, such that both enzymes are homogeneously distributed and the rate of peroxide
consumption is greater than the rate of production, is expected to produce sensors with
increased longevity that will hopefully be suitable for long-term diabetic monitoring
applications.
It is noteworthy to state that an attempt was made to incorporate catalase kinetics
into the model, as such would have allowed an additional theoretical-experimental
comparison. Moreover, such a model could enhance the design of sensors for use in
long-term applications by systematically investigating the effect of physical parameter
variations. More important, a model of this type could aid in the determination of an
optimum catalase concentration, such that long-term stability as well as sensitivity are
optimized, while reducing “trial and error” efforts. The incorporation of catalase into the
model requires the addition o f three partial differential equations, and since the three
individual forms of catalase are susceptible to hydrogen peroxide poisoning, the pseudo
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steady-state assumption cannot be made.

Thus, the obtainment of a solution would

require the simultaneous solution of a series of ten partial differential equations, a feat
which was unobtainable given the accessible computation power and solver robustness.

5.4

Conclusion

A mathematical model describing reaction-diffusion-deactivation kinetics has
been derived for spherical enzymatic smart tattoo systems and presented in this chapter.
In this model, the effect o f enzyme inactivation on sensor response properties over a
defined operational time can be closely examined.

Additionally, the model used

experimentally determined calibration data to transform predicted substrate levels into
predicted changes in PtOEP/RITC peak ratio, such that a direct comparison with
experimental data could be performed.

Model output predicted 98% loss of initial

sensitivity over 5 days of continuous operation.

Upon direct comparison with

experimentally determined data, it was found that model output underestimated the effect
o f deactivation. Experimental data showed that after 5 hours of continuous operation,
approximately 80% o f initial sensitivity was loss, approximately 8-fold more than that
predicted from the simulations. Given that these devices would ultimately be used for
long-term continuous monitoring scenarios, the current design was deemed unacceptable.
Additional sensors were prepared containing co-immobilized glucose oxidase and
catalase, in an attempt to reduce enzyme exposure to hydrogen peroxide and
subsequently reduce the effects of enzyme inactivation. Results were indeed promising,
at sensors containing catalase showed a marked decrease, approximately 2-fold, in
sensitivity loss over time.

Although these results are indeed encouraging, additional

work is needed to optimize the bi-enzyme immobilization, namely enzyme distribution
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and respective enzyme concentrations needed to minimize component interaction with
hydrogen peroxide; these results should yield sensors with increased longevity, hopefully
more suited for long-term applications. Additionally, significant disagreement between
simulation and experimental data were observed, the majority of which was attributed the
model only considering a single sensor. Therefore, a more complete understanding on
how individual sensors function within a sensor population is desired to aid in the
development o f more accurate models.

Thus, in the following chapter, an imaging

technique with the ability to monitor individual sensor function within a population is
presented.
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CHAPTER 6

REAL-TIME IMAGING OF
SENSOR FUNCTION

6.1 Introduction
In chapter 4, the preparation and characterization of enzymatic smart tattoo
concepts under dynamic conditions was demonstrated. The response properties of these
sensors have been most notably shown to depend on bulk glucose levels, bulk oxygen
levels, nanofilm coating thickness, and sensor concentration, the results of which
indicated the importance of understanding how the response of individual sensors within
a given population affects the overall response properties. Additionally, in chapter 5 a
reaction-diffusion model was introduced that allowed response properties over time to be
predicted. Simulation results grossly underestimated those experimentally obtained. It
was hypothesized that the inconsideration of population dynamics (the model only
simulates a single sensor) dominantly contributed to the observed experimentaltheoretical disagreement. Therefore, is it critical to understand the effect of sensor group
dynamics (i.e. how do individual sensors function within a population) on overall
response properties, as such knowledge would be valuable in the a priori design of
enzymatic smart tattoos implants. However, little information on sensor group dynamics

223
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can be obtained using the device detailed in Figure 33, as this device optically
interrogates a fixed volume o f sensors and collects the subsequent emission, resulting in
an averaged response over the illuminated volume. Thus, in order to investigate the
dynamics of a sensor population, a device allowing selective analysis of individual
sensors within a group is needed. Thereby, this chapter will focus on the development of
such a device.
The most important requirement of this device is the ability to examine the
behaviors o f individual sensors within a population, thus a direct interface with
fluorescence imaging instrumentation is required. Additionally, the device should allow
dynamic testing of sensor properties, requiring the incorporation of a flow cell. With
these basic requirements, an optically transparent microfluidic flow cell was envisioned.
Interestingly, previous reports have shown that microfluidic devices can be designed such
that two input streams remain partitioned throughout the length o f the channel, assuming
laminar flow properties, o f course.200 In these devices, the location of the fluidic partition
(i.e. the junction between the inlet streams throughout the length of channel) can be
moved by simply varying the flow-rate of one inlet relative to the other. By integrating
this function into the proposed device, a selected region of an immobilized sensor
population could be exposed to buffer while a separate region is exposed to glucose.
Variations in inlet flow rate would allow the glucose-exposed region to be dynamically
varied, while capturing the response properties of a group of sensors or individual sensors
within a region of interest. Thus, this device will advance the understanding of how the
response o f individual sensors within a population contribute to overall response
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properties, ultimately providing insight on designing clinically viable implantation
schemes.

6.2
6.2.1

Experimental Details

Materials
Nano™ SU-8 50 and 100 and SU-8 Developer were purchased from MicroChem

Corporation and used in conjunction with 4” silicon wafers obtained from Silicon Quest,
Inc. during the photolithography process. Soft lithography was performed using PDMS
(Sylgard® 184 Silicon Elastomer Base) and accompanying initiator (Sylgard® 184
Curing Agent), both o f which were obtained from Dow Coming Corporation.
Fluorescein isothiocyanate conjugated to dextran (FITC-dextran, Sigma), P-D-glucose
(MP Biomedicals, Inc.), and phosphate buffered saline (PBS, Sigma) were used during
device testing. Additionally, hydrochloric acid (HC1, Sigma), isopropyl alcohol (IPA,
VWR), and acetone (VWR) were used as needed throughout the experimental
procedures.
6.2.2

MicroChannel Fabrication
The microchannel master mold was fabricated using conventional contact
•

photolithography techniques.

901

The channel mask was designed with AutoCAD 2006

(Autodesk) and subsequently printed onto a transparency film with an emulsion printer
(Linotronic, Linotype-Hell). The channel design is shown in Figure 99 with approximate
dimensions.
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Figure 99. Mask layout used during channel preparation.

Because earlier results presented in chapter 4 were obtained with sensors
immobilized on double-sided pressure-sensitive polyacrylate adhesive (3M), a channel
with high aspect ratio features was desired to accommodate the adhesive/sensors.
Therefore, a photoresist capable of producing feature heights > 200 pm was chosen, as a
channel o f this height would accommodate the thickness of the adhesive layer (~ 80 pm)
and the average thickness o f the sensor layer that was shown to contain approximately 3
layers o f packed sensors (~ 50 pm, Figure 58), while still allowing fluid flow over the
sample. For this reason, Nano™ SU-8 100, an epoxy-based, ultra-thick, negative tone
photoresist, capable o f producing structures with thicknesses > 200 pm, was chosen.
First, a silicon wafer was cleaned by rinsing in acetone and IPA, then dried by
baking for 10 min at 250°C on a hot plate (PC-420D, Coming). After cooling to room
temperature, SU-8 100 was slowly dispensed onto the center of the wafer and excess
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bubbles were removed via desiccation (Bel-Art).

A spin-coater (G3P-8, Specialty

Coating Systems) set to 500 rpm, with a 10 rpm/second ramp, was used to spread the
photoresist within 2 mm of the wafer edge. The wafer was subsequently desiccated to
remove any remaining bubbles.

Following the second desiccation, the wafer was

reintroduced into the spin-coater, and spun at 500 rpm (100 rpm/second ramp) for 10
seconds to evenly spread the resist over the entire wafer surface. Finally, the speed was
increased to 1000 rpm at 300 rpm/second for 30 seconds to attain an approximate
thickness of 250 pm.
Soft baking, a process used to evaporate the solvent and densify the film, was
performed in a two-step operation which has been shown to promote photoresist adhesion
to the silicon substrate.202 Prior to soft baking, the wafer was placed on a hot plate at
35°C for 15 minutes to minimize the edge-bead and promote film uniformity. The plate
temperature was then increased (1°C / minute) until reaching 65°C, at which point baking
ensued for 30 minutes. Following the initial baking step, the temperature was ramped
(1°C / minute) to 95°C and the SU-8 100 coated wafer baked for an additional 90
minutes. After subsequent cooling to 50°C, the wafer was removed from the hot plate
and cooled to room temperature. The mask depicted in Figure 99 was placed in direct
contact with the coated wafer and exposed to UV illumination for 15 minutes via a mask
aligner (EV420, Electronic Visions, Inc.).
A post-exposure bake was performed to crosslink the exposed photoresist region.
Again a ramped, two-step baking process was used to minimize stress, wafer bowing, and
resist cracking.202 Using the same temperature ramp used in the soft bake procedure, the
temperature was increased to 65°C for 1 minute, then 95°C for 20 minutes. Following
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the post-exposure bake, the temperature was lowered in 5°C increments until room
temperature was reached.

This time-consuming process was instated to reduce the

likelihood o f catastrophic adhesion failure when developing the photoresist.

The

photoresist was developed in SU-8 Developer for 20 minutes, during which strong
agitation was required to remove weakly-crosslinked SU-8 100 around the feature edges.
After development, the wafer was thoroughly rinsed with IPA and dried under streaming
nitrogen, thus marking the end of the master mold fabrication. Additionally, the feature
thickness was quantified using a micrometer (ID-S1012E, Mitutoyo), with 15 random
measurements over the feature surface.
Once the master mold was created, the channel design could be transferred to
PDMS using conventional soft lithography techniques.201’ 202

Liquid PDMS was

thoroughly mixed with its initiator in a 5:1 volumetric ratio. After that, the PDMS was
desiccated to remove any bubbles, poured onto the wafer containing the positive relief
channel pattern, and baked for 8 hours at 65°C in a convection oven (SW-11TA, Blue M
Electric Company). Following removal of the wafer from the oven, care had to be taken
to avoid rapid cooling, as this would likely result in catastrophic adhesion failure due to
the difference in contraction rates of the wafer and the photoresist. After the wafer
cooled to room temperature, the positive relief pattern was slowly removed from the
wafer.
6.2.3

Preparation of Inlet Ports
Next, inlet and outlet ports were fabricated using a coring technique adapted from
•

•

previous work as described in the following protocol.

90T

A 16-gauge needle [VWR, 1.65

mm outer diameter, 1.19 mm inner diameter, Figure 100A] was modified by removing
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the tip, as shown below in Figure 100B. The flat tip was subsequently beveled (Figure
100C) using a 5 pm roughness lapping film (LFG5P, ThorLabs).

A

B

C

Figure 100. Fabrication of the coring tool. A.)Unmodified 16-gauge needle. B.)
Needle following tip removal. C.) Beveled needle to be used as the coring tool.
(Artwork courtesy Dustin Ritter.)
A 5-speed drill press (Homier Distributing Co.) containing the coring tool was
used to prepare the fluidic ports.

When inserted into PDMS, the coring tool would

produce a port approximately 1.19 mm in diameter (Figure 101A - C), allowing the
insertion o f a flat-tipped 16-gauge needle into the structure with minimal tearing.
Additionally, the difference between the inlet port and the needle diameter, ~ 460 pm,
would result in the formation of a compression seal between the needle and the inlet port
(Figure 101D), thereby minimizing leakage at the substrate-interconnect interface.
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A

B

□

PDMS

Figure 101. Coring procedure. A.) Insertion into the PDMS structure. B.) Coring
tool advancement and collection of the core within the lumen. C.) Core extraction.
D) Compression seal formation between port and inserted needle. (Artwork
courtesy Dustin Ritter.)

It is important to state that to minimize tearing of the PDMS structure, the drill
press was used at its lowest speed (760 rpm) and the coring tool was lowered steadily into
the PDMS. It was also found that freezing the PDMS for 10 minutes prior to coring
stiffened the PDMS and reduced the chance of tearing.
6.2.4

Flow Cell Assembly
Following preparation of the inlet and outlet ports, the PDMS substrate as well as

a 4” glass wafer were stringently cleaned using the following procedures. The glass
wafer was rinsed with acetone and IPA, dried with nitrogen and baked at 250°C for 10
minutes on a hot plate to ensure a dry surface. Subsequently, the PDMS substrate was
soaked in 1 M HC1 for 10 minutes, rinsed with DI water, and dried under streaming
nitrogen. It should be noted that these two surfaces would ultimately be mated through
oxygen plasma bonding, which requires a clean surface to produce high bonding strength.
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After the glass substrate was cleaned, a 3 mm square o f double-sided pressuresensitive polyacrylate adhesive was cut and placed on the glass wafer. To ensure proper
placement o f the PDMS channel following oxygen plasma activation, the channel was
positioned over the adhesive surface prior to oxygen plasma exposure and alignment
marks were made on the bottom of the glass wafer. The PDMS substrate was removed
n

and a droplet of sensors ranging from 2 to 5 pL (stock concentration ~ 10 particles/mL)
was placed on the adhesive surface and dried under streaming nitrogen.
The surfaces o f the PDMS substrate and glass wafer were activated using oxygen
plasma (MicroRIE Series 800, Technics).

During oxygen plasma exposure, a thin,

highly-disordered oxide film is formed on and reacts with both the PDMS and the glass
surfaces.

Upon joining o f the activated surfaces, covalent bonds are formed as the

bonding interface dries, resulting in a stable junction of the two substrates.204 Prior to
surface activation, a microscope cover slip was cut to size with a diamond scribe
(ThorLabs) and placed over the sensors during exposure, as an effort to reduce sensor
exposure to the oxygen plasma.

The glass wafer was subsequently exposed for 15

seconds at 70 W with the oxygen partial pressure at 75 mtorr. Similarly, the PDMS
substrate was exposed at the same radio frequency (RF) power and oxygen partial
pressure for 10 seconds.205 Immediately, the two activated surfaces were joined, and
allowed to sit for at least 2 hours. It should be noted that to promote uniform binding
between the two substrates, an evenly-distributed weight (~ 1 kg) was applied.
6.2.5

Experimental Setup
Before sensor testing, experiments were performed to verify that the channel

design would produce laminar flow characteristics. First, a 1 mm-wide by 50 pm-deep
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channel o f a similar profile as that depicted in Figure 99 was fabricated and tested for
laminar flow as a proof o f concept. The smaller dimensions were chosen in an effort to
keep the Reynolds number below 2000, as is required to achieve laminar flow conditions.
Furthermore, different channel designs could be fabricated much quicker and easier when
the photolithography process was performed with a target thickness of 50 pm.

The

microchannel fabrication method was identical to that given for the 400 pm-deep
channel, except that SU-8 50 was used instead of SU-8 100. Consequently the spin
speeds and baking, exposure, and development times during the photolithography process
were different.202 After testing the small-scale channel, the laminar flow characteristics
o f the 4 mm-wide by 400 pm-deep channel (Figure 99) were examined. Additionally,
experiments were performed to investigate the effect of varying inlet volumetric flow
rates on the fluidic partition location.
For preliminary experiments where the laminar flow characteristics were
quantified, two syringe pumps (KDS100 and KDS210, KD Scientific) equipped with 3
mL syringes containing FITC-dextran (1 mg/mL) and 0.01 M PBS were used.

The

interconnects consisted o f three flat-tipped 16-gauge needles (VWR) inserted into the
channel inlet ports. Syringes were connected to the interconnects by 1/8” outer diameter
PEEK® tubing (Upchurch Scientific) equipped with standard Luer-Lock® fittings
(VMR).

Imaging was performed with a Nikon Eclipse TE2000-U epifluorescence

microscope equipped with a long-pass FITC cube (Optical Insights, excitation filter: 455
± 35 nm, dichroic mirror: 500 nm, emission filter: > 515 nm). Images were captured
with a CoolSNAP ES CCD camera (Photometries), and analysis was performed using
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MetaMorph® Imaging software. An image depicting the completed experimental setup is
given in Figure 102.

Figure 102. linage of experimental setup, depicting placement of the microfluidic
flow cell on the microscope stage.

For sensor response imaging, a long-pass rhodamine cube (530 ± 15 nm
excitation) in conjunction with a Dual-View® dual-emission filter (Optical Insights,
equipped with 580 ± 12.5 and 640 ± 12.5 nm filters) was used to produce two
simultaneous images projected onto equal portions of the CCD detector.

Thus, the

simultaneous acquisition of RITC and PtOEP images could be obtained. Additionally, a
macro was written to collect a real-time ratiometric series, by dividing the respective
PtOEP and RITC images. Macro practicality was tested by placing 4 pL droplet of
sensors on a microscope slide, then introducing 2 pL of 600 mg/dL p-D-glucose, while
collecting image frames every 3 seconds for a total of 2 minutes.
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After the ability to collect real-time ratiometric images was demonstrated, the
microfluidic device was subsequently tested using inlet solutions of 600 mg/dL glucose
and 0.01 M PBS, respectively.

6.3
6.3.1

Results and Discussion

MicroChannel Fabrication
An important concept in this device is the ability to examine the dynamic

response o f individual sensor behavior in a group setting, through exposure of varying
flow rates.

It is expected that eventual experiments using high flow rates will be

performed, such that the flow cell would be exposed to high fluidic pressures; therefore, a
reliable means o f interconnecting fluidic inlets to the flow cell is needed.

The

interconnection method used in the work presented herein used a modified needle as a
coring tool to remove a cylindrical core of the PDMS substrate in diameter to that of the
inner lumen. A digital image of the coring tool fabricated for this work is given in the
following figure.
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Figure 103. Images of coring tool profile. Top (left) and side (right) view.

From Figure 103, it is important to point out the beveled tip, which allows the
formation of a compression seal between the flow cell and the fluidic inlets. Although no
quantitative data was independently verified, from previous work it has been shown that
the interconnection method produced devices which could withstand pressures up to 550
kPa, whereupon the failure occurred between the PDMS-glass bond.203 It should be
noted that throughout all testing described herein, leaking due to interconnection or
bonding

failure

was

not

observed;

thereby,

indicating

the

efficacy

of the

interconnection/substrate-binding method to this application.
Following port fabrication, sensors were immobilized on the glass substrate and
the surfaces of the two substrates joined using oxygen plasma bonding. The following
image depicts the completed microfluidic device, including ports and immobilized
sensors.
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Figure 104. Competed microfluidic device.

It is important to note that prior to binding the substrates, the channel height was
determined to be 408.6 ± 21.5 pm, which was approximately 1.5 fold greater than that
which was expected. It is theorized that the room temperature during the lithography
processes was below the temperature used by the photoresist manufacturer to characterize
feature height, thus increasing viscosity and causing greater feature sizes than expected.
Additionally, an image of the sensors immobilized within the channel is given in
the following figure.
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Figure 105. Image of immobilized sensors within the microchannel.

The image in Figure 105 was acquired by using UV illumination (Black Ray) and
collecting subsequent emission via a digital camera. From this image, it is apparent that
the adhesive is excited by UV illumination as well as the sensors.

This image

demonstrates the ability to immobilize sensors within the microfluidic device, thus
completing device fabrication.
6.3.2

Laminar Flow Properties
An interesting design consideration of the microfluidic device presented in this

work is to use inlet flow rate variation to controllably perturb a localized region of
sensors with glucose. In order for this consideration to be obtained, the device must
exhibit laminar flow properties. To characterize the flow properties of this device, a
microchannel void of adhesive and sensors was prepared as described earlier. Using inlet
solutions of PBS and PBS containing FITC-dextran, respectively, identical flow rates
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(3mL/hr) were used and the fluorescent profile through the channel length was examined
(Figure 106).

PBS

PBS + FITC-dextran

500 \.im
Figure 106. Channel flow profile using PBS and PBS containing FITC-dextran.
Note inlet flow rates were both set to 3 mL/hr.

From this image, it is important to note that when inlet flow rates are equal, the
partition is located at the center of the channel, as expected. In theory, by varying the
relative inlet flow rates, the partition location could be shifted. To test this, the flow rate
of the FITC-containing inlet
solely containing buffer
(Q r~ Q

f it c / Q

( Q f it c )

(Q b u jje r ),

was varied relative to the flow rate of the channel

such that the relative inlet flow rate ratio was defined as

buffer)-
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Figure 107. Fluorescence micrographs depicting shift in partition location by
varying relative inlet flow rates. Note that Qr —1 = 3mL hr'1 / 3mL hr'1
magnification = 40X.

Figure 107 demonstrates the ability to control the partition location by simply
altering the relative inlet flow rates. It should be noted that these data were acquired in a
time sequence, indicating that the partition can be returned to its initial position, which in
Figure 107 is center-channel.
6.3.3

Real-time Ratiometric Imaging
The most critical requirement in the device described in this chapter is the ability

to analyze individual sensor response within a sensor population in order to understand
how individual response properties contribute to the overall response. To accomplish this
feat, fluorescence imaging techniques were employed. Given that the sensor response is
ratiometric in nature, a method was needed to allow real-time ratiometric imaging, as
such would allow the temporal ratiometric response of individual sensors within the field
of view to be analyzed. However, in order to prepare an accurate ratiometric image, it is
necessary to simultaneously obtain images containing PtOEP and RITC emission,
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respectively.

Therefore, a DualView® emission filter was used optically process the

image prior to collection. With this device, the simultaneous acquisition of two emission
images with a sole detector is possible through the projection of the images on the top
and bottom half of the detector, respectively.

A typical fluorescence micrograph

containing separate PtOEP and RITC images of a sensor population is given in the
following figure.

PtOEP

RITC

50 urn

Figure 108. Typical fluorescence micrograph depicting PtOEP (top) and RITC
(bottom) emission images acquired for an immobilized sensor population.
Note total magnification = 100X.

It should be noted that PtOEP emission intensity is low relative to that of the
RITC image. This observation is expected, as this image was collected under ambient
conditions (air-equilibrated buffer). Additionally, the image presented in Figure 108 is as
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exactly collected; therefore, in order to produce a ratiometric image, the respective
images needed to be separated prior to division. Example ratiometric images will be
given later in this section.
To acquire real-time ratiometric data, a macro was written to capture a series of
time-lapse images implementing user-defined inputs (i.e. time of duration and frequency
of acquisition). Following the time-lapse acquisition, the PtOEP and RITC images are
separated and divided, resulting in a series of real-time ratiometric images.

It is

important to state that PtOEP images were not corrected for RITC contributions and
should be addressed in future macro versions. To test the macro, a suspension of sensors
was placed on a standard microscope slide, at which time the macro was executed. A
droplet of glucose was added to the sensor suspension during image acquisition (total
glucose concentration = 200 mg/mL), after which the setup remained undisturbed until
acquisition was completed (120 second total acquisition time). The resulting temporal
profile of ratiometric images was subsequently analyzed.
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Figure 109. Ratiometric images of sensor prior to glucose exposure (top) and after
exposure to a 200mg/mL initial concentration for 90 sec. Arrow highlights
the same sensor before and after glucose exposure. Note total
magnification = 100X.

From the image data presented in Figure 109, it is evident that an increase in
ratiometric intensity is observed within individual sensors following exposure to 200
mg/dL initial bulk conditions. Thus, the ability to collect ratiometric images depicting
the response properties of individual sensors over time has been demonstrated. In order
to obtain dynamic data, the ratiometric time-lapse was subjected to region of interest
(ROI) analysis.

This method involves defining a common spatial ROI of circular

geometry in the acquired images and analyzing the fluorescence emission intensity
normalized to the total number of pixels within the ROI with respect to time. These data
result in a graphical representation of the average temporal fluorescence intensity within
the ROI. Four ROIs were used for analyzing the change in ratiometric intensity with
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respect to time, three of which were within sensors and the fourth of which was that of
the entire image (i.e. average response of imaged population).

Figure 110. ROIs used to analyze change in ratiometric intensity within individual
sensors during exposure to glucose. Note that ROI 4 contains the entire image.
(Arrow used as reference).

Using the ROIs depicted in Figure 110, the time-dependent percent change in
ratiometric intensity within each ROI was determined and is presented in the following
plot.
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Figure 111. Percent change in ratiometric intensity of three individual sensors
(ROIs 1 - 3 ) and all sensors within the viewing field (ROI 4).

It should be reiterated that this experiment was not conducted with sensors
immobilized within the microfluidic device; in fact, the sensors were mobile throughout
the experiment. Therefore, the sensors selected for analysis were those which exhibited
less relative mobility throughout the course of the experiment. From these data, it is
important to recognize that response time is approximately 30 seconds less than previous
observations in the dynamic testing apparatus, which was shown in Chapter 4 to be
approximately 80 seconds. In previous experiments where immobilized sensors were
used for analysis, it was shown that the immobilized sensor layer was comprised of
approximately three sensor layers, thus additional time may be required for underlying
sensors to “see” bulk substrate levels and respond. Therefore, the total response time of
the population would be a function of the time required for all sensors to equilibrate,
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whereas in a suspension, sensors may be exposed to bulk conditions more rapidly, thus
increasing response time.
Another point o f interest is that total percent change observed in ROI 1-3 varies
significantly. This observation could be explained by individual sensors being exposed
to different bulk conditions, or more likely, varying physical parameters, such as
immobilized enzyme concentration or particle diameter.

Furthermore, previous

simulations indicate that an increase in sensor radius from 10 to 20 pm, would result in a
6 % decrease in local oxygen concentration (larger sensor radii would increase the
volume over which the oxygen concentration is at its lowest steady-state value) at
glucose concentration o f approximately 200 mg/dL.41 Using the data presented in Figure
47, a 6 % reduction in steady-state oxygen levels observed at 200 mg/dL glucose would
not significantly change steady-state peak ratio values, implicating that the stead-state
intensity variation presented in Figure 111, may not be solely due to size variations. It is
also important to consider that variations in sensor enzyme concentrations may also
contribute to the discrepancies observed in the stead-state intensities. Although it is
difficult to speculate whether or not the sensors analyzed containing significantly
different enzyme concentrations, it is a useful exercise to consider the affect of variations
in enzyme concentration on sensor function. Should immobilized enzyme concentrations
fail to significantly reduce steady-state oxygen levels within the sensor or be such that
catalysis occurs mainly at the outer region of the sensor, an insensitive response would be
inevitable. Previous work has shown a distinct optimum enzyme concentration produces
a highly sensitive response, and deviations on the order of pM concentrations could
significantly affect response characteristics,

an observation compounded when
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considering variations in sensor radius as well.41

Thus, it is plausible that the

discrepancies observed in Figure 111 arise from variations in the physical properties of
the sensor analyzed, supporting the notion that not all sensors within a population
respond will equally to glucose levels, as expected.
Additionally, it is important to note that ROI 4, which contains the entire
ratiometric image and presents an average response of all of the sensors within Figure
110, shows the lowest percent change in ratiometric intensity. Most likely, this low
percent change is a result of high background noise from out-of-plane fluorescence,
which significantly dampens the individual sensor contribution to overall signal.
Nonetheless, these data support that individual sensors within a population display
significant difference in response characteristics, which may be attributed to location
and/or physical properties. To obtain a more concise understanding, a similar analysis of
immobilized sensors exposed to dynamic conditions is needed.
6.3.4

Sensor Response Testing
in MicroChannel
The results presented in the previous section were of non-immobilized sensors

operating under static conditions - a stark contrast to the experimental conditions used in
chapters 4 and 5 to analyze sensor performance. Therefore, sensors were immobilized
within the microfluidic device and exposed to a step change in glucose (200 mg/dL,
lOmL/hr) during time-lapse imaging, a similar process to that used in previous chapters.
A ratiometric series was subsequently obtained and the average ratiometric intensity
within 3 random sensors was determined.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

247

0.3

200 mg/dL glucose step

0.25
= >

<
w
c
CD
c

0.2
0.15
ROM
ROI 2
ROI 3

0.05

0

50

100

150

200

Time (sec)
Figure 112. Change in ratiometric intensity within three random senor specimens
immobilized within the microfluidic channel in response to a 200 mg/dL
glucose step.

From these data, it is important to note that no significant change in ratiometric
intensity was observed following sensor exposure to 200 mg/dL glucose. The experiment
was repeated and the response of sensors at various locations within the immobilized
population was performed with similar results. It was then hypothesized that the flow
rates used may have dampened the response, possibly due to forced convection. Despite
flow rate variations over the instrumentation range, no response was observed.

An

additional set of sensors was prepared and response properties were first validated using
the dynamic testing apparatus, yet no response was obtained when tested in the
microfluidic device. It is speculated that despite covering the immobilized sensors with a
glass coverslip during oxygen plasma activation, that sensor exposure was not completely
inhibited, the results of which could contribute to the lack of a discemable response.
Therefore, an investigation of the effect of oxygen plasma on sensor behavior is indeed
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warranted, the results o f which may indicate alternative methods to bond the PDMS and
glass substrates are needed.

6.4

Conclusion

The preparation of a microfluidic device for use in image analysis of smart tattoo
function under dynamic testing conditions was described. The device was designed such
that two inlet fluids would flow laminarly throughout the length of the channel. By
varying the relative volumetric flow rate of the inlet fluids, buffer and glucose,
respectively, the location at which the fluids converged within the channel can be
precisely controlled, allowing a distinct region of sensors within an immobilized
population to be exposed to glucose.

The ability to acquire a real-time series of

ratiometric images depicting the response characteristics of individual sensors within a
population was demonstrated. Results indicated that individual sensors have significantly
different response characteristics that ultimately contribute to overall response properties.
More importantly, future work will investigate the effect of sample preparation
procedures, namely oxygen plasma, with hopes of obtaining response data of sensors
immobilized within the reported microfluidic devices.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER 7

CONCLUSIONS AND FUTURE WORK

7.1

Conclusions

Smart tattoo type sensors are being investigated as a means to alleviate pain and
discomfort associated with traditional finger-prick measurements. In this dissertation,
enzymatic smart tattoos have been developed and characterized for potential use in
minimally-invasive diabetic monitoring systems.

While enzymatic smart tattoos

comprising hydrogel supports and ruthenium-based oxygen indicators have been
previously demonstrated, the efficacy of these prototypes was limited by low glucose
sensitivity (~ 0.2 % change / mg dL'1).

Thus, this work was initially focused on

increasing glucose sensitivity, which was addressed by selecting metalloporphyrin
oxygen indicators and hybrid silicate (algilica) supports as platforms upon which to build
highly sensitive devices.
Metalloporphyrin complexes exhibit higher excitation wavelengths, which reduce
the effects o f tissue scatter and absorption, increased photostability, and higher oxygen
sensitivity than ruthenium-based indicators, and in conjunction with algilica matrices,
which readily allow co-immobilization of hydrophilic (GOx) and hydrophobic (PtOEP)
molecules, glucose sensitivities two orders of magnitude greater than previous enzymatic
smart tattoos were achieved.

These results indicate the importance of selecting an

249
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oxygen indicator that is sensitive over the operational range of the sensor, as well as
selecting a support matrix conducive to oxygen transport. Despite high sensitivities (~ 5
% change / mg dL'1), these prototypes failed to be sensitive over the accepted monitoring
range o f 50 - 350 mg/dL, limiting diabetic monitoring applications.

Therefore, an

additional component of this work centered on developing a means to extend the sensing
range by controlling substrate delivery into the sensor.
One of the more significant findings to emerge from this work is the ability to
control device sensitivity and range through controlling substrate flux into the sensor via
the application of surface adsorbed polyelectrolyte nanofilms. This simple, yet efficient
technique (12 nm thick films were shown to significantly affect response properties)
allowed the upper sensing range to be tuned over 90 - 250 mg/dL, indicating that
polyelectrolyte nanofilms provide an effective means to control substrate flux.

This

finding suggests that applications requiring mass transport control of molecular species,
including filtration technologies, may benefit from the use o f polyelectrolyte nanofilms.
Furthermore, it is important to highlight limitations of these results; particularly, the
upper range limit achieved is still below that of the accepted monitoring range. While the
range may be extended by simply increasing the nanofilms thickness, films comprised of
alternative constituents may increase upper range limits while minimizing film
thicknesses.
An additional study was performed to determine the long-term stability of sensor
function under continuous operating conditions.

The most obvious finding of this

investigation was theoretical and experimental data indicated poor device longevity (90
% loss o f sensitivity after 24 hours), suggesting that current prototypes are unfit for long
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term applications.

Towards the goal of developing suitable long-term devices, first

generation bi-enzyme smart tattoos containing co-immobilized catalase were developed
to reduce enzyme inactivation from hydrogen peroxide.

This design modification

increased long-term stability by two-fold, suggesting that the incorporation of catalase
enhances the operational life span of enzymatic smart tattoos and should be aggressively
pursued in the next generation of prototypes. While this finding is indeed encouraging,
additional work, which will be addressed later in this chapter, is required to optimize co
immobilization techniques.

Nonetheless, results are promising, because with future

developments these sensors could reduce the pain and bother associated with traditional
diabetic monitoring techniques, which may increase patience compliance with suggested
monitoring frequencies and aid in reducing the onset of complications.
Although this work represents a significant advancement in enzymatic smart
tattoo technology, it is important to emphasize that the materials/techniques applied in
this dissertation are broadly applicable to other areas o f science and engineering. For
example, the algilica support matrix used exclusively in this dissertation is comprised of
hydrophilic polymer moieties, as well as silica domains, making this material attractive
for the uniform entrapment of both hydrophobic and hydrophilic molecules.

Thus,

applications requiring molecular immobilization, bioencapsulation for example, may
benefit from a similar approach. Additionally, the simple means of fabricating algilica
supports lays the ground work for the future development of additional novel hybrid solgel materials whose future applications may be further widespread. Another and perhaps
more important application which may benefit from the general approach detailed in this
work is the area of biosensors. Using a similar approach, it may be possible to develop
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additional enzymatic biosensors sensitive to lactate and glutamate, for example, through
immobilization o f their respective oxidation enzymes (lactate oxidase and glutamate
oxidase, respectively).

Such devices may prove useful in studying other aspects of

physiology such as localized metabolic trends.
7.1.1

Novel Contributions to
Engineering and Science
The novel contribution of the author to the field of engineering and science

include:
1. Co-development o f the novel immobilization matrix used in this dissertation algilica.
2. Development o f indicator and enzyme immobilization strategies for algilica;
extensive characterization under dynamic testing conditions.
3. Demonstration o f the ability to engineer device sensitivity and analytical range by
varying nanofilm thickness.
4. Obtainment o f transdermal spectra from implanted enzymatic smart tattoos (presented
in the following section).
5. Development o f a mathematical model to simulate the effect of continuous operation
on sensor lifetime.
6. Preparation o f bi-enzymatic smart tattoos more suitable for long-term applications.
7. Development o f an imaging technique allowing real-time ratiometric monitoring of
sensor dynamics.
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7.2

Preliminary Acquisition of
Transdermal Spectra

Skin is a complex tissue comprised of many non-homogeneously distributed
components that absorb and scatter light in a complex fashion, which in turn attenuates
the propagating light.

These properties can in turn complicate the controlled delivery

of excitation light to the sensor implants, as well as hinder the efficient collection of
emission light. Independent o f how well the sensors perform in bench top situations, the
concept would be rendered useless should transdermal readouts be unobtainable.
Therefore, the ability to excite and collect transdermal emission data is o f utmost
importance to the ultimate success o f this work.
Sensor migration (i.e. sensor movement from the initial site of implantation) over
time would result in decreased emission intensities as well as alterations in response
properties (it was shown earlier in Chapter 4 that sensor concentration effects response
dynamics). In an attempt to counteract this effect, the sensors were suspended in 20 wt%
Pluronic F127. This unique material is classified as a low critical solution temperature
(LCST) gel, such that it exists in sol (liquid) state below the transition temperature and in
gel (solid) state at temperatures above. Previous work has shown that the transition
temperature can be controlled by simply adjusting the concentration of Pluronic F127.206
Exploiting this property, it was hypothesized that this material could be used as a delivery
vessel for enzymatic smart tattoos, such that prior to implantation, the sensor suspension
would exist in the sol state and transition to gel state would take place once implanted
into the dermis. In theory, this in vivo transition would decrease sensor migration from
the initial point o f injection over time. It is important to note that immediately following
injection, the implant did indeed solidify, as indicated by the presence o f a bolus under
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the skin surface. Following the 4-day recuperation period, the bolus remained clearly
visible, indicating that the use of this material as a delivery vessel for smart tattoos is
viable.

Although this result was promising, it is out of the scope of this work to

characterize the spatial and temporal distribution of the sensors after implantation, as well
as the effect of Pluronic F I27 on sensor function.
In vivo protocols were reviewed and approved by the Institutional Animal Care
and Use Committee (LACUC) before initiation of in vivo experiments. Sensors were
prepared using the previously described method. Implantation samples were prepared by
suspending the sensors in a 20 wt% of Pluronic F127 (Aldrich) dissolved in 0.01 M PBS
(pH = 7.4) to a final concentration of ~ 108 sensors/mL and stored at 4 °C until needed.
Prior to implantation, approximately 100 pL of sensor suspension was loaded into 25 lA
gauge insulin syringes (Becton, Dickinson and Company) and sterilized under UV
illumination (Black Ray) for approximately 10 minutes. As a control, a 20 wt% of
Pluronic F127 dissolved in 0.01 M PBS (pH = 7.4) was also prepared and sterilized using
the same procedure.
Sprague-Dawley rats (-300 g) were selected as the animal model for this
preliminary work.

A peritoneal injection o f Nembutal® (50 mg/mL, Abbott) was

administered at 1 pL/g o f body weight to induce anesthesia, after which the dorsal region
was shaved and sterilized with isopropyl alcohol (VWR).

Prior to the implantation

procedure, the animal was placed on a temperature regulating pad. Next, the respective
samples were injected into the dermis of the dorsal region. Following the implantation
procedure, the animal was allowed 4 days to recuperate, after which the animal was
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inspected for localized irritation (redness, loss of hair, and scabbing), none of which was
found.
Although no discomfort is associated with the acquisition o f transdermal spectra,
the animal was anesthetized using the same protocol described above, to eliminate
excessive stress associated with handling. Transdermal spectra were acquired using a 6around-1 optical fiber to deliver excitation light from a Hg-Xe arc lamp (Model 68811,
Oriel) containing a 530 ± 5 nm interference filter (ThorLabs) to the injection site. Sensor
emission was subsequently delivered to a diode array spectrometer (USB 2000,
OceanOptics) through the collection bundle as depicted in Figure 113. Additionally,
index matching gel (Thor labs) was used as a medium between the optical fiber and skin.

Arc lamp

optical fiber

Spectrometer
Computer

Figure 113. Schematic of instrumentation setup used to acquire in vivo transdermal
spectra.

Following the recuperation period, transdermal spectra (10 per site) o f the
implantation sites containing the smart tattoos and the control were acquired (Figure
114).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

256

200

Control
Sensor Implants

175
150
3< 125

£(0

100

Ic

75

550

600

650

700

Wavelength (nm)

Figure 114. In vivo transdermal sensor and control spectrum obtained in a rat
model.

The first point of note is that when compared to the control, the emission
spectrum acquired for the site containing the smart tattoos are clearly similar to those
obtained in vitro (Figure 39, RITC emission maximum at 580 nm and PtOEP emission
maximum at 645 nm), indicating that it is achievable to collect transdermal spectra using
the sensor concepts detailed in this work. To our knowledge, the ability to successfully
interrogate and collect emission data from an implanted glucose sensor population has
been published only once, further implicating the promise of the reported concepts.207 It
is important to state that the sole objective of this set of experiments was to determine if
the acquisition of transdermal spectra was possible with the current sensor design (which
it is); therefore, no attempt was made to obtain in vivo calibration data and assess in vivo
function, and will be addressed in the following section.
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7.3
7.3.1

Future Work

Algilica-Based Ratiometric
Oxygen Sensors
In Chapter 3, self-referenced oxygen sensors based on PtOEP immobilization

within algilica microspheres were presented. The results presented were obtained under
steady-state conditions.

Results depicting dynamic operation would be useful in

determining response time, which would be instrumental in the future applications of
such devices, as well as indicating if polyelectrolyte nanofilms affect oxygen diffusivity
within the sensors.
7.3.2

Algilica-Based Ratiometric
Glucose Sensors
In Chapter 4, enzymatic smart tattoos were fabricated using algilica particles,

porphyrin indicators, and fluorescent nanofilms. Given the limited long-term stability of
prototypes based only on glucose oxidase, of primary importance is the optimization of
catalase incorporation into the sensing scheme.

Initially, this would involve the

development of immobilization strategies that allow the homogeneous distribution of
both glucose oxidase and catalase into the sensor. Additionally, a significant amount of
effort should be invested in determining the appropriate ratio of immobilized enzymes
needed to decrease the affects of hydrogen peroxide while maximizing sensor
performance, as unnecessarily high concentrations of catalase may minimize the
concentration of immobilized glucose oxidase causing decreased sensitivity, while
markedly low concentrations would result in decreased sensor longevity. Following the
determination of these factors, the characterization of the bulk oxygen effect,
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concentration effect, and most important, the effect of nanofilm thickness should be
performed and compared with the results presented in Chapter 4.
Additional work should focus on testing sensor performance under increasingly
physiological conditions, including testing under physiological temperature conditions, as
well as testing under daily blood-glucose profiles of non-diabetics and diabetics (both
compliants and non-compliants of the recommended testing frequencies).
In vivo experiments on multiple animals investigating host response on sensor
function is also o f considerable importance (preliminary results will be presented in the
following section).

Standard blood-draw measurements in conjunction with glucose

infusions should be used to calibrate the implanted devices.

After which, device

accuracy is tracked over time, and the reduction of device sensitivity corroborated with
histological finding (i.e. biodegradation and bioremediation). It would also be interesting
to integrate the effect o f bioremediation into Monte Carlo models, which simulate photon
transport through skin tissue, to investigate the collection efficiency of transdermal
spectra over time. Furthermore, given the implantation results reported in this work were
obtained with hand injections, it is important to develop repeatable implantation
strategies so that measurements across multiple implantation sites could be easily
compared.
O f additional importance is the implementation of oxygen-sensing functionality
with a population o f smart tattoos. This functionality would allow the simultaneous
measurement o f the bulk oxygen levels within a sensor population and could be used to
account for non-glucose specific shifts in bulk oxygen levels, such as altitude changes,
illnesses, physical exertion, ect.
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It would also be advantageous for future work to focus on the development of a
dynamic test bed which more accurately simulates in vivo conditions, such as flow rates
similar to those found in the dermis (mL/hr) as well as replicating the spatial distributions
expected to be seen in in vivo implants. This would ultimately involve the development
of skin phantom, through which glucose can readily flow at a similar rate observed in
vivo (mL/hr). This in itself would be quite a feat to develop, but would provide the
ability to collect response data under increasingly physiological conditions.
Additionally, o f equal importance is the characterization of substrate diffusivities
through the algilica. The author is aware that currently efforts are underway to develop a
testing apparatus that allows substrate transport properties through various media to be
determined, and awaits with great anticipation the results. Furthermore, this test bed
could be used to test the effect of nanofilm coating on oxygen diffusion through algilica,
the results o f which could allow the proposition of additional theories as to why device
sensitivity increases with the addition of the initial five nanofilm bilayers, as well as the
development o f more accurate models, as discussed in the following section.
7.3.3

Sensor Modeling
In Chapter 5, a model that simulated the continuous operation o f sensors while

considering the effects o f enzyme inactivation was presented. Simulation results as well
as experimentally obtained results in the implementation of a design change to produce
sensors more suitable for long-term applications.

This was accomplished through

catalase incorporation into the sensing scheme; however, incorporation of catalase
kinetics into the model was not successful, due to required addition of three partial
differential equations. Further complications arise from the three individual forms of
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catalase also being susceptible to hydrogen peroxide poisoning; thus, the pseudo steadystate assumption can not be made. Therefore, the obtainment of a solution would require
the simultaneous solution of a series of ten partial differential equations.

Various

differential equation solves were used, and to no avail, a closed-loop solution was not
obtained, due in part to the lack of computing power available at the time of the work.
Nonetheless, future work should focus on integration of catalase kinetics into the model,
as such a model could aid in the determining the optimal concentration of immobilized
catalase needed to maximize long-term stability and device sensitivity.
O f more importance is the derivation of a model that considers the sensor function
o f an entire population. It is recommended that substrate diffusivities through algilica
supports be determined (as described above) and used as model inputs, which should
increase theoretical-experimental agreement. A particularly interesting paper detailing the
derivation o f a sorption kinetic model used to describe a population of polydispersed
particles may be o f particular use in expanding “group functionality” to the current
model.196 The results o f which could be used to prepare a model that more accurately
predicts experimental observations as well as be incorporated in to optimization
algorithms which could elucidate optimum physical characteristics needed to develop
sensors suited for long-term application.
7.3.4

Ratiometric Imaging of
Sensor Performance
In Chapter 6, a microfluidic device was developed to allow imaging of individual

sensor function under dynamic conditions. Unfortunately, little progress was made in
acquiring data from the microfluidic device. It was hypothesized that oxygen plasma
exposure to the sensor could have caused the loss of sensor function. This hypothesis
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could be tested by exposing sensors to varying level of oxygen plasma characterizing the
results under dynamic conditions. Results may require the development of additional
immobilization schemes.
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